index,sex,IBD_type,med_class,antibody_level,seroconversion,age_group,DX_days,vaccine_status,serology_date,vac_date,days_from_vac,vac_type,age_at_collection,decade
1,female,CD,Anti-TNF Only,24272,positive,adult,164,primary,16-Jun-21,15-Mar-21,93,vector,51,50 to 59
2,female,CD,Anti-TNF Only,49273,positive,adult,,booster2,27-Nov-21,20-Aug-21,99,vector,51,50 to 59
3,female,CD,Anti-TNF Only,784,positive,pediatric,105,booster2,12-Mar-22,17-Oct-21,146,vector,1,00 to 09
4,female,UC,Combination Therapy,1431,positive,pediatric,,primary,28-May-21,24-Dec-20,155,mRNA,11,10 to 17
5,female,UC,Combination Therapy,486,positive,pediatric,,booster1,09-Jul-21,26-Feb-21,133,mRNA,17,10 to 17
6,female,UC,Combination Therapy,165,negative,pediatric,,booster2,11-Nov-21,14-Jun-21,150,mRNA,1,00 to 09
7,female,UC,Combination Therapy,819,positive,adult,,booster2,30-Jan-22,01-Aug-21,182,mRNA,42,40 to 49
8,female,UC,Combination Therapy,1110,positive,adult,,booster2,03-Jun-22,29-Jan-22,125,mRNA,42,40 to 49
9,male,UC,Ustekinumab Only,1442,positive,adult,,primary,15-May-21,29-Dec-20,137,mRNA,37,30 to 39
10,male,UC,Ustekinumab Only,852,positive,adult,233,booster1,20-Jul-21,05-Feb-21,165,mRNA,37,30 to 39
11,male,UC,Ustekinumab Only,862,positive,adult,146,booster1,15-Oct-21,30-Mar-21,199,mRNA,37,30 to 39
12,male,UC,Ustekinumab Only,1034,positive,adult,120,booster2,10-Nov-21,12-May-21,182,mRNA,37,30 to 39
13,male,UC,Ustekinumab Only,909,positive,adult,27,booster2,11-Feb-22,23-Oct-21,111,mRNA,38,30 to 39
14,female,CD,No Immunosuppressives,382,positive,elderly,341,booster1,04-Jun-21,15-Dec-20,171,mRNA,82,70+
15,female,CD,No Immunosuppressives,27227,positive,elderly,194,booster1,29-Oct-21,22-Jul-21,99,mRNA,82,70+
16,female,CD,No Immunosuppressives,40041,positive,elderly,138,booster2,24-Dec-21,25-Sep-21,90,mRNA,83,70+
17,female,CD,Corticosteroids,1023,positive,elderly,61,booster2,11-Mar-22,18-Sep-21,174,mRNA,83,70+
18,female,CD,Corticosteroids,548,positive,elderly,30,booster2,10-Jun-22,19-Dec-21,173,mRNA,83,70+
19,female,CD,Corticosteroids,333,positive,adult,164,primary,03-Jun-21,25-Dec-20,160,vector,55,50 to 59
20,female,CD,Corticosteroids,464,positive,adult,320,booster1,12-Aug-21,22-Mar-21,143,vector,55,50 to 59
21,female,CD,No Immunosuppressives,12898,positive,adult,216,booster1,24-Nov-21,23-Aug-21,93,vector,56,50 to 59
22,female,CD,No Immunosuppressives,26958,positive,adult,140,booster2,08-Feb-22,10-Nov-21,90,vector,56,50 to 59
23,female,CD,No Immunosuppressives,7140,positive,adult,68,booster2,21-Apr-22,23-Jan-22,88,vector,56,50 to 59
24,male,UC,No Immunosuppressives,328,positive,elderly,205,primary,15-May-21,31-Oct-20,196,mRNA,63,60 to 69
25,male,UC,No Immunosuppressives,30132,positive,elderly,268,booster1,17-Jul-21,29-Apr-21,79,mRNA,63,60 to 69
26,male,UC,No Immunosuppressives,223,positive,elderly,457,booster2,22-Jan-22,24-Aug-21,151,mRNA,63,60 to 69
27,male,UC,No Immunosuppressives,16912,positive,elderly,586,booster2,31-May-22,27-Mar-22,65,mRNA,64,60 to 69
28,female,CD,Ustekinumab Only,50995,positive,adult,,primary,12-Jun-21,16-Apr-21,57,mRNA,17,10 to 17
29,female,UC,Anti-TNF Only,1410,positive,adult,,primary,21-May-21,06-Nov-20,196,mRNA,49,40 to 49
30,female,UC,No Immunosuppressives,1070,positive,adult,,booster1,20-Jul-21,07-Feb-21,163,mRNA,49,40 to 49
31,female,UC,Anti-TNF Only,55817,positive,adult,,booster1,16-Oct-21,20-Jul-21,88,mRNA,50,50 to 59
32,female,UC,Anti-TNF Only,482,positive,adult,,booster2,20-Nov-21,15-May-21,189,mRNA,50,50 to 59
33,male,UC,Combination Therapy,3949,positive,adult,,primary,10-Jun-21,08-Mar-21,94,mRNA,42,40 to 49
34,male,UC,Combination Therapy,1050,positive,adult,,booster1,26-Aug-21,22-Feb-21,185,mRNA,42,40 to 49
35,male,UC,Combination Therapy,44631,positive,adult,,booster1,18-Nov-21,07-Sep-21,72,mRNA,42,40 to 49
36,male,UC,Corticosteroids,1012,positive,adult,,booster2,30-Dec-21,27-Aug-21,125,mRNA,42,40 to 49
37,male,UC,Combination Therapy,206,positive,pediatric,,booster2,28-Apr-22,01-Nov-21,178,mRNA,10,10 to 17
38,male,CD,Anti-TNF Only,47432,positive,pediatric,,booster1,09-May-21,11-Mar-21,59,mRNA,10,10 to 17
39,female,CD,No Immunosuppressives,78156,positive,pediatric,105,primary,25-May-21,17-Mar-21,69,vector,11,10 to 17
40,female,CD,No Immunosuppressives,344,positive,pediatric,187,booster1,17-Jul-21,18-Feb-21,149,vector,17,10 to 17
41,female,CD,No Immunosuppressives,16,negative,adult,96,booster2,16-Oct-21,30-May-21,139,vector,59,50 to 59
42,female,CD,No Immunosuppressives,641,positive,adult,9,booster2,29-Jan-22,21-Aug-21,161,vector,59,50 to 59
43,female,CD,Combination Therapy,568,positive,adult,90,booster1,15-Jun-21,18-Jan-21,148,mRNA,59,50 to 59
44,female,CD,Combination Therapy,64485,positive,pediatric,5,booster1,08-Sep-21,05-Jul-21,65,mRNA,1,00 to 09
45,female,CD,Combination Therapy,813,positive,pediatric,38,booster2,21-Oct-21,24-May-21,150,mRNA,2,00 to 09
46,female,CD,Combination Therapy,40403,positive,pediatric,169,booster2,01-Mar-22,24-Nov-21,97,mRNA,12,10 to 17
47,female,CD,Combination Therapy,33,negative,pediatric,291,booster2,01-Jul-22,14-Feb-22,137,mRNA,12,10 to 17
48,male,UC,No Immunosuppressives,62037,positive,adult,,primary,20-May-21,13-Feb-21,96,mRNA,36,30 to 39
49,male,UC,No Immunosuppressives,1481,positive,adult,,booster1,29-Jun-21,25-Jan-21,155,mRNA,36,30 to 39
50,male,UC,No Immunosuppressives,1267,positive,adult,,booster1,02-Nov-21,23-Apr-21,193,mRNA,36,30 to 39
51,male,UC,No Immunosuppressives,246,positive,adult,,booster2,18-Feb-22,07-Aug-21,195,mRNA,36,30 to 39
52,male,UC,No Immunosuppressives,514,positive,adult,,booster2,11-May-22,20-Nov-21,172,mRNA,37,30 to 39
53,male,UC,Anti-TNF Only,61046,positive,elderly,,primary,14-May-21,21-Mar-21,54,mRNA,70,70+
54,male,UC,Anti-TNF Only,,,elderly,,booster1,03-Aug-21,29-May-21,66,mRNA,70,70+
55,male,UC,Anti-TNF Only,47642,positive,elderly,,booster2,08-Dec-21,18-Sep-21,81,mRNA,71,70+
56,male,UC,Anti-TNF Only,45462,positive,elderly,,booster2,16-Apr-22,25-Feb-22,50,mRNA,71,70+
57,male,UC,Anti-TNF Only,869,positive,elderly,,booster2,31-May-22,24-Dec-21,158,mRNA,71,70+
58,female,UC,No Immunosuppressives,610,positive,adult,,primary,26-May-21,31-Dec-20,146,vector,59,50 to 59
59,female,UC,No Immunosuppressives,56921,positive,adult,,booster1,24-Jun-21,19-Apr-21,66,vector,59,50 to 59
60,female,UC,No Immunosuppressives,1377,positive,adult,,booster1,07-Oct-21,28-May-21,132,vector,60,60 to 69
61,female,UC,No Immunosuppressives,726,positive,adult,,booster2,17-Feb-22,06-Sep-21,164,vector,60,60 to 69
62,female,UC,No Immunosuppressives,115,negative,adult,,booster2,04-May-22,15-Nov-21,170,vector,60,60 to 69
63,female,UC,No Immunosuppressives,1195,positive,adult,,primary,05-Jun-21,29-Dec-20,158,mRNA,33,30 to 39
64,female,UC,No Immunosuppressives,378,positive,adult,,booster1,14-Aug-21,06-Mar-21,161,mRNA,33,30 to 39
65,female,UC,No Immunosuppressives,71439,positive,adult,262,primary,01-Jun-21,07-Mar-21,86,mRNA,36,30 to 39
66,female,UC,No Immunosuppressives,73534,positive,adult,218,booster1,15-Jul-21,15-Apr-21,91,mRNA,37,30 to 39
67,female,UC,No Immunosuppressives,58191,positive,adult,77,booster1,03-Dec-21,02-Oct-21,62,mRNA,37,30 to 39
68,female,UC,No Immunosuppressives,64343,positive,adult,23,booster2,26-Jan-22,07-Nov-21,80,mRNA,37,30 to 39
69,female,UC,No Immunosuppressives,1175,positive,adult,,booster2,14-May-22,04-Jan-22,130,mRNA,37,30 to 39
70,male,UC,Vedolizumab Only,69474,positive,adult,401,primary,03-Jun-21,21-Mar-21,74,mRNA,28,18 to 29
71,male,UC,Vedolizumab Only,59312,positive,adult,350,booster1,24-Jul-21,17-Apr-21,98,mRNA,28,18 to 29
72,male,UC,Vedolizumab Only,801,positive,adult,210,booster1,11-Dec-21,13-Jun-21,181,mRNA,28,18 to 29
73,male,UC,Vedolizumab Only,14459,positive,adult,39,booster2,31-May-22,11-Mar-22,81,mRNA,29,18 to 29
74,female,CD,Ustekinumab Only,1478,positive,adult,,primary,14-Jun-21,23-Feb-21,111,mRNA,46,40 to 49
75,female,CD,Ustekinumab Only,298,positive,adult,,booster1,23-Jul-21,06-Jan-21,198,mRNA,46,40 to 49
76,female,CD,Ustekinumab Only,70404,positive,adult,,booster1,18-Jan-22,21-Nov-21,58,mRNA,47,40 to 49
77,female,CD,Ustekinumab Only,723,positive,adult,,booster2,19-Feb-22,16-Aug-21,187,mRNA,47,40 to 49
78,female,CD,Ustekinumab Only,251,positive,adult,,booster2,06-Jun-22,25-Nov-21,193,mRNA,47,40 to 49
79,male,CD,Combination Therapy,47459,positive,adult,,primary,21-May-21,19-Feb-21,91,mRNA,28,18 to 29
80,male,CD,Combination Therapy,,,adult,,booster1,05-Aug-21,05-Jun-21,61,mRNA,28,18 to 29
81,male,CD,Combination Therapy,53469,positive,adult,,booster2,29-Oct-21,04-Aug-21,86,mRNA,28,18 to 29
82,male,CD,Combination Therapy,838,positive,adult,,booster2,10-Mar-22,18-Oct-21,143,mRNA,28,18 to 29
83,female,CD,Combination Therapy,2,negative,adult,,primary,26-May-21,14-Dec-20,163,mRNA,52,50 to 59
84,female,CD,Combination Therapy,781,positive,adult,,booster1,24-Jul-21,30-Jan-21,175,mRNA,52,50 to 59
85,female,CD,Combination Therapy,1012,positive,adult,,booster1,18-Oct-21,07-May-21,164,mRNA,52,50 to 59
86,female,CD,Combination Therapy,12716,positive,adult,,booster2,21-Jan-22,20-Nov-21,62,mRNA,53,50 to 59
87,female,CD,Combination Therapy,23782,positive,adult,,booster2,12-May-22,13-Mar-22,60,mRNA,53,50 to 59
88,male,CD,Corticosteroids,48343,positive,elderly,,primary,15-Jun-21,01-Apr-21,75,vector,70,70+
89,male,CD,Corticosteroids,1134,positive,elderly,,booster1,09-Sep-21,22-Feb-21,199,vector,70,70+
90,male,CD,Corticosteroids,1385,positive,elderly,,booster2,17-Dec-21,26-Aug-21,113,vector,71,70+
91,male,CD,Corticosteroids,20996,positive,elderly,,booster2,17-Mar-22,28-Dec-21,79,vector,71,70+
92,male,CD,Corticosteroids,1072,positive,elderly,,booster2,21-Jun-22,18-Dec-21,185,vector,71,70+
93,female,CD,Anti-TNF Only,1167,positive,elderly,112,primary,12-May-21,08-Dec-20,155,mRNA,67,60 to 69
94,female,CD,Anti-TNF Only,893,positive,elderly,26,booster1,06-Aug-21,05-Feb-21,182,mRNA,67,60 to 69
95,female,CD,Anti-TNF Only,54356,positive,elderly,48,booster1,19-Oct-21,08-Aug-21,72,mRNA,67,60 to 69
96,female,CD,Anti-TNF Only,9125,positive,elderly,162,booster2,10-Feb-22,11-Dec-21,61,mRNA,68,60 to 69
97,female,CD,Anti-TNF Only,1371,positive,elderly,245,booster2,04-May-22,20-Oct-21,196,mRNA,68,60 to 69
98,female,UC,Anti-TNF Only,36743,positive,adult,275,primary,25-May-21,13-Mar-21,73,mRNA,28,18 to 29
99,male,UC,No Immunosuppressives,221,positive,elderly,,booster1,01-Jun-21,19-Nov-20,194,mRNA,72,70+
100,male,UC,No Immunosuppressives,1385,positive,elderly,233,booster1,24-Sep-21,01-May-21,146,mRNA,72,70+
101,male,UC,No Immunosuppressives,62327,positive,elderly,146,booster2,23-Mar-22,22-Dec-21,91,mRNA,73,70+
102,male,UC,No Immunosuppressives,394,positive,elderly,120,booster2,20-May-22,03-Feb-22,106,mRNA,73,70+
103,female,CD,No Immunosuppressives,896,positive,elderly,27,primary,02-Jun-21,01-Jan-21,152,mRNA,68,60 to 69
104,female,CD,No Immunosuppressives,50524,positive,elderly,341,booster1,17-Jul-21,12-May-21,66,mRNA,68,60 to 69
105,female,CD,No Immunosuppressives,1042,positive,elderly,194,booster1,02-Dec-21,28-Jul-21,127,mRNA,68,60 to 69
106,female,CD,No Immunosuppressives,11,negative,elderly,138,booster2,02-Feb-22,16-Oct-21,109,mRNA,69,60 to 69
107,female,CD,No Immunosuppressives,686,positive,elderly,61,booster2,19-May-22,06-Nov-21,194,mRNA,69,60 to 69
108,female,CD,No Immunosuppressives,372,positive,elderly,30,booster2,07-Jul-22,22-Mar-22,107,mRNA,69,60 to 69
109,female,UC,Anti-TNF Only,,,adult,233,primary,27-May-21,13-Mar-21,75,mRNA,33,30 to 39
110,female,UC,Anti-TNF Only,326,positive,adult,209,booster1,22-Jul-21,25-Feb-21,147,mRNA,34,30 to 39
111,female,UC,Anti-TNF Only,437,positive,adult,125,booster2,14-Oct-21,11-Jun-21,125,mRNA,34,30 to 39
112,female,UC,Anti-TNF Only,36,negative,adult,13,booster2,03-Feb-22,22-Aug-21,165,mRNA,34,30 to 39
113,female,CD,Anti-TNF Only,55,negative,adult,,booster1,20-Jul-21,18-Mar-21,124,vector,24,18 to 29
114,female,CD,Anti-TNF Only,1261,positive,adult,,booster2,12-Nov-21,14-Jul-21,121,vector,24,18 to 29
115,female,CD,Anti-TNF Only,373,positive,adult,,booster2,05-Mar-22,05-Sep-21,181,vector,25,18 to 29
116,female,CD,Anti-TNF Only,38900,positive,adult,,booster2,29-Apr-22,05-Mar-22,55,vector,25,18 to 29
117,female,CD,Ustekinumab Only,375,positive,pediatric,,primary,05-Jun-21,17-Feb-21,108,mRNA,12,10 to 17
118,female,CD,Ustekinumab Only,1465,positive,pediatric,,primary,29-Jul-21,31-Mar-21,120,mRNA,7,00 to 09
119,female,CD,Ustekinumab Only,1255,positive,pediatric,146,primary,29-Jul-21,19-Feb-21,160,mRNA,12,10 to 17
120,female,CD,Ustekinumab Only,2351,positive,pediatric,,booster1,28-Aug-21,21-May-21,99,mRNA,4,00 to 09
121,male,CD,Anti-TNF Only,4755,positive,adult,,primary,22-May-21,24-Mar-21,59,mRNA,31,30 to 39
122,male,CD,Anti-TNF Only,1283,positive,adult,,booster1,11-Sep-21,08-Apr-21,156,mRNA,32,30 to 39
123,male,CD,Anti-TNF Only,324,positive,adult,,booster2,06-Nov-21,13-Jun-21,146,mRNA,32,30 to 39
124,male,CD,Corticosteroids,976,positive,adult,,primary,19-May-21,13-Nov-20,187,mRNA,52,50 to 59
125,male,CD,Corticosteroids,627,positive,adult,,booster1,24-Aug-21,11-May-21,105,mRNA,52,50 to 59
126,male,CD,Corticosteroids,1084,positive,adult,,booster2,29-Oct-21,17-Apr-21,195,mRNA,52,50 to 59
127,male,CD,Corticosteroids,76881,positive,adult,,booster2,02-Mar-22,11-Dec-21,81,mRNA,53,50 to 59
128,male,CD,No Immunosuppressives,63991,positive,adult,,primary,09-Jun-21,14-Apr-21,56,vector,50,50 to 59
129,male,CD,No Immunosuppressives,20359,positive,adult,120,booster1,31-Jul-21,23-Apr-21,99,vector,50,50 to 59
130,male,CD,No Immunosuppressives,73520,positive,adult,,booster2,12-Feb-22,18-Nov-21,86,vector,50,50 to 59
131,male,CD,No Immunosuppressives,279,positive,adult,,booster2,28-Jun-22,07-Jan-22,172,vector,51,50 to 59
132,female,CD,No Immunosuppressives,120,negative,adult,,primary,21-May-21,04-Feb-21,106,vector,62,60 to 69
133,female,CD,No Immunosuppressives,39401,positive,elderly,,booster1,10-Aug-21,07-Jun-21,64,vector,62,60 to 69
134,female,CD,No Immunosuppressives,625,positive,elderly,,booster1,25-Nov-21,17-May-21,192,vector,62,60 to 69
135,male,UC,Ustekinumab Only,1277,positive,adult,390,primary,09-May-21,23-Dec-20,137,mRNA,39,30 to 39
136,male,UC,Ustekinumab Only,41754,positive,adult,300,booster1,07-Aug-21,05-Jun-21,63,mRNA,39,30 to 39
137,male,UC,Ustekinumab Only,225,positive,adult,185,booster2,30-Nov-21,26-May-21,188,mRNA,39,30 to 39
138,male,UC,Ustekinumab Only,1471,positive,adult,73,booster2,22-Mar-22,23-Sep-21,180,mRNA,39,30 to 39
139,female,CD,Vedolizumab Only,593,positive,elderly,27,primary,14-May-21,15-Jan-21,119,mRNA,72,70+
140,female,CD,Vedolizumab Only,849,positive,elderly,,booster1,27-Nov-21,12-Aug-21,107,mRNA,72,70+
141,female,CD,Vedolizumab Only,525,positive,elderly,,booster2,18-Feb-22,09-Oct-21,132,mRNA,73,70+
142,female,UC,Combination Therapy,77903,positive,adult,237,primary,22-May-21,16-Feb-21,95,mRNA,35,30 to 39
143,female,UC,Combination Therapy,340,positive,adult,162,booster1,05-Aug-21,28-Jan-21,189,mRNA,35,30 to 39
144,female,UC,Combination Therapy,66409,positive,adult,50,booster2,25-Nov-21,17-Sep-21,69,mRNA,35,30 to 39
145,female,UC,Combination Therapy,624,positive,adult,56,booster2,11-Mar-22,14-Oct-21,148,mRNA,36,30 to 39
146,female,UC,Combination Therapy,786,positive,elderly,,primary,23-Jun-21,16-Dec-20,189,mRNA,71,70+
147,female,UC,Combination Therapy,,,elderly,,booster1,10-Aug-21,21-Apr-21,111,mRNA,71,70+
148,female,UC,Combination Therapy,578,positive,elderly,,booster1,23-Dec-21,01-Sep-21,113,mRNA,71,70+
149,female,UC,Combination Therapy,1042,positive,elderly,341,booster2,22-Jun-22,22-Feb-22,120,mRNA,72,70+
150,female,UC,Anti-TNF Only,472,positive,adult,225,primary,01-Jul-21,15-Feb-21,136,mRNA,54,50 to 59
151,female,UC,Anti-TNF Only,1414,positive,adult,169,booster1,26-Aug-21,16-Feb-21,191,mRNA,54,50 to 59
152,female,UC,Anti-TNF Only,869,positive,adult,8,booster1,03-Feb-22,28-Sep-21,128,mRNA,55,50 to 59
153,male,CD,Anti-TNF Only,755,positive,adult,345,primary,14-May-21,08-Dec-20,157,mRNA,48,40 to 49
154,male,CD,Anti-TNF Only,999,positive,adult,302,booster1,26-Jun-21,16-Dec-20,192,mRNA,48,40 to 49
155,male,CD,Anti-TNF Only,1161,positive,adult,187,booster2,19-Oct-21,15-Apr-21,187,mRNA,48,40 to 49
156,male,CD,Anti-TNF Only,92,negative,adult,36,booster2,19-Mar-22,17-Nov-21,122,mRNA,49,40 to 49
157,female,CD,Vedolizumab Only,467,positive,adult,,primary,26-May-21,06-Feb-21,109,mRNA,46,40 to 49
158,female,CD,Vedolizumab Only,977,positive,adult,,booster2,17-May-22,29-Jan-22,108,mRNA,47,40 to 49
159,male,UC,No Immunosuppressives,,,adult,194,primary,13-May-21,03-Jan-21,130,vector,61,60 to 69
160,male,UC,No Immunosuppressives,941,positive,adult,,booster1,25-Aug-21,12-Apr-21,135,vector,61,60 to 69
161,male,UC,No Immunosuppressives,64828,positive,adult,,booster2,05-Mar-22,13-Jan-22,51,vector,62,60 to 69
162,female,CD,Anti-TNF Only,165,negative,elderly,,booster1,25-May-21,05-Jan-21,140,mRNA,64,60 to 69
163,female,CD,Anti-TNF Only,59748,positive,elderly,,booster1,16-Sep-21,16-Jun-21,92,mRNA,65,60 to 69
164,female,CD,Anti-TNF Only,512,positive,elderly,,booster2,02-Feb-22,29-Aug-21,157,mRNA,65,60 to 69
165,female,CD,Anti-TNF Only,69744,positive,elderly,,booster2,31-Mar-22,09-Jan-22,81,mRNA,65,60 to 69
166,female,CD,Anti-TNF Only,6867,positive,elderly,,booster2,18-May-22,04-Mar-22,75,mRNA,65,60 to 69
167,male,UC,Corticosteroids,1176,positive,elderly,23,primary,25-May-21,28-Dec-20,148,mRNA,64,60 to 69
168,male,UC,Corticosteroids,22343,positive,elderly,108,booster1,18-Aug-21,22-Jun-21,57,mRNA,65,60 to 69
169,male,UC,Corticosteroids,66965,positive,elderly,138,booster2,31-Dec-21,15-Oct-21,77,mRNA,65,60 to 69
170,male,UC,Corticosteroids,62123,positive,elderly,355,booster2,22-Apr-22,24-Jan-22,88,mRNA,65,60 to 69
171,female,UC,Anti-TNF Only,449,positive,elderly,232,primary,21-May-21,29-Nov-20,173,mRNA,70,70+
172,female,UC,Anti-TNF Only,330,positive,elderly,137,booster1,24-Aug-21,02-Apr-21,144,mRNA,70,70+
173,female,UC,Anti-TNF Only,16,negative,elderly,64,booster2,05-Nov-21,23-Apr-21,196,mRNA,70,70+
174,female,UC,Anti-TNF Only,493,positive,elderly,25,booster2,02-Feb-22,06-Oct-21,119,mRNA,70,70+
175,female,UC,Anti-TNF Only,773,positive,elderly,117,booster2,05-May-22,09-Nov-21,177,mRNA,71,70+
176,female,CD,Immunomodulator Only,51639,positive,adult,,primary,14-May-21,09-Mar-21,66,mRNA,51,50 to 59
177,female,CD,Immunomodulator Only,15,negative,adult,,booster1,07-Jul-21,20-Dec-20,199,mRNA,52,50 to 59
178,female,CD,Immunomodulator Only,326,positive,adult,,booster2,13-Nov-21,04-Jun-21,162,mRNA,52,50 to 59
179,female,CD,Immunomodulator Only,68071,positive,adult,61,booster2,12-Feb-22,21-Dec-21,53,mRNA,52,50 to 59
180,female,CD,Immunomodulator Only,1286,positive,adult,,booster2,13-May-22,23-Jan-22,110,mRNA,52,50 to 59
181,male,CD,Anti-TNF Only,931,positive,adult,,booster1,22-Jul-21,21-Feb-21,151,mRNA,53,50 to 59
182,female,CD,Vedolizumab Only,384,positive,adult,,primary,16-Jun-21,01-Jan-21,166,mRNA,57,50 to 59
183,female,CD,Vedolizumab Only,25966,positive,adult,,booster2,26-Mar-22,10-Jan-22,75,mRNA,57,50 to 59
184,male,CD,No Immunosuppressives,281,positive,elderly,,primary,08-May-21,12-Nov-20,177,mRNA,66,60 to 69
185,male,CD,No Immunosuppressives,50100,positive,elderly,,booster1,27-Jul-21,24-Apr-21,94,mRNA,66,60 to 69
186,male,CD,No Immunosuppressives,344,positive,elderly,,booster1,20-Nov-21,21-Jun-21,152,mRNA,67,60 to 69
187,male,CD,No Immunosuppressives,1445,positive,elderly,,booster2,19-Jan-22,15-Sep-21,126,mRNA,67,60 to 69
188,male,CD,No Immunosuppressives,64096,positive,elderly,,booster2,06-May-22,12-Feb-22,83,mRNA,67,60 to 69
189,female,CD,Vedolizumab Only,1314,positive,adult,30,booster1,06-Aug-21,31-Jan-21,187,mRNA,56,50 to 59
190,female,CD,Vedolizumab Only,1200,positive,adult,,booster2,27-Nov-21,25-Jul-21,125,mRNA,56,50 to 59
191,female,CD,Vedolizumab Only,74854,positive,adult,,booster2,28-Jan-22,07-Dec-21,52,mRNA,56,50 to 59
192,female,CD,Anti-TNF Only,25400,positive,adult,359,primary,19-May-21,26-Mar-21,54,mRNA,47,40 to 49
193,female,CD,Anti-TNF Only,1328,positive,adult,304,booster1,13-Jul-21,08-Feb-21,155,mRNA,47,40 to 49
194,female,CD,Anti-TNF Only,75127,positive,adult,239,booster1,16-Sep-21,27-Jul-21,51,mRNA,47,40 to 49
195,female,CD,Anti-TNF Only,1321,positive,adult,220,booster2,05-Oct-21,26-Jun-21,101,mRNA,47,40 to 49
196,female,CD,Anti-TNF Only,748,positive,adult,112,booster2,21-Jan-22,15-Sep-21,128,mRNA,48,40 to 49
197,female,CD,Anti-TNF Only,68327,positive,adult,50,booster2,24-Mar-22,20-Jan-22,63,mRNA,48,40 to 49
198,female,CD,Anti-TNF Only,226,positive,adult,40,booster2,22-Jun-22,23-Jan-22,150,mRNA,48,40 to 49
199,female,CD,Combination Therapy,35772,positive,adult,164,primary,22-Jun-21,07-Apr-21,76,vector,37,30 to 39
200,female,CD,Combination Therapy,43980,positive,pediatric,320,booster2,18-Nov-21,29-Sep-21,50,vector,1,00 to 09
201,female,CD,Combination Therapy,653,positive,adult,216,booster2,10-Feb-22,25-Oct-21,108,vector,38,30 to 39
202,male,CD,Anti-TNF Only,775,positive,adult,140,primary,30-May-21,04-Feb-21,115,mRNA,27,18 to 29
203,male,CD,Anti-TNF Only,1716,positive,adult,68,booster1,21-Jul-21,25-Apr-21,87,mRNA,27,18 to 29
204,male,CD,Anti-TNF Only,69682,positive,adult,205,booster2,07-Jan-22,06-Nov-21,62,mRNA,28,18 to 29
205,female,CD,Ustekinumab Only,1491,positive,pediatric,268,booster1,31-Jul-21,04-Mar-21,149,mRNA,17,10 to 17
206,female,CD,Ustekinumab Only,1078,positive,adult,457,booster2,25-Feb-22,07-Sep-21,171,mRNA,54,50 to 59
207,female,CD,Ustekinumab Only,718,positive,adult,586,booster2,14-Jun-22,12-Dec-21,184,mRNA,54,50 to 59
208,male,CD,Immunomodulator Only,547,positive,adult,,primary,30-Jun-21,14-Dec-20,198,mRNA,43,40 to 49
209,male,CD,Immunomodulator Only,,,adult,320,booster1,07-Aug-21,21-Apr-21,108,mRNA,43,40 to 49
210,male,CD,Immunomodulator Only,5643,positive,adult,,booster2,15-Jan-22,14-Oct-21,93,mRNA,44,40 to 49
211,female,UC,Vedolizumab Only,1038,positive,adult,217,primary,09-Jun-21,14-Jan-21,146,mRNA,34,30 to 39
212,female,UC,Vedolizumab Only,1409,positive,adult,57,booster1,10-Mar-22,07-Sep-21,184,mRNA,35,30 to 39
213,male,UC,Combination Therapy,1839,positive,elderly,,primary,23-Jun-21,27-Apr-21,57,mRNA,64,60 to 69
214,male,UC,Combination Therapy,412,positive,elderly,,booster2,12-Nov-21,25-Jun-21,140,mRNA,65,60 to 69
215,male,UC,Combination Therapy,219,positive,elderly,,booster2,18-Feb-22,28-Aug-21,174,mRNA,65,60 to 69
216,male,UC,Combination Therapy,72632,positive,elderly,,booster2,10-Jun-22,26-Mar-22,76,mRNA,65,60 to 69
217,male,CD,Anti-TNF Only,1353,positive,adult,354,booster1,02-Jul-21,19-Mar-21,105,vector,18,18 to 29
218,male,CD,Anti-TNF Only,762,positive,adult,230,booster2,03-Nov-21,23-Apr-21,194,vector,19,18 to 29
219,male,CD,Anti-TNF Only,25649,positive,adult,216,booster2,19-Mar-22,19-Jan-22,59,vector,19,18 to 29
220,female,UC,Tofacitinib Only,565,positive,adult,,primary,03-Jul-21,05-Jan-21,179,mRNA,42,40 to 49
221,female,UC,Tofacitinib Only,420,positive,adult,,booster1,31-Jul-21,31-Mar-21,122,mRNA,42,40 to 49
222,other,UC,Tofacitinib Only,742,positive,pediatric,,booster2,22-Feb-22,23-Aug-21,183,mRNA,2,00 to 09
223,other,UC,Tofacitinib Only,543,positive,adult,,primary,27-May-21,23-Nov-20,185,mRNA,50,50 to 59
224,other,UC,Tofacitinib Only,780,positive,adult,,booster1,21-Aug-21,10-Mar-21,164,mRNA,50,50 to 59
225,female,UC,Tofacitinib Only,1012,positive,adult,,booster1,09-Dec-21,21-Jun-21,171,mRNA,50,50 to 59
226,female,UC,Tofacitinib Only,5825,positive,adult,,booster2,18-Feb-22,18-Nov-21,92,mRNA,51,50 to 59
227,female,UC,Tofacitinib Only,635,positive,adult,,booster2,09-Jun-22,07-Dec-21,184,mRNA,51,50 to 59
228,female,UC,Anti-TNF Only,67161,positive,adult,304,booster1,22-Jul-21,19-Apr-21,94,mRNA,37,30 to 39
229,female,UC,Anti-TNF Only,515,positive,adult,140,booster2,07-Jan-22,22-Jul-21,169,mRNA,38,30 to 39
230,female,CD,Anti-TNF Only,538,positive,elderly,181,booster1,09-Jul-21,24-Feb-21,135,mRNA,63,60 to 69
231,female,CD,Anti-TNF Only,441,positive,elderly,,booster2,06-Jan-22,26-Jun-21,194,mRNA,64,60 to 69
232,female,CD,Anti-TNF Only,334,positive,elderly,91,booster2,07-Apr-22,12-Oct-21,177,mRNA,64,60 to 69
233,male,CD,Immunomodulator Only,536,positive,adult,,booster1,24-Jul-21,05-Mar-21,141,mRNA,32,30 to 39
234,male,CD,Immunomodulator Only,247,positive,adult,,booster2,20-Nov-21,24-Jul-21,119,mRNA,32,30 to 39
235,male,CD,Immunomodulator Only,866,positive,adult,,booster2,21-May-22,05-Jan-22,136,mRNA,33,30 to 39
236,female,UC,Corticosteroids,675,positive,adult,189,booster1,07-Jul-21,03-Mar-21,126,mRNA,50,50 to 59
237,female,UC,Corticosteroids,432,positive,adult,132,booster1,02-Sep-21,17-Mar-21,169,mRNA,50,50 to 59
238,female,UC,Corticosteroids,502,positive,adult,98,booster2,20-Apr-22,19-Oct-21,183,mRNA,51,50 to 59
239,female,CD,No Immunosuppressives,34252,positive,adult,68,primary,03-Jun-21,05-Apr-21,59,vector,58,50 to 59
240,female,CD,No Immunosuppressives,22889,positive,adult,,booster1,22-Aug-21,15-May-21,99,vector,58,50 to 59
241,female,CD,No Immunosuppressives,61736,positive,adult,,booster2,01-Apr-22,20-Jan-22,71,vector,59,50 to 59
242,female,CD,No Immunosuppressives,11925,positive,adult,,booster2,15-Jun-22,24-Apr-22,52,vector,59,50 to 59
243,female,CD,Ustekinumab Only,335,positive,adult,,primary,02-Jun-21,19-Dec-20,165,mRNA,45,40 to 49
244,female,CD,Ustekinumab Only,79305,positive,adult,,booster1,19-Aug-21,22-Jun-21,58,mRNA,45,40 to 49
245,female,CD,Ustekinumab Only,2419,positive,adult,,booster2,14-Oct-21,29-Jul-21,77,mRNA,45,40 to 49
246,female,CD,Ustekinumab Only,50722,positive,adult,,booster2,13-Feb-22,24-Nov-21,81,mRNA,45,40 to 49
247,female,CD,Ustekinumab Only,1209,positive,elderly,231,primary,02-Jul-21,24-Dec-20,190,mRNA,64,60 to 69
248,female,CD,Ustekinumab Only,57198,positive,elderly,199,booster1,03-Aug-21,05-Jun-21,59,mRNA,64,60 to 69
249,female,CD,Ustekinumab Only,890,positive,elderly,205,booster2,17-Dec-21,08-Jul-21,162,mRNA,64,60 to 69
250,female,CD,Ustekinumab Only,5906,positive,elderly,49,booster2,08-Apr-22,12-Feb-22,55,mRNA,65,60 to 69
251,female,CD,Ustekinumab Only,9616,positive,elderly,105,booster2,03-Jun-22,30-Mar-22,65,mRNA,65,60 to 69
252,male,CD,No Immunosuppressives,25509,positive,adult,,primary,18-May-21,14-Feb-21,93,mRNA,53,50 to 59
253,male,CD,No Immunosuppressives,28740,positive,adult,,booster1,05-Jun-21,08-Apr-21,58,mRNA,53,50 to 59
254,male,CD,No Immunosuppressives,1408,positive,adult,,booster2,05-Oct-21,16-Apr-21,172,mRNA,53,50 to 59
255,male,CD,No Immunosuppressives,944,positive,adult,,booster2,26-Jan-22,25-Jul-21,185,mRNA,53,50 to 59
256,male,CD,No Immunosuppressives,1194,positive,adult,,booster2,11-Mar-22,29-Sep-21,163,mRNA,53,50 to 59
257,male,CD,No Immunosuppressives,649,positive,adult,,booster2,08-Jul-22,02-Feb-22,156,mRNA,54,50 to 59
258,male,UC,Anti-TNF Only,77147,positive,elderly,,primary,04-Jun-21,26-Mar-21,70,mRNA,67,60 to 69
259,male,UC,Anti-TNF Only,1194,positive,elderly,268,booster1,10-Aug-21,31-Mar-21,132,mRNA,67,60 to 69
260,male,UC,Anti-TNF Only,1333,positive,elderly,,booster2,23-Nov-21,14-Jun-21,162,mRNA,67,60 to 69
261,male,CD,Vedolizumab Only,59660,positive,elderly,,primary,27-Jun-21,01-Apr-21,87,vector,68,60 to 69
262,male,CD,Vedolizumab Only,34937,positive,elderly,,booster1,24-Feb-22,25-Dec-21,61,vector,69,60 to 69
263,female,UC,No Immunosuppressives,736,positive,adult,,booster1,29-Aug-21,18-Apr-21,133,vector,23,18 to 29
264,female,UC,No Immunosuppressives,78035,positive,adult,,booster2,27-Apr-22,03-Feb-22,83,vector,24,18 to 29
265,male,CD,Anti-TNF Only,15,negative,adult,,primary,09-Jun-21,09-Dec-20,182,mRNA,20,18 to 29
266,male,CD,Anti-TNF Only,7561,positive,adult,,booster1,14-Sep-21,09-Jun-21,97,mRNA,20,18 to 29
267,female,CD,Anti-TNF Only,862,positive,adult,205,primary,25-Jun-21,27-Feb-21,118,mRNA,37,30 to 39
268,female,CD,Anti-TNF Only,716,positive,adult,157,booster1,12-Aug-21,06-Mar-21,159,mRNA,37,30 to 39
269,female,CD,Anti-TNF Only,13326,positive,adult,457,booster1,21-Dec-21,18-Oct-21,64,mRNA,37,30 to 39
270,male,CD,Anti-TNF Only,32520,positive,elderly,,primary,09-Jun-21,14-Mar-21,87,mRNA,64,60 to 69
271,male,CD,Anti-TNF Only,135,negative,elderly,,booster2,26-Mar-22,28-Sep-21,179,mRNA,65,60 to 69
272,male,UC,Anti-TNF Only,66979,positive,adult,,booster1,10-Jun-21,22-Mar-21,80,mRNA,40,40 to 49
273,male,UC,Anti-TNF Only,75721,positive,adult,,booster2,23-Jun-22,14-Apr-22,70,mRNA,41,40 to 49
274,male,CD,Anti-TNF Only,525,positive,adult,,primary,04-Jun-21,25-Nov-20,191,mRNA,22,18 to 29
275,male,CD,Anti-TNF Only,24274,positive,adult,,booster1,24-Aug-21,03-Jun-21,82,mRNA,22,18 to 29
276,female,CD,Anti-TNF Only,1166,positive,adult,268,booster1,11-Jun-21,23-Dec-20,170,mRNA,49,40 to 49
277,female,CD,Anti-TNF Only,431,positive,adult,157,booster1,30-Sep-21,30-Apr-21,153,mRNA,49,40 to 49
278,female,CD,Anti-TNF Only,368,positive,adult,124,booster2,02-Nov-21,21-Jul-21,104,mRNA,49,40 to 49
279,female,CD,Anti-TNF Only,25164,positive,adult,586,booster2,16-Feb-22,16-Nov-21,92,mRNA,49,40 to 49
280,male,UC,No Immunosuppressives,1182,positive,adult,,primary,23-Jun-21,09-Feb-21,134,mRNA,48,40 to 49
281,male,UC,No Immunosuppressives,1109,positive,adult,,booster1,03-Aug-21,17-Mar-21,139,mRNA,48,40 to 49
282,male,UC,No Immunosuppressives,73306,positive,adult,,booster2,31-May-22,05-Mar-22,87,mRNA,49,40 to 49
283,male,UC,Ustekinumab Only,63678,positive,adult,,primary,02-Jul-21,29-Apr-21,64,mRNA,54,50 to 59
284,male,UC,Ustekinumab Only,1452,positive,adult,,booster1,01-Aug-21,21-Apr-21,102,mRNA,54,50 to 59
285,male,UC,Ustekinumab Only,671,positive,adult,,booster1,15-Dec-21,17-Jun-21,181,mRNA,55,50 to 59
286,male,UC,Ustekinumab Only,58644,positive,adult,,booster2,16-Feb-22,05-Dec-21,73,mRNA,55,50 to 59
287,male,UC,Ustekinumab Only,17255,positive,adult,,booster2,28-May-22,04-Apr-22,54,mRNA,55,50 to 59
288,male,CD,Anti-TNF Only,680,positive,adult,,primary,10-Jun-21,20-Jan-21,141,mRNA,47,40 to 49
289,male,CD,Anti-TNF Only,19949,positive,adult,,booster1,24-Sep-21,29-Jun-21,87,mRNA,47,40 to 49
290,male,CD,Anti-TNF Only,277,positive,adult,,booster2,30-Dec-21,28-Aug-21,124,mRNA,47,40 to 49
291,male,CD,Anti-TNF Only,4775,positive,adult,,booster2,29-Jan-22,09-Dec-21,51,mRNA,48,40 to 49
292,male,CD,Anti-TNF Only,301,positive,adult,,booster2,15-Mar-22,26-Oct-21,140,mRNA,48,40 to 49
293,male,CD,Anti-TNF Only,1079,positive,adult,,booster2,05-Jul-22,03-Mar-22,124,mRNA,48,40 to 49
294,female,CD,Immunomodulator Only,420,positive,adult,,primary,25-Jun-21,05-Jan-21,171,mRNA,34,30 to 39
295,female,CD,Immunomodulator Only,44950,positive,adult,,booster1,24-Jul-21,14-May-21,71,mRNA,34,30 to 39
296,female,CD,Immunomodulator Only,564,positive,adult,,booster2,06-Feb-22,12-Sep-21,147,mRNA,34,30 to 39
297,male,CD,Anti-TNF Only,17845,positive,adult,,primary,23-Jun-21,06-Apr-21,78,mRNA,43,40 to 49
298,male,CD,Anti-TNF Only,1217,positive,adult,,booster1,20-Aug-21,22-Apr-21,120,mRNA,44,40 to 49
299,male,CD,Ustekinumab Only,732,positive,adult,,primary,30-Jun-21,22-Jan-21,159,mRNA,21,18 to 29
300,female,CD,Anti-TNF Only,4614,positive,adult,,booster1,02-Jun-21,03-Apr-21,60,mRNA,62,60 to 69
301,female,CD,Anti-TNF Only,1375,positive,elderly,,booster1,31-Aug-21,15-May-21,108,mRNA,62,60 to 69
302,female,CD,Anti-TNF Only,43,negative,elderly,,booster2,16-Oct-21,06-May-21,163,mRNA,62,60 to 69
303,female,CD,Anti-TNF Only,6,negative,elderly,,booster2,02-Feb-22,19-Aug-21,167,mRNA,63,60 to 69
304,female,CD,Anti-TNF Only,61,negative,elderly,,booster2,23-Mar-22,12-Dec-21,101,mRNA,63,60 to 69
305,female,CD,Anti-TNF Only,1369,positive,elderly,,booster2,07-Jul-22,02-Jan-22,186,mRNA,63,60 to 69
306,female,CD,Ustekinumab Only,61284,positive,adult,,primary,17-Jun-21,30-Mar-21,79,vector,41,40 to 49
307,female,CD,Ustekinumab Only,641,positive,adult,,booster1,27-Jul-21,05-Mar-21,144,vector,41,40 to 49
308,female,CD,Ustekinumab Only,378,positive,adult,,booster1,29-Dec-21,20-Jul-21,162,vector,42,40 to 49
309,male,CD,Anti-TNF Only,68831,positive,elderly,,booster1,07-Jul-21,06-May-21,62,mRNA,76,70+
310,male,CD,Vedolizumab Only,47777,positive,adult,39,pre_dose,10-Jun-21,20-Mar-21,82,vector,33,30 to 39
311,female,CD,Combination Therapy,14006,positive,adult,310,primary,24-Jun-21,18-Apr-21,67,mRNA,37,30 to 39
312,male,CD,Immunomodulator Only,274,positive,adult,308,primary,05-Jun-21,27-Dec-20,160,mRNA,52,50 to 59
313,male,CD,Immunomodulator Only,430,positive,pediatric,249,booster1,03-Aug-21,21-Apr-21,104,mRNA,13,10 to 17
314,male,CD,Immunomodulator Only,146,negative,adult,57,booster2,11-Feb-22,05-Sep-21,159,mRNA,52,50 to 59
315,male,CD,Immunomodulator Only,1285,positive,adult,63,booster2,11-Jun-22,29-Jan-22,133,mRNA,53,50 to 59
316,male,UC,No Immunosuppressives,405,positive,adult,208,primary,15-Jun-21,05-Mar-21,102,vector,33,30 to 39
317,male,UC,No Immunosuppressives,41372,positive,adult,156,booster1,06-Aug-21,11-Jun-21,56,vector,34,30 to 39
318,other ,UC,No Immunosuppressives,1337,positive,adult,2,booster1,07-Jan-22,01-Jul-21,190,vector,34,30 to 39
319,male,UC,No Immunosuppressives,19550,positive,adult,,booster2,14-Jun-22,23-Apr-22,52,vector,34,30 to 39
320,male,CD,Combination Therapy,47218,positive,adult,,primary,13-Jun-21,19-Mar-21,86,mRNA,49,40 to 49
321,other ,CD,Combination Therapy,685,positive,adult,,booster1,10-Jul-21,13-Mar-21,119,mRNA,49,40 to 49
322,male,CD,Combination Therapy,53134,positive,adult,,booster2,12-Nov-21,31-Aug-21,73,mRNA,49,40 to 49
323,male,CD,Combination Therapy,711,positive,adult,,booster2,19-Jul-22,09-Feb-22,160,mRNA,50,50 to 59
324,male,CD,No Immunosuppressives,1379,positive,adult,,booster1,25-Aug-21,11-Mar-21,167,mRNA,31,30 to 39
325,male,CD,No Immunosuppressives,746,positive,adult,,booster2,18-Mar-22,03-Dec-21,105,mRNA,32,30 to 39
326,male,CD,Ustekinumab Only,26851,positive,adult,,primary,09-Jun-21,13-Mar-21,88,mRNA,49,40 to 49
327,male,CD,Ustekinumab Only,1391,positive,adult,,booster1,22-Aug-21,24-Mar-21,151,mRNA,49,40 to 49
328,male,CD,Ustekinumab Only,29750,positive,adult,,booster1,06-Jan-22,10-Oct-21,88,mRNA,50,50 to 59
329,female,UC,Anti-TNF Only,461,positive,adult,,booster1,29-Jun-21,14-Dec-20,197,mRNA,28,18 to 29
330,female,UC,Anti-TNF Only,25342,positive,adult,130,booster1,09-Sep-21,21-Jun-21,80,mRNA,28,18 to 29
331,female,UC,Anti-TNF Only,1060,positive,adult,24,booster1,10-Feb-22,03-Oct-21,130,mRNA,29,18 to 29
332,male,UC,No Immunosuppressives,650,positive,adult,,primary,17-Jun-21,17-Jan-21,151,mRNA,32,30 to 39
333,male,UC,No Immunosuppressives,197,negative,adult,,booster1,12-Aug-21,02-Apr-21,132,mRNA,32,30 to 39
334,male,UC,No Immunosuppressives,711,positive,adult,,booster2,26-Mar-22,13-Oct-21,164,mRNA,33,30 to 39
335,female,UC,No Immunosuppressives,703,positive,adult,,primary,01-Jul-21,11-Mar-21,112,mRNA,58,50 to 59
336,female,UC,No Immunosuppressives,940,positive,adult,,booster1,07-Oct-21,09-Apr-21,181,mRNA,59,50 to 59
337,female,UC,No Immunosuppressives,57233,positive,adult,,booster2,05-Feb-22,12-Nov-21,85,mRNA,59,50 to 59
338,female,UC,No Immunosuppressives,1135,positive,adult,,booster2,14-Jul-22,10-Jan-22,185,mRNA,60,60 to 69
339,female,CD,Ustekinumab Only,1702,positive,adult,,booster1,15-Sep-21,10-Jun-21,97,mRNA,41,40 to 49
340,female,UC,Corticosteroids,664,positive,adult,,primary,17-Jun-21,28-Jan-21,140,mRNA,56,50 to 59
341,female,UC,Corticosteroids,27659,positive,adult,,booster1,20-Jul-21,26-May-21,55,mRNA,56,50 to 59
342,female,UC,Corticosteroids,684,positive,adult,,booster1,24-Aug-21,09-Mar-21,168,mRNA,56,50 to 59
343,female,UC,Corticosteroids,1102,positive,adult,,booster2,01-Feb-22,06-Sep-21,148,mRNA,57,50 to 59
344,female,UC,Corticosteroids,31095,positive,adult,,booster2,24-May-22,25-Feb-22,88,mRNA,57,50 to 59
345,female,CD,Ustekinumab Only,32806,positive,adult,,booster1,24-Jun-21,03-May-21,52,vector,56,50 to 59
346,female,CD,Ustekinumab Only,47680,positive,adult,,booster1,17-Sep-21,14-Jun-21,95,vector,57,50 to 59
347,female,CD,Ustekinumab Only,1029,positive,adult,,booster2,09-Dec-21,14-Jun-21,178,vector,57,50 to 59
348,female,CD,Ustekinumab Only,1318,positive,adult,,booster2,23-Feb-22,04-Nov-21,111,vector,57,50 to 59
349,male,CD,Anti-TNF Only,14865,positive,adult,,primary,15-Jun-21,08-Apr-21,68,mRNA,62,60 to 69
350,male,CD,Anti-TNF Only,5551,positive,elderly,,booster1,13-Aug-21,19-Jun-21,55,mRNA,62,60 to 69
351,male,CD,Anti-TNF Only,497,positive,elderly,,booster2,27-Nov-21,15-May-21,196,mRNA,62,60 to 69
352,male,CD,Anti-TNF Only,428,positive,elderly,,booster2,22-Feb-22,14-Nov-21,100,mRNA,63,60 to 69
353,male,CD,Anti-TNF Only,76011,positive,elderly,,booster2,19-Apr-22,12-Jan-22,97,mRNA,63,60 to 69
354,female,UC,No Immunosuppressives,717,positive,adult,28,pre_dose,11-Jun-21,12-Dec-20,181,mRNA,56,50 to 59
355,female,UC,No Immunosuppressives,51073,positive,adult,69,primary,22-Jul-21,23-May-21,60,mRNA,56,50 to 59
356,female,UC,No Immunosuppressives,73506,positive,adult,84,booster1,06-Aug-21,22-May-21,76,mRNA,56,50 to 59
357,female,UC,No Immunosuppressives,263,positive,adult,252,booster1,21-Jan-22,16-Sep-21,127,mRNA,56,50 to 59
358,female,UC,No Immunosuppressives,73783,positive,adult,272,booster2,10-Feb-22,09-Nov-21,93,mRNA,56,50 to 59
359,female,UC,No Immunosuppressives,24232,positive,adult,,booster2,01-Jun-22,31-Mar-22,62,mRNA,57,50 to 59
360,male,UC,Combination Therapy,45700,positive,adult,,primary,18-Jun-21,15-Apr-21,64,mRNA,18,18 to 29
361,male,UC,Anti-TNF Only,4220,positive,adult,74,booster1,02-Jul-21,09-Apr-21,84,mRNA,43,40 to 49
362,male,UC,Anti-TNF Only,68750,positive,adult,25,booster1,09-Oct-21,09-Jul-21,92,mRNA,43,40 to 49
363,male,UC,Anti-TNF Only,10958,positive,adult,176,booster2,09-Mar-22,29-Dec-21,70,mRNA,44,40 to 49
364,male,UC,Anti-TNF Only,624,positive,adult,,booster1,24-Jul-21,21-Jan-21,184,vector,31,30 to 39
365,male,UC,Anti-TNF Only,31288,positive,adult,,booster1,06-Jan-22,02-Oct-21,96,vector,32,30 to 39
366,male,UC,Anti-TNF Only,1265,positive,adult,,booster2,05-Mar-22,21-Oct-21,135,vector,32,30 to 39
367,male,UC,Anti-TNF Only,1151,positive,adult,,booster2,25-Jun-22,07-Mar-22,110,vector,32,30 to 39
368,male,CD,Anti-TNF Only,1363,positive,adult,,primary,23-Jun-21,20-Dec-20,185,vector,36,30 to 39
369,male,CD,Anti-TNF Only,54704,positive,adult,,booster1,13-Jul-21,22-Apr-21,82,vector,36,30 to 39
370,male,CD,Anti-TNF Only,1311,positive,adult,,booster2,07-Apr-22,03-Nov-21,155,vector,37,30 to 39
371,male,CD,Anti-TNF Only,13735,positive,adult,,booster2,30-Jun-22,21-Apr-22,70,vector,37,30 to 39
372,female,CD,Combination Therapy,16530,positive,adult,,primary,30-Jun-21,04-May-21,57,mRNA,24,18 to 29
373,female,CD,Combination Therapy,31504,positive,adult,,booster1,13-Aug-21,12-Jun-21,62,mRNA,24,18 to 29
374,female,CD,Combination Therapy,478,positive,adult,,booster2,02-Dec-21,27-May-21,189,mRNA,24,18 to 29
375,female,CD,Combination Therapy,71430,positive,adult,,booster2,24-Mar-22,25-Dec-21,89,mRNA,24,18 to 29
376,male,CD,Vedolizumab Only,23135,positive,adult,,booster1,13-Jul-21,01-May-21,73,mRNA,37,30 to 39
377,male,CD,Vedolizumab Only,1398,positive,adult,,booster2,03-Dec-21,01-Aug-21,124,mRNA,38,30 to 39
378,male,CD,Combination Therapy,1219,positive,adult,36,primary,25-Jun-21,11-Jan-21,165,mRNA,42,40 to 49
379,male,CD,Combination Therapy,,,adult,,booster1,18-Aug-21,28-Jun-21,51,mRNA,42,40 to 49
380,male,CD,Combination Therapy,1265,positive,adult,184,booster2,20-Nov-21,06-May-21,198,mRNA,42,40 to 49
381,male,CD,Combination Therapy,1346,positive,adult,302,booster2,18-Mar-22,21-Oct-21,148,mRNA,43,40 to 49
382,male,CD,Anti-TNF Only,1353,positive,adult,,primary,18-Jun-21,13-Dec-20,187,mRNA,40,40 to 49
383,male,CD,Anti-TNF Only,42848,positive,adult,,booster1,10-Jul-21,10-May-21,61,mRNA,40,40 to 49
384,male,CD,Anti-TNF Only,12155,positive,adult,,booster2,13-Nov-21,13-Aug-21,92,mRNA,40,40 to 49
385,male,CD,Anti-TNF Only,1026,positive,adult,,booster2,04-Mar-22,02-Sep-21,183,mRNA,40,40 to 49
386,male,CD,Anti-TNF Only,1198,positive,adult,,booster2,15-Apr-22,16-Oct-21,181,mRNA,40,40 to 49
387,female,UC,No Immunosuppressives,70886,positive,adult,238,primary,30-Jun-21,30-Apr-21,61,mRNA,40,40 to 49
388,female,UC,No Immunosuppressives,16494,positive,adult,193,booster1,14-Aug-21,16-May-21,90,mRNA,40,40 to 49
389,female,UC,No Immunosuppressives,1307,positive,pediatric,,booster2,13-Nov-21,01-Aug-21,104,mRNA,5,00 to 09
390,female,UC,No Immunosuppressives,1887,positive,pediatric,4,booster2,19-Feb-22,05-Dec-21,76,mRNA,10,10 to 17
391,male,UC,Ustekinumab Only,1477,positive,pediatric,,booster1,17-Jun-21,09-Jan-21,159,mRNA,5,00 to 09
392,male,UC,Ustekinumab Only,23548,positive,pediatric,,booster1,14-Oct-21,02-Aug-21,73,mRNA,11,10 to 17
393,male,UC,Ustekinumab Only,860,positive,pediatric,,booster2,18-Dec-21,11-Jun-21,190,mRNA,7,00 to 09
394,male,UC,Ustekinumab Only,1271,positive,pediatric,,booster2,01-Apr-22,09-Oct-21,174,mRNA,5,00 to 09
395,male,UC,Ustekinumab Only,27633,positive,pediatric,,booster2,29-Jun-22,05-Apr-22,85,mRNA,1,00 to 09
396,female,CD,Combination Therapy,908,positive,pediatric,31,primary,23-Jun-21,10-Feb-21,133,mRNA,3,00 to 09
397,female,CD,Ustekinumab Only,1394,positive,pediatric,,primary,22-Jul-21,09-Feb-21,163,mRNA,2,00 to 09
398,female,CD,Ustekinumab Only,8858,positive,pediatric,,booster1,17-Sep-21,10-Jul-21,69,mRNA,6,00 to 09
399,female,CD,Ustekinumab Only,1498,positive,pediatric,105,booster1,07-Jan-22,21-Jun-21,200,mRNA,1,00 to 09
400,male,CD,Ustekinumab Only,1406,positive,pediatric,187,primary,15-Jun-21,26-Dec-20,171,mRNA,17,10 to 17
401,male,CD,Ustekinumab Only,739,positive,adult,96,booster1,07-Aug-21,22-Apr-21,107,mRNA,45,40 to 49
402,male,CD,Ustekinumab Only,1357,positive,adult,9,booster2,15-Oct-21,25-May-21,143,mRNA,45,40 to 49
403,male,CD,Ustekinumab Only,1021,positive,adult,90,booster2,22-Jan-22,15-Sep-21,129,mRNA,45,40 to 49
404,male,CD,Ustekinumab Only,1168,positive,adult,5,booster2,14-May-22,05-Jan-22,129,mRNA,46,40 to 49
405,female,UC,Anti-TNF Only,1160,positive,adult,38,booster1,04-Jun-21,31-Jan-21,124,mRNA,62,60 to 69
406,female,UC,Anti-TNF Only,487,positive,elderly,169,booster1,22-Sep-21,15-Mar-21,191,mRNA,62,60 to 69
407,female,UC,Anti-TNF Only,53370,positive,elderly,291,booster2,16-Dec-21,15-Sep-21,92,mRNA,62,60 to 69
408,female,UC,Anti-TNF Only,37948,positive,elderly,,booster2,21-Apr-22,15-Feb-22,65,mRNA,63,60 to 69
409,male,CD,Anti-TNF Only,74569,positive,adult,187,primary,13-Jul-21,05-May-21,69,vector,45,40 to 49
410,male,CD,No Immunosuppressives,1494,positive,elderly,,booster1,01-Jul-21,09-Feb-21,142,mRNA,66,60 to 69
411,male,CD,No Immunosuppressives,301,positive,elderly,,booster2,21-Jan-22,19-Aug-21,155,mRNA,67,60 to 69
412,male,CD,Vedolizumab Only,570,positive,adult,,primary,01-Jun-21,19-Dec-20,164,vector,53,50 to 59
413,male,CD,Vedolizumab Only,882,positive,adult,,booster1,06-Aug-21,06-Feb-21,181,vector,53,50 to 59
414,male,CD,Vedolizumab Only,67787,positive,adult,,booster2,14-Jan-22,17-Oct-21,89,vector,54,50 to 59
415,male,CD,Vedolizumab Only,424,positive,adult,,booster2,05-Jul-22,30-Dec-21,187,vector,54,50 to 59
416,male,CD,Ustekinumab Only,442,positive,elderly,,booster1,13-Aug-21,04-May-21,101,mRNA,70,70+
417,male,CD,Ustekinumab Only,110,negative,elderly,,booster2,10-Mar-22,23-Oct-21,138,mRNA,70,70+
418,male,CD,Ustekinumab Only,75038,positive,elderly,,booster2,28-Jun-22,21-Apr-22,68,mRNA,71,70+
419,male,CD,Anti-TNF Only,59405,positive,adult,96,booster1,05-Aug-21,30-May-21,67,mRNA,40,40 to 49
420,male,CD,Anti-TNF Only,79344,positive,adult,243,booster1,29-Jan-22,04-Nov-21,86,mRNA,41,40 to 49
421,male,CD,Anti-TNF Only,85,negative,adult,267,booster2,22-Feb-22,14-Aug-21,192,mRNA,41,40 to 49
422,male,CD,Anti-TNF Only,696,positive,adult,386,booster2,21-Jun-22,08-Jan-22,164,mRNA,41,40 to 49
423,female,CD,Anti-TNF Only,1456,positive,adult,,booster1,09-Jun-21,09-Dec-20,182,mRNA,56,50 to 59
424,female,CD,Anti-TNF Only,1361,positive,adult,,booster1,31-Jul-21,08-Feb-21,173,mRNA,56,50 to 59
425,female,CD,Anti-TNF Only,1167,positive,adult,,booster2,05-Oct-21,01-Apr-21,187,mRNA,56,50 to 59
426,female,CD,Anti-TNF Only,1133,positive,adult,,booster2,29-Jan-22,11-Aug-21,171,mRNA,57,50 to 59
427,male,CD,Anti-TNF Only,1261,positive,adult,191,primary,28-Jul-21,18-Jan-21,191,mRNA,43,40 to 49
428,male,CD,Anti-TNF Only,607,positive,adult,86,booster1,10-Nov-21,20-May-21,174,mRNA,43,40 to 49
429,male,CD,Anti-TNF Only,223,positive,adult,9,booster1,12-Feb-22,09-Oct-21,126,mRNA,43,40 to 49
430,male,UC,Anti-TNF Only,61398,positive,adult,,primary,02-Jul-21,18-Apr-21,75,vector,42,40 to 49
431,male,UC,Anti-TNF Only,1296,positive,adult,,booster1,10-Sep-21,16-Apr-21,147,vector,42,40 to 49
432,male,UC,Anti-TNF Only,6364,positive,adult,,booster1,04-Dec-21,10-Oct-21,55,vector,42,40 to 49
433,male,CD,Anti-TNF Only,1119,positive,elderly,,booster1,22-Jun-21,29-Dec-20,175,mRNA,78,70+
434,male,CD,Anti-TNF Only,33626,positive,elderly,,booster2,13-Oct-21,25-Jul-21,80,mRNA,78,70+
435,male,CD,Anti-TNF Only,1212,positive,elderly,,booster2,02-Feb-22,19-Aug-21,167,mRNA,78,70+
436,male,CD,Anti-TNF Only,14652,positive,elderly,,booster2,29-Mar-22,29-Jan-22,59,mRNA,78,70+
437,male,CD,Anti-TNF Only,2166,positive,elderly,,booster2,19-Jul-22,04-May-22,76,mRNA,79,70+
438,female,CD,Combination Therapy,44,negative,adult,,booster1,26-Sep-21,04-Jun-21,114,mRNA,44,40 to 49
439,male,UC,No Immunosuppressives,1228,positive,adult,90,primary,02-Jul-21,09-Mar-21,115,vector,60,60 to 69
440,male,UC,No Immunosuppressives,387,positive,adult,,booster1,20-Aug-21,27-Feb-21,174,vector,60,60 to 69
441,male,UC,No Immunosuppressives,52238,positive,adult,,booster2,13-Jan-22,31-Oct-21,74,vector,61,60 to 69
442,male,UC,No Immunosuppressives,60,negative,adult,,booster2,17-May-22,20-Nov-21,178,vector,61,60 to 69
443,male,UC,Anti-TNF Only,1498,positive,adult,,booster1,26-Aug-21,19-Feb-21,188,mRNA,38,30 to 39
444,male,UC,Anti-TNF Only,96,negative,adult,52,booster1,02-Jul-21,19-Mar-21,105,mRNA,38,30 to 39
445,male,UC,Anti-TNF Only,37358,positive,adult,217,booster1,14-Dec-21,08-Sep-21,97,mRNA,38,30 to 39
446,male,UC,Anti-TNF Only,25965,positive,adult,393,booster2,08-Jun-22,16-Apr-22,53,mRNA,39,30 to 39
447,female,UC,No Immunosuppressives,803,positive,adult,38,pre_dose,30-Jun-21,12-Mar-21,110,mRNA,19,18 to 29
448,female,UC,No Immunosuppressives,812,positive,adult,117,primary,17-Sep-21,20-Mar-21,181,mRNA,19,18 to 29
449,female,UC,No Immunosuppressives,6729,positive,adult,5,booster1,12-Feb-22,16-Nov-21,88,mRNA,20,18 to 29
450,female,CD,Ustekinumab Only,8003,positive,adult,,primary,30-Jun-21,29-Mar-21,93,mRNA,39,30 to 39
451,female,CD,Ustekinumab Only,1376,positive,adult,,booster1,23-Jul-21,08-Feb-21,165,mRNA,39,30 to 39
452,female,CD,Ustekinumab Only,712,positive,adult,,booster1,16-Nov-21,21-Jul-21,118,mRNA,40,40 to 49
453,female,CD,Ustekinumab Only,35764,positive,adult,,booster2,21-Jan-22,25-Oct-21,88,mRNA,40,40 to 49
454,female,CD,Ustekinumab Only,185,negative,adult,,booster2,13-May-22,18-Jan-22,115,mRNA,40,40 to 49
455,male,CD,No Immunosuppressives,40186,positive,adult,,primary,15-Jul-21,15-May-21,61,mRNA,51,50 to 59
456,male,CD,No Immunosuppressives,704,positive,adult,,booster1,20-Aug-21,15-Mar-21,158,mRNA,51,50 to 59
457,male,CD,No Immunosuppressives,57888,positive,adult,,booster1,02-Dec-21,23-Sep-21,70,mRNA,51,50 to 59
458,male,CD,No Immunosuppressives,685,positive,adult,,booster2,25-Feb-22,04-Oct-21,144,mRNA,52,50 to 59
459,other ,CD,No Immunosuppressives,9960,positive,adult,38,booster2,21-May-22,19-Feb-22,91,mRNA,52,50 to 59
460,male,UC,Anti-TNF Only,353,positive,adult,,booster1,21-Jul-21,31-Jan-21,171,mRNA,25,18 to 29
461,female,CD,Anti-TNF Only,1127,positive,adult,294,booster1,01-Jul-21,14-Feb-21,137,vector,47,40 to 49
462,other ,CD,Anti-TNF Only,544,positive,adult,197,booster1,06-Oct-21,12-Apr-21,177,vector,48,40 to 49
463,female,CD,Anti-TNF Only,1109,positive,adult,111,booster2,31-Dec-21,03-Sep-21,119,vector,48,40 to 49
464,female,CD,Anti-TNF Only,60389,positive,adult,34,booster2,18-Mar-22,10-Dec-21,98,vector,48,40 to 49
465,male,UC,No Immunosuppressives,313,positive,adult,,booster1,09-Jul-21,28-Dec-20,193,mRNA,54,50 to 59
466,male,UC,No Immunosuppressives,493,positive,adult,,booster2,22-Apr-22,02-Nov-21,171,mRNA,55,50 to 59
467,male,CD,Combination Therapy,412,positive,adult,,booster1,25-Aug-21,12-Mar-21,166,mRNA,55,50 to 59
468,male,CD,Combination Therapy,30083,positive,adult,,booster2,18-Jun-22,31-Mar-22,79,mRNA,56,50 to 59
469,female,CD,Anti-TNF Only,74,negative,adult,169,booster1,15-Jul-21,21-Jan-21,175,mRNA,57,50 to 59
470,female,CD,Anti-TNF Only,757,positive,adult,,booster2,09-Oct-21,17-Apr-21,175,mRNA,57,50 to 59
471,female,CD,Anti-TNF Only,848,positive,adult,,booster2,18-Mar-22,28-Nov-21,110,mRNA,58,50 to 59
472,female,CD,Anti-TNF Only,62928,positive,adult,,booster2,01-Jul-22,04-May-22,58,mRNA,58,50 to 59
473,male,CD,Anti-TNF Only,1258,positive,adult,,booster1,31-Aug-21,17-Apr-21,136,mRNA,58,50 to 59
474,female,CD,Anti-TNF Only,61333,positive,adult,199,booster1,07-Aug-21,16-Jun-21,52,mRNA,61,60 to 69
475,female,CD,Anti-TNF Only,661,positive,adult,157,booster1,18-Sep-21,13-Apr-21,158,mRNA,61,60 to 69
476,female,CD,Anti-TNF Only,57,negative,adult,69,booster2,15-Dec-21,13-Jun-21,185,mRNA,61,60 to 69
477,female,CD,Anti-TNF Only,234,positive,adult,11,booster2,05-Mar-22,17-Sep-21,169,mRNA,62,60 to 69
478,male,UC,Tofacitinib Only,101,negative,elderly,,booster1,04-Aug-21,12-Feb-21,173,vector,62,60 to 69
479,male,UC,Tofacitinib Only,24942,positive,elderly,291,booster2,26-May-22,01-Apr-22,55,vector,63,60 to 69
480,female,CD,Ustekinumab Only,1330,positive,adult,,booster1,24-Jul-21,11-Feb-21,163,mRNA,45,40 to 49
481,male,UC,Vedolizumab Only,1401,positive,adult,,booster1,19-Jun-21,31-Jan-21,139,mRNA,43,40 to 49
482,male,UC,Vedolizumab Only,844,positive,adult,,booster2,10-Dec-21,05-Jun-21,188,mRNA,44,40 to 49
483,male,UC,Vedolizumab Only,1232,positive,adult,,booster2,04-Feb-22,03-Oct-21,124,mRNA,44,40 to 49
484,female,CD,No Immunosuppressives,1251,positive,adult,226,booster1,03-Jul-21,15-Feb-21,138,mRNA,38,30 to 39
485,female,CD,No Immunosuppressives,1473,positive,adult,82,booster1,24-Nov-21,24-Jul-21,123,mRNA,38,30 to 39
486,female,CD,No Immunosuppressives,8643,positive,adult,41,booster2,04-Jan-22,28-Sep-21,98,mRNA,38,30 to 39
487,female,CD,No Immunosuppressives,437,positive,adult,79,booster2,04-May-22,12-Jan-22,112,mRNA,39,30 to 39
488,male,CD,No Immunosuppressives,848,positive,elderly,,booster1,04-Aug-21,03-Apr-21,123,mRNA,71,70+
489,male,CD,No Immunosuppressives,21720,positive,elderly,,booster1,15-Oct-21,01-Aug-21,75,mRNA,71,70+
490,male,CD,No Immunosuppressives,16529,positive,elderly,,booster2,28-Dec-21,21-Oct-21,68,mRNA,71,70+
491,male,CD,No Immunosuppressives,837,positive,elderly,,booster2,19-Apr-22,06-Oct-21,195,mRNA,71,70+
492,female,UC,No Immunosuppressives,10425,positive,adult,,booster1,18-Jul-21,19-May-21,60,vector,54,50 to 59
493,female,UC,No Immunosuppressives,553,positive,adult,,booster2,06-Feb-22,07-Aug-21,183,vector,55,50 to 59
494,female,UC,Vedolizumab Only,33828,positive,adult,,booster1,29-Jul-21,05-May-21,85,vector,59,50 to 59
495,female,UC,Vedolizumab Only,1184,positive,adult,,booster1,07-Jan-22,25-Jun-21,196,vector,60,60 to 69
496,female,UC,Vedolizumab Only,1360,positive,adult,,booster2,15-Mar-22,09-Nov-21,126,vector,60,60 to 69
497,female,UC,Vedolizumab Only,18183,positive,adult,,booster2,22-Jul-22,22-Apr-22,91,vector,60,60 to 69
498,male,CD,Anti-TNF Only,28313,positive,elderly,,booster1,07-Jul-21,04-May-21,64,mRNA,71,70+
499,male,CD,Anti-TNF Only,,,elderly,,booster2,02-Oct-21,13-Jul-21,81,mRNA,71,70+
500,male,CD,Anti-TNF Only,65672,positive,elderly,,booster2,10-Mar-22,05-Jan-22,64,mRNA,72,70+
501,male,CD,Anti-TNF Only,2360,positive,elderly,,booster2,15-Jun-22,07-Apr-22,69,mRNA,72,70+
502,male,CD,Anti-TNF Only,706,positive,elderly,,booster2,26-Jul-22,07-Jan-22,200,mRNA,72,70+
503,male,CD,Anti-TNF Only,881,positive,adult,,booster1,05-Aug-21,03-Apr-21,124,mRNA,56,50 to 59
504,male,CD,Anti-TNF Only,233,positive,adult,,booster1,17-Dec-21,23-Aug-21,116,mRNA,56,50 to 59
505,male,CD,Anti-TNF Only,39484,positive,adult,,booster2,11-Mar-22,01-Jan-22,69,mRNA,56,50 to 59
506,male,CD,Anti-TNF Only,71441,positive,adult,,booster2,31-May-22,24-Mar-22,68,mRNA,57,50 to 59
507,male,UC,No Immunosuppressives,641,positive,adult,,booster1,14-Jul-21,09-Jan-21,186,vector,59,50 to 59
508,male,UC,No Immunosuppressives,1059,positive,adult,,booster1,22-Dec-21,01-Aug-21,143,vector,60,60 to 69
509,male,CD,Anti-TNF Only,6889,positive,elderly,,primary,30-Jun-21,23-Mar-21,99,mRNA,69,60 to 69
510,male,CD,Anti-TNF Only,,,elderly,,booster1,25-Aug-21,16-May-21,101,mRNA,69,60 to 69
511,male,CD,Anti-TNF Only,28952,positive,elderly,,booster1,15-Dec-21,23-Oct-21,53,mRNA,69,60 to 69
512,male,CD,Anti-TNF Only,34,negative,elderly,,booster1,29-Jul-22,17-Mar-22,134,mRNA,70,70+
513,female,UC,No Immunosuppressives,60102,positive,adult,,booster1,20-Jul-21,13-Apr-21,98,mRNA,50,50 to 59
514,male,UC,Tofacitinib Only,43337,positive,adult,,booster1,10-Jul-21,29-Apr-21,72,vector,34,30 to 39
515,male,UC,Tofacitinib Only,1065,positive,adult,,booster2,09-Apr-22,01-Dec-21,129,vector,35,30 to 39
516,female,CD,Anti-TNF Only,958,positive,adult,,booster1,15-Jul-21,31-Mar-21,106,mRNA,41,40 to 49
517,female,CD,Anti-TNF Only,52458,positive,adult,,booster2,07-Oct-21,14-Jul-21,85,mRNA,41,40 to 49
518,female,CD,Anti-TNF Only,1067,positive,adult,,booster2,08-Feb-22,13-Oct-21,118,mRNA,42,40 to 49
519,female,CD,Anti-TNF Only,1019,positive,adult,,booster2,03-Apr-22,18-Nov-21,136,mRNA,42,40 to 49
520,male,CD,Ustekinumab Only,67,negative,adult,,booster1,10-Aug-21,10-Mar-21,153,mRNA,53,50 to 59
521,male,CD,Ustekinumab Only,1177,positive,adult,,booster1,25-Jan-22,05-Aug-21,173,mRNA,53,50 to 59
522,female,CD,Ustekinumab Only,636,positive,adult,,booster1,30-Jul-21,13-Jan-21,198,mRNA,43,40 to 49
523,female,CD,Ustekinumab Only,1007,positive,adult,,booster2,30-Sep-21,31-May-21,122,mRNA,43,40 to 49
524,female,CD,Ustekinumab Only,1204,positive,adult,,booster2,27-Jan-22,11-Sep-21,138,mRNA,43,40 to 49
525,female,CD,Ustekinumab Only,46115,positive,adult,,booster2,29-Jan-22,12-Nov-21,78,mRNA,43,40 to 49
526,male,UC,Corticosteroids,1478,positive,adult,,primary,07-Aug-21,15-Apr-21,114,mRNA,21,18 to 29
527,male,UC,Corticosteroids,72774,positive,adult,,booster1,24-Sep-21,12-Jul-21,74,mRNA,21,18 to 29
528,male,UC,Corticosteroids,1309,positive,adult,,booster2,20-Nov-21,29-May-21,175,mRNA,21,18 to 29
529,male,UC,Corticosteroids,1466,positive,adult,,booster2,10-Mar-22,23-Sep-21,168,mRNA,21,18 to 29
530,male,UC,Corticosteroids,1248,positive,adult,,booster2,30-Jun-22,04-Jan-22,177,mRNA,21,18 to 29
531,female,CD,Immunomodulator Only,1298,positive,adult,,booster1,06-Aug-21,25-Feb-21,162,vector,38,30 to 39
532,female,CD,Immunomodulator Only,67,negative,adult,,booster2,13-Nov-21,31-Jul-21,105,vector,39,30 to 39
533,female,CD,Immunomodulator Only,1072,positive,adult,,booster2,23-Feb-22,17-Aug-21,190,vector,39,30 to 39
534,female,CD,Anti-TNF Only,,,adult,98,primary,09-Oct-21,44320,158,vector,39,30 to 39
535,male,CD,Combination Therapy,1204,positive,adult,,primary,03-Sep-21,11-Mar-21,176,mRNA,60,60 to 69
536,male,CD,Combination Therapy,71643,positive,adult,,booster1,01-Oct-21,23-Jul-21,70,mRNA,60,60 to 69
537,male,CD,Combination Therapy,1314,positive,adult,,booster1,11-Feb-22,26-Sep-21,138,mRNA,61,60 to 69
538,female,CD,Anti-TNF Only,46459,positive,adult,135,booster1,29-Sep-21,28-Jun-21,93,vector,59,50 to 59
539,female,CD,Anti-TNF Only,59,negative,adult,,booster2,19-Nov-21,30-Jul-21,112,vector,59,50 to 59
540,female,CD,Anti-TNF Only,69162,positive,adult,40,booster2,23-Mar-22,28-Jan-22,54,vector,60,60 to 69
541,male,CD,Anti-TNF Only,46098,positive,adult,,booster1,18-Sep-21,17-Jul-21,63,mRNA,55,50 to 59
542,male,CD,Anti-TNF Only,1128,positive,adult,,booster2,15-Mar-22,26-Sep-21,170,mRNA,56,50 to 59
543,female,CD,Combination Therapy,1085,positive,adult,,booster1,13-Oct-21,19-Jun-21,116,mRNA,28,18 to 29
544,female,CD,Combination Therapy,627,positive,adult,,booster2,27-Nov-21,24-Jul-21,126,mRNA,28,18 to 29
545,female,CD,Combination Therapy,787,positive,adult,,booster2,22-Apr-22,28-Dec-21,115,mRNA,28,18 to 29
546,female,CD,Combination Therapy,49821,positive,adult,,booster2,27-May-22,05-Apr-22,52,mRNA,29,18 to 29
547,female,CD,Vedolizumab Only,12760,positive,adult,,booster1,17-Sep-21,10-Jul-21,69,mRNA,54,50 to 59
548,female,CD,Vedolizumab Only,897,positive,adult,,booster2,03-Nov-21,28-May-21,159,mRNA,54,50 to 59
549,female,CD,Vedolizumab Only,723,positive,adult,,booster2,12-May-22,14-Dec-21,149,mRNA,55,50 to 59
550,female,CD,Combination Therapy,1258,positive,adult,21,booster1,06-Oct-21,17-Apr-21,172,mRNA,21,18 to 29
551,female,CD,Combination Therapy,1245,positive,adult,62,booster2,16-Nov-21,11-Jul-21,128,mRNA,21,18 to 29
552,female,CD,Combination Therapy,7160,positive,adult,181,booster2,15-Mar-22,02-Jan-22,72,mRNA,21,18 to 29
553,female,CD,Anti-TNF Only,1425,positive,elderly,,booster1,30-Sep-21,24-May-21,129,vector,72,70+
554,male,UC,Immunomodulator Only,691,positive,adult,36,booster1,01-Dec-21,22-Jul-21,132,mRNA,26,18 to 29
555,female,CD,Anti-TNF Only,419,positive,adult,,booster2,11-Feb-22,14-Aug-21,181,mRNA,50,50 to 59
556,male,UC,Vedolizumab Only,725,positive,elderly,,primary,26-May-21,11-Nov-20,196,mRNA,66,60 to 69
557,male,UC,Vedolizumab Only,1468,positive,elderly,,booster1,26-Jun-21,09-Jan-21,168,mRNA,66,60 to 69
558,male,UC,Vedolizumab Only,78010,positive,elderly,,booster2,14-Oct-21,31-Jul-21,75,mRNA,66,60 to 69
559,male,UC,Vedolizumab Only,15852,positive,elderly,,booster2,28-Jan-22,21-Nov-21,68,mRNA,67,60 to 69
560,female,UC,Combination Therapy,366,positive,adult,357,primary,19-May-21,02-Feb-21,106,vector,46,40 to 49
561,female,UC,Combination Therapy,38860,positive,adult,306,booster1,09-Jul-21,05-May-21,65,vector,46,40 to 49
562,female,UC,Combination Therapy,363,positive,adult,94,booster2,06-Feb-22,12-Aug-21,178,vector,47,40 to 49
563,female,UC,Combination Therapy,378,positive,adult,56,booster2,16-Mar-22,30-Sep-21,167,vector,47,40 to 49
564,other,UC,Combination Therapy,50,negative,adult,55,booster2,05-Jul-22,15-Mar-22,112,vector,47,40 to 49
565,female,CD,Anti-TNF Only,38400,positive,adult,30,pre_dose,21-Apr-21,26-Jan-21,85,mRNA,32,30 to 39
566,female,CD,Anti-TNF Only,1034,positive,adult,395,booster2,21-Apr-22,07-Jan-22,104,mRNA,33,30 to 39
567,male,CD,Ustekinumab Only,12668,positive,adult,,primary,25-Sep-21,04-Aug-21,52,vector,60,60 to 69
568,male,CD,Ustekinumab Only,542,positive,adult,,booster1,23-Oct-21,26-May-21,150,vector,60,60 to 69
569,female,CD,Vedolizumab Only,22687,positive,adult,,booster1,03-Aug-21,07-Jun-21,57,mRNA,29,18 to 29
570,female,CD,Vedolizumab Only,20299,positive,adult,259,primary,22-May-21,13-Feb-21,98,mRNA,39,30 to 39
571,female,CD,Vedolizumab Only,20231,positive,adult,212,booster1,08-Jul-21,05-Apr-21,94,mRNA,39,30 to 39
572,female,CD,Vedolizumab Only,44005,positive,adult,135,booster1,23-Sep-21,12-Jul-21,73,mRNA,39,30 to 39
573,female,CD,Vedolizumab Only,72,negative,adult,4,booster2,01-Feb-22,25-Aug-21,160,mRNA,39,30 to 39
574,female,CD,Vedolizumab Only,1124,positive,adult,18,booster2,23-Feb-22,17-Aug-21,190,mRNA,40,40 to 49
575,male,UC,Anti-TNF Only,22,negative,adult,271,pre_dose,24-Apr-21,22-Oct-20,184,mRNA,27,18 to 29
576,female,CD,Vedolizumab Only,565,positive,adult,,primary,22-Jun-21,16-Feb-21,126,vector,36,30 to 39
577,female,CD,Vedolizumab Only,59856,positive,adult,,booster1,04-Sep-21,10-Jun-21,86,vector,36,30 to 39
578,female,CD,Vedolizumab Only,1488,positive,adult,,booster1,16-Dec-21,18-Aug-21,120,vector,37,30 to 39
579,female,CD,Vedolizumab Only,68071,positive,adult,,booster2,30-Mar-22,06-Feb-22,52,vector,37,30 to 39
580,female,CD,Vedolizumab Only,811,positive,adult,,booster2,23-Jun-22,16-Jan-22,158,vector,37,30 to 39
581,male,UC,Anti-TNF Only,1424,positive,adult,,booster1,22-Jul-21,06-Feb-21,166,mRNA,51,50 to 59
582,male,UC,Anti-TNF Only,225,positive,adult,,booster1,06-Jan-22,26-Jul-21,164,mRNA,51,50 to 59
583,female,CD,Vedolizumab Only,850,positive,adult,,primary,14-Apr-21,09-Dec-20,126,mRNA,35,30 to 39
584,female,CD,Vedolizumab Only,62679,positive,adult,,booster1,10-Jun-21,01-Apr-21,70,mRNA,35,30 to 39
585,female,CD,Vedolizumab Only,1081,positive,adult,,booster1,30-Sep-21,23-Mar-21,191,mRNA,35,30 to 39
586,female,CD,Vedolizumab Only,1189,positive,adult,,booster2,29-Mar-22,26-Oct-21,154,mRNA,36,30 to 39
587,female,CD,Anti-TNF Only,317,positive,adult,,booster1,19-Sep-21,27-Apr-21,145,mRNA,57,50 to 59
588,female,CD,Anti-TNF Only,56308,positive,adult,,booster2,30-Jan-22,10-Dec-21,51,mRNA,57,50 to 59
589,female,CD,Anti-TNF Only,734,positive,adult,,booster2,24-Apr-22,02-Jan-22,112,mRNA,57,50 to 59
590,female,CD,Anti-TNF Only,38100,positive,adult,,booster1,20-Jul-21,05-May-21,76,mRNA,58,50 to 59
591,female,CD,Anti-TNF Only,619,positive,adult,,booster2,18-Nov-21,26-Jun-21,145,mRNA,58,50 to 59
592,female,CD,Anti-TNF Only,46098,positive,adult,,booster2,01-Mar-22,27-Dec-21,64,mRNA,58,50 to 59
593,female,CD,Vedolizumab Only,51384,positive,adult,,booster1,14-Dec-21,12-Oct-21,63,mRNA,32,30 to 39
594,female,CD,Vedolizumab Only,73102,positive,adult,,booster2,25-Mar-22,14-Jan-22,70,mRNA,33,30 to 39
595,male,CD,Anti-TNF Only,1144,positive,adult,,booster1,07-Jul-21,18-Feb-21,139,mRNA,42,40 to 49
596,male,CD,Anti-TNF Only,12634,positive,adult,,booster1,01-Sep-21,27-May-21,97,mRNA,42,40 to 49
597,male,CD,Anti-TNF Only,279,positive,adult,,booster2,22-Dec-21,31-Jul-21,144,mRNA,42,40 to 49
598,male,CD,Anti-TNF Only,133,negative,adult,,booster2,08-Jun-22,18-Jan-22,141,mRNA,43,40 to 49
599,female,CD,Vedolizumab Only,78038,positive,elderly,,primary,18-May-21,25-Mar-21,54,mRNA,67,60 to 69
600,female,CD,Vedolizumab Only,171,negative,elderly,,booster1,13-Jul-21,10-Mar-21,125,mRNA,67,60 to 69
601,female,CD,Vedolizumab Only,46463,positive,elderly,,booster1,06-Jan-22,02-Nov-21,65,mRNA,67,60 to 69
602,female,CD,Vedolizumab Only,454,positive,elderly,,booster2,03-Feb-22,07-Aug-21,180,mRNA,67,60 to 69
603,male,UC,Anti-TNF Only,416,positive,adult,,booster1,15-Jul-21,24-Feb-21,141,mRNA,28,18 to 29
604,female,CD,Ustekinumab Only,595,positive,adult,,booster1,27-May-21,06-Dec-20,172,mRNA,35,30 to 39
605,female,CD,Ustekinumab Only,136,negative,adult,262,booster1,21-Aug-21,20-Mar-21,154,mRNA,36,30 to 39
606,female,CD,Ustekinumab Only,198,negative,adult,218,booster2,12-Mar-22,24-Sep-21,169,mRNA,36,30 to 39
607,female,CD,Ustekinumab Only,798,positive,adult,77,primary,02-Jun-21,21-Jan-21,132,mRNA,48,40 to 49
608,female,CD,Ustekinumab Only,521,positive,adult,23,booster1,04-Aug-21,17-Apr-21,109,mRNA,48,40 to 49
609,female,CD,Ustekinumab Only,747,positive,adult,,booster1,19-Jan-22,19-Jul-21,184,mRNA,49,40 to 49
610,female,CD,Ustekinumab Only,69314,positive,adult,,booster2,17-Jun-22,06-Apr-22,72,mRNA,49,40 to 49
611,female,CD,Vedolizumab Only,1355,positive,adult,220,booster1,06-Jul-21,28-Feb-21,128,vector,40,40 to 49
612,female,CD,Vedolizumab Only,12788,positive,adult,71,booster2,02-Dec-21,12-Oct-21,51,vector,41,40 to 49
613,female,CD,Vedolizumab Only,1003,positive,adult,41,booster2,24-Mar-22,08-Sep-21,197,vector,41,40 to 49
614,female,CD,Anti-TNF Only,1405,positive,elderly,,booster1,10-Aug-21,08-Apr-21,124,mRNA,67,60 to 69
615,female,CD,Anti-TNF Only,681,positive,elderly,,booster2,25-Jan-22,04-Sep-21,143,mRNA,67,60 to 69
616,female,CD,Anti-TNF Only,476,positive,elderly,,booster2,04-Jun-22,17-Nov-21,199,mRNA,68,60 to 69
617,female,CD,Ustekinumab Only,926,positive,adult,18,pre_dose,09-Jun-21,05-Jan-21,155,vector,58,50 to 59
618,female,CD,Ustekinumab Only,33685,positive,adult,59,primary,20-Jul-21,28-Apr-21,83,vector,58,50 to 59
619,female,CD,Ustekinumab Only,453,positive,adult,,booster1,12-Aug-21,08-Mar-21,157,vector,58,50 to 59
620,female,CD,Ustekinumab Only,23107,positive,adult,294,booster2,12-Mar-22,17-Jan-22,54,vector,59,50 to 59
621,female,CD,Ustekinumab Only,71237,positive,adult,405,booster2,01-Jul-22,11-May-22,51,vector,59,50 to 59
622,female,CD,Combination Therapy,16,negative,adult,,primary,04-Jun-21,03-Dec-20,183,mRNA,36,30 to 39
623,female,CD,Combination Therapy,,,adult,,booster1,29-Jul-21,19-Feb-21,160,mRNA,36,30 to 39
624,female,CD,Combination Therapy,1217,positive,adult,,booster2,11-Mar-22,05-Sep-21,187,mRNA,37,30 to 39
625,female,CD,Anti-TNF Only,36026,positive,elderly,40,pre_dose,05-Mar-21,30-Dec-20,65,mRNA,64,60 to 69
626,female,CD,Anti-TNF Only,764,positive,elderly,265,primary,16-Oct-21,15-Jun-21,123,mRNA,64,60 to 69
627,female,CD,Anti-TNF Only,130,negative,elderly,331,booster1,21-Dec-21,27-Jul-21,147,mRNA,65,60 to 69
628,female,UC,Vedolizumab Only,730,positive,adult,,booster1,06-Aug-21,14-Feb-21,173,mRNA,24,18 to 29
629,female,UC,Vedolizumab Only,1177,positive,adult,,booster2,26-Jan-22,09-Aug-21,170,mRNA,25,18 to 29
630,female,UC,Vedolizumab Only,538,positive,adult,,booster2,22-May-22,09-Nov-21,194,mRNA,25,18 to 29
631,female,CD,Combination Therapy,59217,positive,adult,218,booster1,16-Sep-21,26-Jun-21,82,vector,35,30 to 39
632,female,CD,Combination Therapy,3316,positive,adult,135,booster2,08-Dec-21,11-Oct-21,58,vector,35,30 to 39
633,female,CD,Ustekinumab Only,943,positive,adult,,booster1,15-Jul-21,13-Feb-21,152,mRNA,43,40 to 49
634,male,CD,Vedolizumab Only,217,positive,adult,290,booster1,22-Jul-21,06-Mar-21,138,mRNA,41,40 to 49
635,male,CD,Vedolizumab Only,1265,positive,adult,177,booster2,12-Nov-21,26-Apr-21,200,mRNA,41,40 to 49
636,male,CD,Vedolizumab Only,942,positive,adult,92,booster2,05-Feb-22,26-Jul-21,194,mRNA,42,40 to 49
637,male,CD,Anti-TNF Only,638,positive,adult,,booster1,22-Aug-21,13-Apr-21,131,mRNA,32,30 to 39
638,male,CD,Anti-TNF Only,8941,positive,adult,,booster2,18-Dec-21,19-Sep-21,90,mRNA,33,30 to 39
639,female,CD,Anti-TNF Only,41988,positive,adult,,booster1,19-Aug-21,27-May-21,84,mRNA,54,50 to 59
640,female,CD,Vedolizumab Only,26753,positive,adult,,booster1,24-Jul-21,20-May-21,65,vector,53,50 to 59
641,female,CD,Vedolizumab Only,61,negative,adult,,booster2,11-Nov-21,26-Apr-21,199,vector,54,50 to 59
642,female,CD,Vedolizumab Only,1012,positive,adult,,booster2,18-Feb-22,19-Oct-21,122,vector,54,50 to 59
643,female,CD,Vedolizumab Only,73212,positive,adult,,booster2,18-Mar-22,13-Dec-21,95,vector,54,50 to 59
644,female,CD,Vedolizumab Only,1008,positive,adult,,booster2,09-Jul-22,11-Feb-22,148,vector,54,50 to 59
645,female,CD,Vedolizumab Only,11,negative,adult,,booster1,25-Aug-21,19-Feb-21,187,mRNA,36,30 to 39
646,female,CD,Vedolizumab Only,1074,positive,adult,,booster2,24-Dec-21,23-Aug-21,123,mRNA,36,30 to 39
647,female,UC,No Immunosuppressives,1475,positive,adult,203,pre_dose,30-Mar-21,10-Oct-20,171,vector,26,18 to 29
648,female,UC,No Immunosuppressives,59130,positive,adult,522,booster2,12-Feb-22,08-Dec-21,66,vector,27,18 to 29
649,male,CD,Ustekinumab Only,633,positive,adult,,pre_dose,25-Feb-21,25-Oct-20,123,mRNA,54,50 to 59
650,female,CD,Anti-TNF Only,342,positive,adult,142,pre_dose,12-Mar-21,21-Sep-20,172,mRNA,50,50 to 59
651,female,CD,Anti-TNF Only,409,positive,adult,225,primary,03-Jun-21,07-Feb-21,116,mRNA,50,50 to 59
652,female,CD,Anti-TNF Only,,,adult,282,booster1,30-Jul-21,07-Apr-21,114,mRNA,50,50 to 59
653,female,CD,Anti-TNF Only,40409,positive,adult,444,booster1,08-Jan-22,01-Oct-21,99,mRNA,50,50 to 59
654,female,CD,Anti-TNF Only,1228,positive,adult,470,booster2,03-Feb-22,28-Jul-21,190,mRNA,50,50 to 59
655,female,CD,Anti-TNF Only,1480,positive,adult,582,booster2,26-May-22,12-Feb-22,103,mRNA,51,50 to 59
656,male,UC,Tofacitinib Only,1468,positive,adult,,booster2,21-Jul-22,06-Apr-22,106,vector,38,30 to 39
657,female,CD,Vedolizumab Only,79101,positive,adult,259,booster1,08-Aug-21,05-May-21,95,mRNA,52,50 to 59
658,female,CD,Vedolizumab Only,1088,positive,adult,18,booster2,12-May-22,01-Feb-22,100,mRNA,53,50 to 59
659,female,CD,Anti-TNF Only,69,negative,adult,262,primary,28-Apr-21,11-Nov-20,168,mRNA,49,40 to 49
660,female,CD,Anti-TNF Only,1188,positive,adult,124,booster2,22-Oct-21,03-May-21,172,mRNA,49,40 to 49
661,female,CD,Combination Therapy,1133,positive,adult,224,booster1,09-Jul-21,06-Mar-21,125,mRNA,23,18 to 29
662,female,CD,Combination Therapy,379,positive,adult,43,booster2,02-Apr-22,28-Nov-21,125,mRNA,24,18 to 29
663,female,CD,Vedolizumab Only,69713,positive,adult,294,primary,27-Feb-21,26-Dec-20,63,mRNA,37,30 to 39
664,female,CD,Vedolizumab Only,1067,positive,adult,287,booster1,06-Mar-21,25-Aug-20,193,mRNA,37,30 to 39
665,female,CD,Vedolizumab Only,35405,positive,adult,,booster1,18-Dec-21,16-Oct-21,63,mRNA,38,30 to 39
666,female,CD,Vedolizumab Only,72996,positive,adult,5,booster1,23-Dec-21,28-Oct-21,56,mRNA,38,30 to 39
667,female,CD,Anti-TNF Only,3630,positive,adult,25,pre_dose,24-Dec-20,03-Oct-20,82,vector,41,40 to 49
668,female,CD,Anti-TNF Only,119,negative,adult,304,primary,29-Sep-21,12-Jun-21,109,vector,42,40 to 49
669,male,CD,Anti-TNF Only,15209,positive,adult,218,pre_dose,02-Feb-21,29-Oct-20,96,mRNA,48,40 to 49
670,male,CD,Anti-TNF Only,4832,positive,adult,408,booster1,22-Jul-21,25-May-21,58,mRNA,48,40 to 49
671,male,CD,Anti-TNF Only,36011,positive,adult,590,booster2,20-Jan-22,28-Nov-21,53,mRNA,48,40 to 49
672,male,CD,Anti-TNF Only,576,positive,adult,696,booster2,06-May-22,20-Nov-21,167,mRNA,49,40 to 49
673,male,CD,Anti-TNF Only,759,positive,adult,738,booster2,17-Jun-22,22-Feb-22,115,mRNA,49,40 to 49
674,female,CD,Anti-TNF Only,16992,positive,adult,101,pre_dose,13-Mar-21,23-Dec-20,80,mRNA,29,18 to 29
675,female,CD,Anti-TNF Only,1129,positive,adult,273,booster1,01-Sep-21,19-Apr-21,135,mRNA,29,18 to 29
676,male,UC,Combination Therapy,601,positive,adult,119,pre_dose,08-Apr-21,28-Oct-20,162,mRNA,44,40 to 49
677,male,UC,Combination Therapy,1093,positive,adult,199,primary,27-Jun-21,25-Jan-21,153,mRNA,44,40 to 49
678,male,UC,Combination Therapy,47376,positive,adult,238,booster1,05-Aug-21,14-Jun-21,52,mRNA,44,40 to 49
679,male,UC,Combination Therapy,35266,positive,adult,77,booster1,23-Dec-21,21-Oct-21,63,mRNA,45,40 to 49
680,female,UC,Anti-TNF Only,25676,positive,adult,359,primary,27-May-21,05-Apr-21,52,mRNA,30,30 to 39
681,female,UC,Anti-TNF Only,465,positive,adult,319,booster1,06-Jul-21,31-Jan-21,156,mRNA,30,30 to 39
682,female,UC,Anti-TNF Only,12946,positive,adult,239,booster1,24-Sep-21,08-Jul-21,78,mRNA,30,30 to 39
683,female,UC,Anti-TNF Only,79441,positive,adult,105,booster2,05-Feb-22,30-Nov-21,67,mRNA,30,30 to 39
684,female,CD,Combination Therapy,1204,positive,adult,236,booster1,06-Aug-21,21-Jan-21,197,mRNA,48,40 to 49
685,female,CD,Combination Therapy,804,positive,adult,98,booster1,22-Dec-21,06-Sep-21,107,mRNA,49,40 to 49
686,female,CD,Combination Therapy,53993,positive,adult,32,booster2,26-Feb-22,28-Dec-21,60,mRNA,49,40 to 49
687,female,CD,Combination Therapy,1147,positive,adult,73,booster2,11-Jun-22,28-Nov-21,195,mRNA,49,40 to 49
688,female,CD,Anti-TNF Only,216,positive,adult,,pre_dose,16-Mar-21,12-Nov-20,124,vector,61,60 to 69
689,female,CD,Anti-TNF Only,1094,positive,adult,23,primary,18-May-21,19-Nov-20,180,vector,61,60 to 69
690,female,CD,Anti-TNF Only,59,negative,adult,,booster1,20-Jul-21,24-Mar-21,118,vector,61,60 to 69
691,female,CD,Anti-TNF Only,376,positive,adult,,booster1,18-Sep-21,25-May-21,116,vector,61,60 to 69
692,female,CD,Anti-TNF Only,16829,positive,adult,,booster2,27-Oct-21,23-Aug-21,65,vector,61,60 to 69
693,female,CD,Anti-TNF Only,702,positive,adult,,booster2,02-Mar-22,16-Sep-21,167,vector,62,60 to 69
694,other,CD,Anti-TNF Only,1212,positive,elderly,,booster2,25-Jun-22,18-Jan-22,158,vector,62,60 to 69
695,female,CD,Anti-TNF Only,28605,positive,adult,198,booster1,19-Aug-21,27-May-21,84,vector,48,40 to 49
696,female,CD,Anti-TNF Only,50767,positive,adult,21,booster1,26-Mar-22,16-Jan-22,69,vector,49,40 to 49
697,female,CD,Combination Therapy,662,positive,adult,,booster1,23-Jul-21,17-Mar-21,128,mRNA,55,50 to 59
698,female,CD,Combination Therapy,41325,positive,adult,,booster2,23-Nov-21,19-Sep-21,65,mRNA,56,50 to 59
699,female,CD,Combination Therapy,8793,positive,adult,,booster2,18-Feb-22,29-Nov-21,81,mRNA,56,50 to 59
700,female,CD,Combination Therapy,530,positive,adult,401,booster2,19-Apr-22,09-Dec-21,131,mRNA,56,50 to 59
701,female,CD,Combination Therapy,195,negative,adult,350,booster2,04-Aug-22,04-Apr-22,122,mRNA,57,50 to 59
702,male,UC,Anti-TNF Only,1115,positive,adult,210,pre_dose,29-Dec-20,20-Jul-20,162,mRNA,59,50 to 59
703,male,UC,Anti-TNF Only,,,adult,39,primary,27-May-21,10-Feb-21,106,mRNA,59,50 to 59
704,male,UC,Anti-TNF Only,1421,positive,adult,,booster1,06-Aug-21,22-Jan-21,196,mRNA,59,50 to 59
705,male,UC,Anti-TNF Only,1067,positive,adult,,booster2,07-Nov-21,07-May-21,184,mRNA,59,50 to 59
706,female,CD,Anti-TNF Only,600,positive,adult,,pre_dose,21-Jan-21,06-Jul-20,199,mRNA,56,50 to 59
707,female,CD,Anti-TNF Only,55903,positive,adult,,pre_dose,24-Feb-21,19-Dec-20,67,mRNA,57,50 to 59
708,female,CD,Anti-TNF Only,2249,positive,adult,,booster1,16-Jun-21,24-Apr-21,53,mRNA,57,50 to 59
709,female,CD,Anti-TNF Only,1447,positive,adult,401,booster1,05-Aug-21,22-Feb-21,164,mRNA,57,50 to 59
710,female,CD,Anti-TNF Only,1472,positive,adult,291,booster1,02-Oct-21,23-Apr-21,162,mRNA,57,50 to 59
711,female,CD,Anti-TNF Only,71351,positive,adult,395,booster2,14-Jan-22,06-Nov-21,69,mRNA,57,50 to 59
712,female,CD,Anti-TNF Only,1084,positive,adult,540,booster2,08-Jun-22,17-Dec-21,173,mRNA,58,50 to 59
713,female,CD,Anti-TNF Only,1481,positive,elderly,321,booster1,22-Jul-21,26-Feb-21,146,mRNA,66,60 to 69
714,female,CD,Anti-TNF Only,1708,positive,elderly,197,booster2,23-Nov-21,28-Aug-21,87,mRNA,66,60 to 69
715,male,CD,Combination Therapy,211,positive,adult,210,pre_dose,29-Jul-21,23-Mar-21,128,vector,56,50 to 59
716,male,CD,Vedolizumab Only,22129,positive,adult,,booster1,27-Jul-21,31-May-21,57,mRNA,46,40 to 49
717,male,CD,Vedolizumab Only,23387,positive,adult,,booster2,18-Nov-21,12-Aug-21,98,mRNA,46,40 to 49
718,male,CD,Vedolizumab Only,61265,positive,adult,,booster2,02-Feb-22,28-Oct-21,97,mRNA,46,40 to 49
719,female,CD,Anti-TNF Only,54983,positive,elderly,350,primary,09-May-21,02-Feb-21,96,mRNA,63,60 to 69
720,female,CD,Anti-TNF Only,66131,positive,elderly,203,booster1,25-Jul-21,03-May-21,83,mRNA,63,60 to 69
721,female,CD,Anti-TNF Only,985,positive,elderly,75,booster1,30-Nov-21,15-May-21,199,mRNA,64,60 to 69
722,female,CD,Anti-TNF Only,440,positive,elderly,158,booster1,21-Jul-22,23-Feb-22,148,mRNA,64,60 to 69
723,male,CD,Combination Therapy,705,positive,adult,,booster1,24-Aug-21,28-Apr-21,118,mRNA,37,30 to 39
724,male,CD,Combination Therapy,1439,positive,adult,,booster2,23-Feb-22,11-Nov-21,104,mRNA,37,30 to 39
725,male,CD,Combination Therapy,379,positive,adult,185,booster1,13-Aug-21,03-May-21,102,vector,59,50 to 59
726,male,CD,Combination Therapy,68690,positive,adult,93,booster2,13-Nov-21,25-Aug-21,80,vector,59,50 to 59
727,male,CD,Combination Therapy,31696,positive,adult,10,booster2,04-Feb-22,17-Nov-21,79,vector,59,50 to 59
728,male,CD,Anti-TNF Only,39108,positive,adult,,pre_dose,31-Mar-21,08-Feb-21,51,mRNA,61,60 to 69
729,male,CD,Anti-TNF Only,1126,positive,adult,210,booster2,11-Nov-21,18-Jul-21,116,mRNA,61,60 to 69
730,male,CD,Anti-TNF Only,424,positive,adult,,booster2,09-Mar-22,24-Nov-21,105,mRNA,62,60 to 69
731,male,CD,Anti-TNF Only,1182,positive,adult,,booster2,04-May-22,14-Dec-21,141,mRNA,62,60 to 69
732,male,CD,Anti-TNF Only,76614,positive,adult,,booster2,05-Aug-22,20-May-22,77,mRNA,62,60 to 69
733,female,CD,Anti-TNF Only,1440,positive,adult,243,booster1,18-Aug-21,12-Feb-21,187,mRNA,40,40 to 49
734,female,CD,Anti-TNF Only,78634,positive,adult,137,booster2,02-Dec-21,24-Sep-21,69,mRNA,40,40 to 49
735,female,CD,Anti-TNF Only,1399,positive,adult,159,pre_dose,28-May-21,13-Dec-20,166,mRNA,42,40 to 49
736,female,CD,Anti-TNF Only,18045,positive,adult,256,booster1,02-Sep-21,11-Jul-21,53,mRNA,42,40 to 49
737,female,CD,Anti-TNF Only,1358,positive,adult,414,booster2,07-Feb-22,06-Oct-21,124,mRNA,43,40 to 49
738,female,CD,Anti-TNF Only,,,adult,,booster1,01-Aug-21,20-Mar-21,134,mRNA,48,40 to 49
739,female,CD,Anti-TNF Only,474,positive,adult,39,booster1,07-Aug-21,17-Feb-21,171,mRNA,51,50 to 59
740,female,CD,Anti-TNF Only,540,positive,adult,,booster2,26-Nov-21,06-Jul-21,143,mRNA,51,50 to 59
741,female,CD,Anti-TNF Only,247,positive,adult,,booster2,24-Feb-22,02-Nov-21,114,mRNA,52,50 to 59
742,male,CD,Anti-TNF Only,431,positive,adult,211,booster1,03-Jul-21,28-Feb-21,125,vector,58,50 to 59
743,male,CD,Anti-TNF Only,32220,positive,adult,133,booster1,19-Sep-21,29-Jul-21,52,vector,58,50 to 59
744,male,CD,Anti-TNF Only,1464,positive,adult,69,booster2,22-Nov-21,29-Jun-21,146,vector,59,50 to 59
745,male,CD,Anti-TNF Only,1020,positive,adult,9,booster2,21-Jan-22,26-Aug-21,148,vector,59,50 to 59
746,female,CD,Combination Therapy,472,positive,adult,292,primary,04-Jul-21,08-Feb-21,146,mRNA,47,40 to 49
747,female,CD,Combination Therapy,458,positive,adult,251,booster1,14-Aug-21,04-Mar-21,163,mRNA,47,40 to 49
748,female,CD,Combination Therapy,656,positive,adult,133,booster2,10-Dec-21,25-Aug-21,107,mRNA,47,40 to 49
749,female,CD,Combination Therapy,56817,positive,adult,,booster2,05-Apr-22,06-Jan-22,89,mRNA,47,40 to 49
750,female,UC,No Immunosuppressives,74212,positive,adult,83,pre_dose,02-Jan-21,30-Sep-20,94,mRNA,34,30 to 39
751,female,UC,No Immunosuppressives,786,positive,adult,293,booster1,31-Jul-21,22-Mar-21,131,mRNA,35,30 to 39
752,female,UC,No Immunosuppressives,31316,positive,adult,607,booster2,10-Jun-22,27-Mar-22,75,mRNA,35,30 to 39
753,male,CD,Combination Therapy,641,positive,adult,57,pre_dose,10-Feb-21,31-Aug-20,163,mRNA,33,30 to 39
754,male,CD,Combination Therapy,491,positive,adult,226,booster1,29-Jul-21,04-Feb-21,175,mRNA,33,30 to 39
755,female,UC,Anti-TNF Only,456,positive,adult,73,pre_dose,19-Feb-21,18-Sep-20,154,vector,47,40 to 49
756,female,UC,Anti-TNF Only,503,positive,adult,217,primary,13-Jul-21,29-Jan-21,165,vector,48,40 to 49
757,female,UC,Anti-TNF Only,26062,positive,adult,240,booster1,05-Aug-21,23-May-21,74,vector,48,40 to 49
758,female,UC,Anti-TNF Only,621,positive,adult,336,booster1,09-Nov-21,25-Apr-21,198,vector,48,40 to 49
759,female,UC,No Immunosuppressives,426,positive,adult,,pre_dose,16-Feb-21,04-Sep-20,165,mRNA,51,50 to 59
760,female,UC,No Immunosuppressives,187,negative,adult,257,booster1,14-Aug-21,11-Feb-21,184,mRNA,51,50 to 59
761,female,UC,No Immunosuppressives,1307,positive,adult,347,booster2,12-Nov-21,24-Jun-21,141,mRNA,51,50 to 59
762,female,UC,No Immunosuppressives,71719,positive,adult,491,booster2,05-Apr-22,10-Feb-22,54,mRNA,52,50 to 59
763,female,CD,Ustekinumab Only,1102,positive,adult,,booster1,29-Oct-21,27-Jun-21,124,mRNA,56,50 to 59
764,female,CD,Combination Therapy,274,positive,adult,,pre_dose,14-Jan-21,22-Aug-20,145,mRNA,52,50 to 59
765,female,CD,Combination Therapy,683,positive,adult,,booster1,29-Jul-21,22-Feb-21,157,mRNA,53,50 to 59
766,female,CD,Combination Therapy,576,positive,adult,,booster2,03-Feb-22,01-Sep-21,155,mRNA,53,50 to 59
767,female,CD,Combination Therapy,15,negative,adult,,booster2,03-Jun-22,20-Jan-22,134,mRNA,53,50 to 59
768,female,CD,Anti-TNF Only,37076,positive,adult,64,booster2,03-Feb-22,04-Dec-21,61,vector,29,18 to 29
769,female,UC,Anti-TNF Only,1429,positive,adult,,booster1,14-Aug-21,05-May-21,101,vector,39,30 to 39
770,female,UC,Anti-TNF Only,938,positive,adult,10,booster2,16-Feb-22,12-Aug-21,188,vector,40,40 to 49
771,female,CD,Anti-TNF Only,1199,positive,elderly,,primary,13-May-21,08-Nov-20,186,mRNA,66,60 to 69
772,female,CD,Anti-TNF Only,1395,positive,elderly,,booster1,12-Aug-21,26-Mar-21,139,mRNA,66,60 to 69
773,female,CD,Anti-TNF Only,6180,positive,elderly,,booster2,12-Nov-21,28-Aug-21,76,mRNA,67,60 to 69
774,female,CD,Anti-TNF Only,810,positive,elderly,,booster2,11-Mar-22,11-Sep-21,181,mRNA,67,60 to 69
775,female,CD,Anti-TNF Only,542,positive,elderly,,booster2,05-May-22,30-Dec-21,126,mRNA,67,60 to 69
776,male,CD,Combination Therapy,1411,positive,adult,,primary,03-Jul-21,20-Feb-21,133,vector,33,30 to 39
777,male,CD,Combination Therapy,67,negative,adult,,booster1,23-Oct-21,04-May-21,172,vector,33,30 to 39
778,male,CD,Anti-TNF Only,807,positive,adult,368,booster1,29-Jul-21,13-Apr-21,107,mRNA,55,50 to 59
779,male,CD,Anti-TNF Only,683,positive,adult,,booster2,12-Nov-21,04-Aug-21,100,mRNA,55,50 to 59
780,male,CD,Anti-TNF Only,78884,positive,adult,165,booster2,17-Feb-22,27-Nov-21,82,mRNA,56,50 to 59
781,female,CD,Anti-TNF Only,391,positive,adult,259,primary,29-Jun-21,12-Feb-21,137,mRNA,47,40 to 49
782,female,CD,Anti-TNF Only,29352,positive,adult,238,booster1,20-Jul-21,10-May-21,71,mRNA,47,40 to 49
783,female,CD,Anti-TNF Only,146,negative,adult,101,booster1,04-Dec-21,12-Aug-21,114,mRNA,47,40 to 49
784,female,CD,Anti-TNF Only,916,positive,adult,68,booster2,06-Jan-22,08-Aug-21,151,mRNA,47,40 to 49
785,female,CD,Anti-TNF Only,114,negative,adult,63,booster2,17-May-22,20-Dec-21,148,mRNA,48,40 to 49
786,male,UC,Anti-TNF Only,78251,positive,adult,173,booster1,26-Aug-21,03-Jun-21,84,mRNA,34,30 to 39
787,male,UC,Anti-TNF Only,44126,positive,adult,89,booster2,18-Nov-21,17-Sep-21,62,mRNA,34,30 to 39
788,male,UC,Anti-TNF Only,1339,positive,adult,14,booster2,01-Mar-22,06-Sep-21,176,mRNA,35,30 to 39
789,female,CD,Anti-TNF Only,66433,positive,adult,,pre_dose,07-Apr-21,14-Jan-21,83,mRNA,51,50 to 59
790,female,CD,Anti-TNF Only,63105,positive,adult,,primary,01-Jun-21,23-Feb-21,98,mRNA,51,50 to 59
791,female,UC,Anti-TNF Only,1473,positive,adult,,booster1,27-Jul-22,19-Feb-22,158,mRNA,54,50 to 59
792,male,CD,Vedolizumab Only,888,positive,elderly,,primary,11-May-21,17-Dec-20,145,mRNA,68,60 to 69
793,male,CD,Vedolizumab Only,31037,positive,elderly,,booster1,06-Jul-21,11-May-21,56,mRNA,68,60 to 69
794,male,CD,Vedolizumab Only,342,positive,elderly,,booster1,28-Oct-21,30-May-21,151,mRNA,68,60 to 69
795,male,CD,Vedolizumab Only,1024,positive,elderly,,booster2,28-Dec-21,08-Jul-21,173,mRNA,69,60 to 69
796,male,CD,Vedolizumab Only,1470,positive,elderly,,booster2,14-Jun-22,21-Dec-21,175,mRNA,69,60 to 69
797,female,CD,Corticosteroids,723,positive,elderly,,primary,20-May-21,03-Nov-20,198,mRNA,66,60 to 69
798,female,CD,Corticosteroids,45786,positive,elderly,,booster1,24-Jul-21,23-Apr-21,92,mRNA,66,60 to 69
799,female,CD,Corticosteroids,1352,positive,elderly,,booster2,03-Mar-22,29-Aug-21,186,mRNA,67,60 to 69
800,female,CD,Corticosteroids,619,positive,elderly,,booster2,14-Jul-22,26-Mar-22,110,mRNA,67,60 to 69
801,female,CD,Anti-TNF Only,1426,positive,adult,,booster1,04-Aug-21,29-Mar-21,128,mRNA,49,40 to 49
802,female,CD,Anti-TNF Only,1313,positive,adult,,booster2,13-Apr-22,06-Nov-21,158,mRNA,50,50 to 59
803,female,CD,Anti-TNF Only,1209,positive,adult,,primary,03-Mar-21,20-Oct-20,134,vector,32,30 to 39
804,female,CD,Anti-TNF Only,63,negative,adult,,booster1,27-Jul-21,10-Feb-21,167,vector,32,30 to 39
805,female,CD,Anti-TNF Only,1433,positive,adult,,booster2,13-Apr-22,02-Jan-22,101,vector,33,30 to 39
806,male,UC,Vedolizumab Only,799,positive,adult,,pre_dose,22-Apr-21,17-Oct-20,187,mRNA,54,50 to 59
807,male,UC,Vedolizumab Only,165,negative,adult,,booster2,19-May-22,11-Nov-21,189,mRNA,55,50 to 59
808,female,UC,Combination Therapy,258,positive,adult,,pre_dose,30-Apr-21,03-Jan-21,117,mRNA,41,40 to 49
809,female,UC,Combination Therapy,414,positive,adult,,booster1,23-Jul-21,19-Feb-21,154,mRNA,41,40 to 49
810,female,UC,Combination Therapy,455,positive,adult,30,booster1,06-Jan-22,10-Aug-21,149,mRNA,41,40 to 49
811,female,UC,Combination Therapy,598,positive,adult,7,booster1,12-Feb-22,20-Sep-21,145,mRNA,41,40 to 49
812,male,UC,Tofacitinib Only,14435,positive,adult,,booster1,29-Aug-21,24-May-21,97,mRNA,32,30 to 39
813,male,UC,Tofacitinib Only,1312,positive,adult,,booster2,13-Feb-22,04-Aug-21,193,mRNA,32,30 to 39
814,female,UC,Anti-TNF Only,494,positive,adult,31,primary,31-Dec-20,44010,186,vector,34,30 to 39
815,male,UC,Ustekinumab Only,805,positive,adult,173,booster1,12-Aug-21,17-Mar-21,148,mRNA,22,18 to 29
816,male,UC,Ustekinumab Only,11956,positive,adult,6,booster1,26-Jan-22,06-Nov-21,81,mRNA,23,18 to 29
817,male,CD,Ustekinumab Only,638,positive,elderly,,booster1,23-Jul-21,11-Jan-21,193,mRNA,66,60 to 69
818,female,CD,Anti-TNF Only,7769,positive,adult,37,pre_dose,13-Jan-21,27-Oct-20,78,mRNA,36,30 to 39
819,female,CD,Anti-TNF Only,2,negative,adult,,pre_dose,01-Sep-21,19-Apr-21,135,mRNA,37,30 to 39
820,female,CD,Anti-TNF Only,55503,positive,adult,13,booster1,02-Feb-22,24-Nov-21,70,mRNA,47,40 to 49
821,female,CD,Anti-TNF Only,614,positive,adult,145,booster2,14-Jun-22,13-Jan-22,152,mRNA,48,40 to 49
822,female,CD,Combination Therapy,,,adult,,primary,22-Oct-21,44427,64,vector,53,50 to 59
823,male,CD,Anti-TNF Only,22,negative,adult,,primary,20-Apr-21,44202,104,vector,43,40 to 49
824,male,CD,Combination Therapy,41500,positive,adult,221,booster1,30-Jun-21,07-May-21,54,mRNA,25,18 to 29
825,male,CD,Combination Therapy,4207,positive,adult,127,booster1,02-Oct-21,02-Aug-21,61,mRNA,26,18 to 29
826,male,CD,Combination Therapy,906,positive,adult,32,booster2,10-Mar-22,23-Nov-21,107,mRNA,26,18 to 29
827,male,CD,Combination Therapy,728,positive,adult,151,booster2,07-Jul-22,01-Mar-22,128,mRNA,26,18 to 29
828,male,CD,Ustekinumab Only,1443,positive,elderly,,primary,01-Jun-21,14-Jan-21,138,mRNA,64,60 to 69
829,male,CD,Ustekinumab Only,26985,positive,elderly,,booster1,11-Aug-21,18-May-21,85,mRNA,64,60 to 69
830,male,CD,Ustekinumab Only,961,positive,elderly,,booster2,10-Feb-22,04-Sep-21,159,mRNA,64,60 to 69
831,male,CD,Ustekinumab Only,72601,positive,elderly,,booster2,05-May-22,18-Feb-22,76,mRNA,65,60 to 69
832,male,CD,Ustekinumab Only,1480,positive,adult,60,pre_dose,23-Apr-21,18-Oct-20,187,mRNA,53,50 to 59
833,male,CD,Ustekinumab Only,1071,positive,adult,93,primary,26-May-21,25-Nov-20,182,mRNA,53,50 to 59
834,male,CD,Ustekinumab Only,58885,positive,adult,166,booster1,07-Aug-21,09-May-21,90,mRNA,53,50 to 59
835,male,CD,Ustekinumab Only,74075,positive,adult,331,booster1,19-Jan-22,28-Oct-21,83,mRNA,54,50 to 59
836,male,CD,Ustekinumab Only,47381,positive,adult,370,booster2,27-Feb-22,03-Jan-22,55,mRNA,54,50 to 59
837,male,CD,Ustekinumab Only,73410,positive,adult,484,booster2,21-Jun-22,20-Mar-22,93,mRNA,54,50 to 59
838,male,CD,Combination Therapy,445,positive,adult,,pre_dose,07-Aug-21,08-Mar-21,152,mRNA,46,40 to 49
839,male,CD,Anti-TNF Only,,,adult,,booster1,05-Aug-21,17-Jan-21,200,vector,35,30 to 39
840,male,CD,Anti-TNF Only,45341,positive,adult,400,booster1,28-Jan-22,29-Nov-21,60,vector,36,30 to 39
841,male,CD,Anti-TNF Only,316,positive,adult,567,booster1,14-Jul-22,08-Mar-22,128,vector,36,30 to 39
842,male,CD,Ustekinumab Only,1437,positive,elderly,,primary,29-Apr-21,10-Dec-20,140,mRNA,76,70+
843,male,CD,Ustekinumab Only,831,positive,elderly,,booster1,10-Jun-21,19-Dec-20,173,mRNA,76,70+
844,male,CD,Ustekinumab Only,1276,positive,elderly,,booster1,16-Sep-21,13-May-21,126,mRNA,76,70+
845,male,CD,Ustekinumab Only,991,positive,elderly,,booster2,22-Jan-22,29-Aug-21,146,mRNA,77,70+
846,male,CD,Ustekinumab Only,1457,positive,elderly,,primary,20-Apr-21,10-Jan-21,100,mRNA,73,70+
847,male,CD,Ustekinumab Only,9775,positive,elderly,,booster1,11-Jun-21,14-Apr-21,58,mRNA,73,70+
848,male,CD,Ustekinumab Only,60823,positive,elderly,,booster1,14-Sep-21,20-Jul-21,56,mRNA,74,70+
849,male,CD,Ustekinumab Only,1267,positive,elderly,,booster2,19-Jan-22,10-Aug-21,162,mRNA,74,70+
850,female,CD,Combination Therapy,1448,positive,adult,335,booster1,25-Jun-21,15-Mar-21,102,mRNA,26,18 to 29
851,female,CD,Combination Therapy,1426,positive,adult,251,booster1,17-Sep-21,04-Apr-21,166,mRNA,27,18 to 29
852,female,CD,Combination Therapy,1214,positive,adult,190,booster2,17-Nov-21,30-Jul-21,110,mRNA,27,18 to 29
853,female,CD,Combination Therapy,64168,positive,adult,41,booster2,15-Apr-22,27-Jan-22,78,mRNA,27,18 to 29
854,male,CD,Vedolizumab Only,74084,positive,elderly,,booster1,10-Jun-21,28-Mar-21,74,mRNA,77,70+
855,male,CD,Vedolizumab Only,51114,positive,elderly,,booster1,08-Sep-21,01-Jun-21,99,mRNA,78,70+
856,male,CD,Vedolizumab Only,534,positive,elderly,,booster2,18-Feb-22,15-Sep-21,156,mRNA,78,70+
857,female,UC,No Immunosuppressives,64656,positive,elderly,,primary,14-May-21,24-Feb-21,79,mRNA,72,70+
858,female,UC,No Immunosuppressives,32067,positive,elderly,,booster1,30-Jul-21,26-Apr-21,95,mRNA,72,70+
859,female,UC,No Immunosuppressives,8574,positive,elderly,,booster2,18-Mar-22,17-Jan-22,60,mRNA,73,70+
860,female,UC,No Immunosuppressives,268,positive,elderly,,booster2,27-May-22,12-Jan-22,135,mRNA,73,70+
861,male,CD,Ustekinumab Only,70106,positive,adult,,primary,27-Jul-21,20-Apr-21,98,mRNA,56,50 to 59
862,male,CD,Ustekinumab Only,1055,positive,adult,,booster1,08-Jan-22,13-Jul-21,179,mRNA,57,50 to 59
863,female,CD,Ustekinumab Only,70728,positive,elderly,,booster1,04-Aug-21,03-Jun-21,62,mRNA,64,60 to 69
864,female,CD,Ustekinumab Only,38255,positive,elderly,,booster2,11-Nov-21,12-Sep-21,60,mRNA,64,60 to 69
865,female,CD,Ustekinumab Only,212,positive,elderly,,booster2,13-Feb-22,09-Sep-21,157,mRNA,64,60 to 69
866,female,CD,Ustekinumab Only,786,positive,elderly,,booster2,21-Apr-22,19-Dec-21,123,mRNA,65,60 to 69
867,female,CD,Ustekinumab Only,1337,positive,elderly,,booster2,04-Aug-22,03-Apr-22,123,mRNA,65,60 to 69
868,female,CD,Corticosteroids,516,positive,adult,,booster1,07-Sep-21,22-May-21,108,mRNA,49,40 to 49
869,female,CD,Corticosteroids,34464,positive,adult,,booster2,07-Oct-21,29-Jul-21,70,mRNA,49,40 to 49
870,female,CD,Corticosteroids,732,positive,adult,,booster2,05-Feb-22,23-Jul-21,197,mRNA,49,40 to 49
871,female,CD,Corticosteroids,74892,positive,adult,,booster2,11-Jul-22,14-Apr-22,88,mRNA,50,50 to 59
872,male,CD,Ustekinumab Only,78230,positive,adult,215,booster1,26-Aug-21,07-Jul-21,50,mRNA,50,50 to 59
873,female,CD,Ustekinumab Only,442,positive,adult,,booster1,29-Jul-21,16-Feb-21,163,vector,43,40 to 49
874,female,CD,Ustekinumab Only,1361,positive,adult,,booster2,26-Jan-22,30-Sep-21,118,vector,44,40 to 49
875,female,CD,Ustekinumab Only,110,negative,adult,,booster2,09-Apr-22,06-Nov-21,154,vector,44,40 to 49
876,female,CD,Ustekinumab Only,5069,positive,adult,,booster2,07-Jul-22,31-Mar-22,98,vector,44,40 to 49
877,female,UC,Anti-TNF Only,122,negative,adult,190,booster1,04-Aug-21,22-Feb-21,163,mRNA,41,40 to 49
878,female,UC,Anti-TNF Only,67727,positive,adult,13,booster2,23-Feb-22,27-Dec-21,58,mRNA,41,40 to 49
879,male,CD,Anti-TNF Only,1271,positive,adult,,pre_dose,03-Apr-21,15-Dec-20,109,mRNA,25,18 to 29
880,male,CD,Anti-TNF Only,1021,positive,adult,371,primary,29-May-21,07-Dec-20,173,mRNA,25,18 to 29
881,male,UC,Anti-TNF Only,47,negative,adult,,primary,27-Jul-21,44204,200,vector,34,30 to 39
882,male,CD,Corticosteroids,445,positive,elderly,,booster1,14-May-21,11-Dec-20,154,mRNA,82,70+
883,male,CD,Corticosteroids,,,elderly,,booster1,11-Jun-21,12-Jan-21,150,mRNA,82,70+
884,male,CD,Corticosteroids,16265,positive,elderly,,booster1,04-Sep-21,28-Jun-21,68,mRNA,82,70+
885,male,CD,Corticosteroids,641,positive,elderly,,booster2,08-Apr-22,22-Oct-21,168,mRNA,83,70+
886,male,CD,Corticosteroids,77,negative,elderly,,booster2,30-Jul-22,06-Mar-22,146,mRNA,83,70+
887,female,CD,Ustekinumab Only,1424,positive,elderly,,primary,01-May-21,09-Jan-21,112,mRNA,66,60 to 69
888,female,CD,Ustekinumab Only,1470,positive,elderly,,booster1,10-Jun-21,30-Jan-21,131,mRNA,66,60 to 69
889,female,CD,Ustekinumab Only,1147,positive,elderly,,booster1,30-Sep-21,24-Apr-21,159,mRNA,66,60 to 69
890,female,CD,Ustekinumab Only,1334,positive,elderly,,booster2,05-Jan-22,10-Sep-21,117,mRNA,67,60 to 69
891,female,UC,Anti-TNF Only,772,positive,adult,272,booster1,10-Sep-21,23-Mar-21,171,mRNA,46,40 to 49
892,female,UC,Anti-TNF Only,1038,positive,adult,216,booster2,05-Nov-21,08-May-21,181,mRNA,46,40 to 49
893,female,UC,Anti-TNF Only,34537,positive,adult,104,booster2,25-Feb-22,27-Nov-21,90,mRNA,47,40 to 49
894,female,UC,Anti-TNF Only,686,positive,adult,48,booster2,22-Apr-22,26-Dec-21,117,mRNA,47,40 to 49
895,male,CD,Anti-TNF Only,187,negative,adult,,booster1,24-Sep-21,23-Apr-21,154,mRNA,54,50 to 59
896,male,CD,Anti-TNF Only,919,positive,adult,,booster2,01-Mar-22,25-Aug-21,188,mRNA,54,50 to 59
897,male,CD,Anti-TNF Only,34978,positive,adult,,booster1,03-Jul-21,28-Mar-21,97,mRNA,39,30 to 39
898,male,CD,Anti-TNF Only,69022,positive,adult,,booster1,28-Aug-21,02-Jul-21,57,mRNA,39,30 to 39
899,male,CD,Anti-TNF Only,79889,positive,adult,,booster2,30-Nov-21,10-Sep-21,81,mRNA,39,30 to 39
900,male,CD,Anti-TNF Only,1280,positive,adult,,booster2,12-Feb-22,24-Aug-21,172,mRNA,39,30 to 39
901,female,CD,Combination Therapy,7372,positive,adult,,pre_dose,24-Mar-21,15-Dec-20,99,mRNA,31,30 to 39
902,female,CD,Combination Therapy,32787,positive,adult,,primary,18-May-21,12-Feb-21,95,mRNA,31,30 to 39
903,female,CD,Combination Therapy,1305,positive,adult,112,booster1,16-Jun-21,02-Dec-20,196,mRNA,31,30 to 39
904,female,CD,Combination Therapy,429,positive,adult,26,booster2,03-Feb-22,04-Oct-21,122,mRNA,32,30 to 39
905,male,CD,Anti-TNF Only,24753,positive,adult,48,booster1,08-Sep-21,19-Jul-21,51,mRNA,28,18 to 29
906,male,CD,Anti-TNF Only,66,negative,adult,162,booster2,17-Nov-21,05-Jul-21,135,mRNA,28,18 to 29
907,male,CD,Ustekinumab Only,1097,positive,adult,245,pre_dose,30-Apr-21,25-Nov-20,156,vector,56,50 to 59
908,male,CD,Ustekinumab Only,754,positive,adult,275,primary,10-Jun-21,18-Feb-21,112,vector,56,50 to 59
909,male,CD,Ustekinumab Only,,,adult,,booster1,05-Aug-21,25-Apr-21,102,vector,56,50 to 59
910,male,CD,Ustekinumab Only,363,positive,adult,,booster2,06-Nov-21,27-May-21,163,vector,57,50 to 59
911,male,CD,Ustekinumab Only,67331,positive,adult,,booster2,03-Mar-22,08-Dec-21,85,vector,57,50 to 59
912,male,CD,Combination Therapy,69424,positive,adult,280,pre_dose,27-Mar-21,31-Dec-20,86,mRNA,45,40 to 49
913,male,CD,Combination Therapy,569,positive,adult,141,booster1,13-Aug-21,27-Mar-21,139,mRNA,45,40 to 49
914,male,CD,Combination Therapy,15081,positive,adult,,booster2,01-Jan-22,29-Sep-21,94,mRNA,46,40 to 49
915,male,CD,Combination Therapy,69477,positive,adult,56,booster2,26-Feb-22,23-Nov-21,95,mRNA,46,40 to 49
916,male,CD,Combination Therapy,801,positive,adult,194,booster2,14-Jul-22,01-Feb-22,163,mRNA,46,40 to 49
917,male,CD,Corticosteroids,42463,positive,adult,,booster1,31-Jul-21,06-Jun-21,55,vector,45,40 to 49
918,male,CD,Combination Therapy,246,positive,adult,,booster2,04-Dec-21,25-May-21,193,vector,45,40 to 49
919,male,CD,Combination Therapy,711,positive,adult,,booster2,09-Mar-22,28-Sep-21,162,vector,46,40 to 49
920,female,CD,Combination Therapy,1091,positive,elderly,,pre_dose,23-Mar-21,27-Oct-20,147,mRNA,63,60 to 69
921,female,CD,Combination Therapy,51391,positive,elderly,,booster2,26-Nov-21,26-Aug-21,92,mRNA,64,60 to 69
922,female,CD,Combination Therapy,483,positive,elderly,,booster2,08-Feb-22,18-Oct-21,113,mRNA,64,60 to 69
923,male,UC,Ustekinumab Only,44905,positive,adult,,booster1,03-Aug-21,19-May-21,76,mRNA,37,30 to 39
924,male,UC,Ustekinumab Only,1302,positive,adult,,booster2,03-Feb-22,30-Sep-21,126,mRNA,37,30 to 39
925,male,CD,Anti-TNF Only,812,positive,elderly,380,primary,01-Jun-21,21-Dec-20,162,vector,65,60 to 69
926,male,CD,Anti-TNF Only,1239,positive,elderly,337,booster1,14-Jul-21,20-Mar-21,116,vector,65,60 to 69
927,male,CD,Anti-TNF Only,1334,positive,elderly,135,booster2,01-Feb-22,28-Jul-21,188,vector,66,60 to 69
928,male,CD,Anti-TNF Only,1199,positive,elderly,36,booster2,11-May-22,11-Dec-21,151,vector,66,60 to 69
929,male,UC,Ustekinumab Only,628,positive,adult,,pre_dose,19-Mar-21,28-Oct-20,142,mRNA,54,50 to 59
930,male,UC,Ustekinumab Only,365,positive,adult,,booster1,24-Nov-21,22-Jul-21,125,mRNA,55,50 to 59
931,male,UC,Ustekinumab Only,1373,positive,adult,,booster2,02-Feb-22,21-Aug-21,165,mRNA,55,50 to 59
932,female,CD,Ustekinumab Only,36319,positive,adult,,primary,23-Jun-21,28-Mar-21,87,mRNA,41,40 to 49
933,female,CD,Ustekinumab Only,42446,positive,adult,,booster1,15-Jul-21,12-Apr-21,94,mRNA,41,40 to 49
934,female,CD,Ustekinumab Only,1256,positive,adult,,booster2,30-Jan-22,08-Oct-21,114,mRNA,41,40 to 49
935,female,CD,Ustekinumab Only,51,negative,adult,,booster2,17-May-22,06-Feb-22,100,mRNA,41,40 to 49
936,female,CD,Anti-TNF Only,55941,positive,adult,226,booster1,18-Sep-21,16-Jun-21,94,mRNA,35,30 to 39
937,female,CD,Anti-TNF Only,42679,positive,adult,212,booster2,02-Oct-21,05-Aug-21,58,mRNA,35,30 to 39
938,female,CD,Anti-TNF Only,9425,positive,adult,100,booster2,22-Jan-22,18-Oct-21,96,mRNA,35,30 to 39
939,male,CD,Anti-TNF Only,981,positive,elderly,112,pre_dose,20-Mar-21,24-Sep-20,177,vector,70,70+
940,male,CD,Anti-TNF Only,592,positive,elderly,,primary,14-May-21,11-Nov-20,184,vector,70,70+
941,male,CD,Anti-TNF Only,1425,positive,elderly,,booster1,08-Jul-21,16-Feb-21,142,vector,70,70+
942,male,CD,Anti-TNF Only,147,negative,elderly,,booster1,29-Sep-21,28-May-21,124,vector,70,70+
943,male,CD,Anti-TNF Only,229,positive,elderly,,booster2,29-Oct-21,20-Apr-21,192,vector,70,70+
944,male,CD,Anti-TNF Only,26989,positive,elderly,,booster2,28-Jan-22,21-Oct-21,99,vector,70,70+
945,male,CD,Ustekinumab Only,1493,positive,elderly,,booster2,20-Apr-22,04-Jan-22,106,vector,71,70+
946,male,CD,Ustekinumab Only,1303,positive,elderly,,booster2,20-Jul-22,03-Apr-22,108,vector,71,70+
947,female,CD,Combination Therapy,64596,positive,adult,223,pre_dose,18-Mar-21,22-Jan-21,55,mRNA,22,18 to 29
948,female,CD,Combination Therapy,40166,positive,adult,89,booster1,30-Jul-21,24-Apr-21,97,mRNA,22,18 to 29
949,female,CD,Combination Therapy,17,negative,adult,26,booster2,27-Oct-21,31-May-21,149,mRNA,23,18 to 29
950,female,CD,Combination Therapy,77,negative,adult,112,booster2,16-Feb-22,16-Oct-21,123,mRNA,23,18 to 29
951,male,UC,Combination Therapy,1183,positive,adult,,primary,19-May-21,28-Jan-21,111,mRNA,49,40 to 49
952,male,UC,Combination Therapy,1025,positive,adult,,booster1,15-Jun-21,13-Dec-20,184,mRNA,49,40 to 49
953,male,UC,Combination Therapy,18568,positive,adult,,booster2,12-Nov-21,17-Aug-21,87,mRNA,49,40 to 49
954,male,UC,Combination Therapy,972,positive,adult,,booster2,11-Feb-22,21-Aug-21,174,mRNA,50,50 to 59
955,male,CD,Ustekinumab Only,,,adult,224,booster1,03-Jul-21,21-Mar-21,104,mRNA,55,50 to 59
956,male,CD,Ustekinumab Only,1313,positive,adult,113,booster2,22-Oct-21,14-Apr-21,191,mRNA,56,50 to 59
957,male,CD,Ustekinumab Only,25336,positive,adult,20,booster2,04-Mar-22,29-Dec-21,65,mRNA,56,50 to 59
958,male,CD,Ustekinumab Only,1289,positive,adult,216,booster1,28-Jul-21,16-Mar-21,134,mRNA,53,50 to 59
959,male,CD,Ustekinumab Only,944,positive,adult,48,booster2,17-Nov-21,22-Jul-21,118,mRNA,53,50 to 59
960,male,CD,Ustekinumab Only,1060,positive,adult,25,booster2,26-Mar-22,13-Nov-21,133,mRNA,54,50 to 59
961,male,CD,Anti-TNF Only,389,positive,elderly,,booster1,12-Aug-21,07-Feb-21,186,vector,69,60 to 69
962,male,CD,Anti-TNF Only,23488,positive,elderly,,booster1,07-Oct-21,13-Aug-21,55,vector,69,60 to 69
963,male,CD,Anti-TNF Only,820,positive,elderly,,booster2,27-Jan-22,13-Oct-21,106,vector,69,60 to 69
964,male,CD,Ustekinumab Only,62642,positive,adult,,booster1,12-Aug-21,08-May-21,96,mRNA,50,50 to 59
965,male,CD,Ustekinumab Only,71,negative,adult,,pre_dose,24-Mar-21,30-Sep-20,175,vector,29,18 to 29
966,male,CD,Ustekinumab Only,1484,positive,adult,,primary,02-Jun-21,24-Jan-21,129,vector,30,30 to 39
967,male,CD,Ustekinumab Only,965,positive,adult,,booster2,15-Jun-22,10-Feb-22,125,vector,31,30 to 39
968,male,CD,Ustekinumab Only,1440,positive,adult,,booster1,30-Jun-21,18-Feb-21,132,mRNA,59,50 to 59
969,male,CD,Ustekinumab Only,79155,positive,adult,162,booster2,28-Jul-21,27-Apr-21,92,mRNA,59,50 to 59
970,male,CD,Ustekinumab Only,161,negative,adult,,booster2,21-Oct-21,16-May-21,158,mRNA,59,50 to 59
971,male,CD,Ustekinumab Only,360,positive,adult,,booster2,10-Feb-22,26-Jul-21,199,mRNA,60,60 to 69
972,male,UC,Combination Therapy,665,positive,adult,,primary,05-May-21,23-Oct-20,194,vector,60,60 to 69
973,male,UC,Combination Therapy,905,positive,adult,,booster1,30-Jul-21,15-Feb-21,165,vector,61,60 to 69
974,male,UC,Combination Therapy,669,positive,adult,,booster2,31-May-22,22-Dec-21,160,vector,61,60 to 69
975,female,UC,Combination Therapy,72283,positive,adult,,pre_dose,16-Mar-21,14-Dec-20,92,mRNA,50,50 to 59
976,female,UC,Combination Therapy,3402,positive,adult,,booster1,11-Aug-21,10-May-21,93,mRNA,51,50 to 59
977,female,UC,Combination Therapy,591,positive,adult,,booster2,18-Nov-21,04-Aug-21,106,mRNA,51,50 to 59
978,female,UC,Combination Therapy,1260,positive,adult,,booster2,02-Mar-22,13-Sep-21,170,mRNA,51,50 to 59
979,female,UC,Combination Therapy,790,positive,adult,245,booster2,16-Apr-22,11-Nov-21,156,mRNA,51,50 to 59
980,female,CD,Ustekinumab Only,5099,positive,elderly,,booster1,27-Jul-21,17-May-21,71,mRNA,64,60 to 69
981,female,CD,Ustekinumab Only,9366,positive,elderly,,booster2,14-Oct-21,07-Aug-21,68,mRNA,64,60 to 69
982,female,CD,Ustekinumab Only,1378,positive,elderly,,booster2,18-Feb-22,05-Aug-21,197,mRNA,64,60 to 69
983,female,CD,Ustekinumab Only,70894,positive,elderly,,booster2,08-May-22,02-Feb-22,95,mRNA,64,60 to 69
984,female,CD,Ustekinumab Only,1237,positive,elderly,,booster2,06-Jul-22,20-Jan-22,167,mRNA,65,60 to 69
985,female,CD,Combination Therapy,746,positive,adult,,primary,04-Jun-21,13-Dec-20,173,mRNA,33,30 to 39
986,female,CD,Combination Therapy,1002,positive,adult,,booster1,03-Jul-21,08-Feb-21,145,mRNA,33,30 to 39
987,female,CD,Combination Therapy,63368,positive,adult,,booster2,16-Nov-21,21-Aug-21,87,mRNA,33,30 to 39
988,female,CD,Combination Therapy,1414,positive,adult,,booster2,25-Jan-22,13-Oct-21,104,mRNA,34,30 to 39
989,female,CD,Combination Therapy,1079,positive,adult,275,booster2,09-Mar-22,14-Nov-21,115,mRNA,34,30 to 39
990,male,CD,Vedolizumab Only,446,positive,adult,263,pre_dose,23-Jan-21,11-Aug-20,165,mRNA,48,40 to 49
991,male,CD,Vedolizumab Only,57338,positive,adult,490,booster1,07-Sep-21,02-Jun-21,97,mRNA,48,40 to 49
992,male,CD,Vedolizumab Only,408,positive,adult,634,booster1,29-Jan-22,30-Aug-21,152,mRNA,49,40 to 49
993,female,CD,Ustekinumab Only,21970,positive,adult,,pre_dose,17-Mar-21,08-Dec-20,99,mRNA,55,50 to 59
994,female,CD,Ustekinumab Only,37503,positive,adult,,booster1,05-Aug-21,03-May-21,94,mRNA,55,50 to 59
995,female,CD,Ustekinumab Only,42724,positive,adult,,booster2,26-Feb-22,09-Dec-21,79,mRNA,56,50 to 59
996,female,CD,Ustekinumab Only,46657,positive,adult,,booster2,28-Jul-22,21-May-22,68,mRNA,56,50 to 59
997,female,UC,Anti-TNF Only,867,positive,adult,,booster2,23-Oct-21,29-Jun-21,116,mRNA,35,30 to 39
998,female,UC,Anti-TNF Only,1142,positive,adult,,booster2,24-Feb-22,24-Sep-21,153,mRNA,35,30 to 39
999,female,CD,Ustekinumab Only,42670,positive,adult,,primary,05-Jun-21,12-Apr-21,54,vector,47,40 to 49
1000,female,CD,Ustekinumab Only,749,positive,adult,233,booster1,02-Jul-21,02-Feb-21,150,vector,47,40 to 49
1001,female,CD,Ustekinumab Only,63300,positive,adult,146,booster1,31-Dec-21,21-Oct-21,71,vector,48,40 to 49
1002,female,CD,Ustekinumab Only,42991,positive,adult,120,booster2,12-Feb-22,13-Dec-21,61,vector,48,40 to 49
1003,female,CD,Ustekinumab Only,1325,positive,adult,27,booster2,24-May-22,08-Jan-22,136,vector,48,40 to 49
1004,male,CD,Anti-TNF Only,49486,positive,adult,341,pre_dose,16-Mar-21,18-Dec-20,88,vector,41,40 to 49
1005,male,CD,Anti-TNF Only,231,positive,adult,194,pre_dose,23-Apr-21,10-Dec-20,134,vector,41,40 to 49
1006,male,CD,Anti-TNF Only,1074,positive,adult,138,pre_dose,12-Feb-22,18-Aug-21,178,vector,42,40 to 49
1007,male,CD,Ustekinumab Only,952,positive,adult,61,booster1,05-Aug-21,15-Apr-21,112,mRNA,34,30 to 39
1008,male,CD,Ustekinumab Only,45645,positive,adult,30,booster2,03-Nov-21,22-Aug-21,73,mRNA,34,30 to 39
1009,male,CD,Ustekinumab Only,1067,positive,adult,233,booster2,08-Feb-22,26-Aug-21,166,mRNA,34,30 to 39
1010,male,CD,Ustekinumab Only,474,positive,adult,209,booster2,01-Apr-22,20-Sep-21,193,mRNA,35,30 to 39
1011,male,CD,Combination Therapy,1014,positive,adult,125,booster1,15-Aug-21,28-Jan-21,199,mRNA,59,50 to 59
1012,male,CD,Combination Therapy,616,positive,adult,13,booster2,06-Feb-22,04-Sep-21,155,mRNA,60,60 to 69
1013,male,CD,Combination Therapy,12349,positive,adult,,booster2,14-Jun-22,14-Mar-22,92,mRNA,60,60 to 69
1014,female,CD,Ustekinumab Only,774,positive,adult,,pre_dose,16-Mar-21,31-Oct-20,136,mRNA,52,50 to 59
1015,female,CD,Ustekinumab Only,334,positive,adult,,booster1,08-Oct-21,15-May-21,146,mRNA,53,50 to 59
1016,female,CD,Ustekinumab Only,17719,positive,adult,,booster2,12-Nov-21,19-Aug-21,85,mRNA,53,50 to 59
1017,female,CD,Ustekinumab Only,16132,positive,adult,,booster2,22-Feb-22,18-Nov-21,96,mRNA,53,50 to 59
1018,male,UC,Corticosteroids,2719,positive,adult,,booster1,01-Sep-21,29-May-21,95,mRNA,61,60 to 69
1019,male,UC,Corticosteroids,27200,positive,adult,146,booster2,01-Dec-21,15-Sep-21,77,mRNA,61,60 to 69
1020,male,UC,Corticosteroids,57203,positive,adult,,booster2,23-Mar-22,19-Dec-21,94,mRNA,61,60 to 69
1021,female,CD,Anti-TNF Only,38402,positive,adult,,booster1,10-Jul-21,04-Apr-21,97,vector,40,40 to 49
1022,female,CD,Anti-TNF Only,187,negative,adult,,booster2,29-Jan-22,08-Sep-21,143,vector,41,40 to 49
1023,female,CD,Anti-TNF Only,378,positive,adult,,booster2,04-Jun-22,13-Dec-21,173,vector,41,40 to 49
1024,female,CD,Ustekinumab Only,25591,positive,adult,,pre_dose,30-Apr-21,22-Jan-21,98,mRNA,46,40 to 49
1025,female,CD,Ustekinumab Only,637,positive,adult,,primary,04-Jun-21,01-Feb-21,123,mRNA,46,40 to 49
1026,female,CD,Ustekinumab Only,882,positive,adult,,booster1,06-Jul-21,14-Mar-21,114,mRNA,46,40 to 49
1027,female,CD,Ustekinumab Only,41221,positive,adult,,booster2,13-Oct-21,20-Jul-21,85,mRNA,46,40 to 49
1028,female,CD,Ustekinumab Only,151,negative,adult,,booster2,01-Feb-22,12-Sep-21,142,mRNA,47,40 to 49
1029,female,CD,Ustekinumab Only,56287,positive,adult,120,booster2,23-Mar-22,20-Jan-22,62,mRNA,47,40 to 49
1030,female,CD,Ustekinumab Only,62377,positive,adult,,booster2,01-Jul-22,08-May-22,54,mRNA,47,40 to 49
1031,female,CD,Combination Therapy,5598,positive,adult,,pre_dose,31-Mar-21,24-Dec-20,97,mRNA,21,18 to 29
1032,female,CD,Combination Therapy,843,positive,adult,,booster1,26-May-21,14-Jan-21,132,mRNA,21,18 to 29
1033,female,CD,Combination Therapy,76170,positive,adult,,booster2,06-Jan-22,14-Oct-21,84,mRNA,22,18 to 29
1034,female,CD,Anti-TNF Only,1456,positive,adult,,pre_dose,14-Apr-21,02-Oct-20,194,vector,56,50 to 59
1035,female,CD,Anti-TNF Only,143,negative,adult,390,primary,26-May-21,03-Jan-21,143,vector,56,50 to 59
1036,female,CD,Anti-TNF Only,618,positive,adult,300,booster1,12-Aug-21,23-Apr-21,111,vector,56,50 to 59
1037,female,CD,Anti-TNF Only,42,negative,adult,185,booster1,02-Sep-21,25-Apr-21,130,vector,56,50 to 59
1038,female,CD,Anti-TNF Only,876,positive,adult,73,booster2,14-Oct-21,22-Apr-21,175,vector,56,50 to 59
1039,female,CD,Anti-TNF Only,233,positive,adult,27,booster2,09-Mar-22,09-Nov-21,120,vector,57,50 to 59
1040,female,CD,Anti-TNF Only,225,positive,adult,,booster2,01-Jun-22,18-Dec-21,165,vector,57,50 to 59
1041,female,CD,Ustekinumab Only,65077,positive,adult,,booster1,01-Aug-21,07-May-21,86,vector,59,50 to 59
1042,female,CD,Ustekinumab Only,623,positive,adult,237,booster2,12-Nov-21,25-Jul-21,110,vector,59,50 to 59
1043,female,CD,Ustekinumab Only,124,negative,adult,162,booster2,10-Mar-22,11-Sep-21,180,vector,60,60 to 69
1044,female,CD,Anti-TNF Only,49744,positive,adult,50,pre_dose,20-Mar-21,09-Jan-21,70,mRNA,48,40 to 49
1045,female,CD,Anti-TNF Only,799,positive,adult,56,booster1,09-Jun-21,01-Dec-20,190,mRNA,48,40 to 49
1046,female,CD,Anti-TNF Only,30031,positive,adult,,booster1,09-Oct-21,28-Jul-21,73,mRNA,48,40 to 49
1047,female,CD,Anti-TNF Only,7971,positive,adult,,booster2,20-Nov-21,31-Aug-21,81,mRNA,48,40 to 49
1048,female,CD,Anti-TNF Only,1055,positive,adult,,booster2,22-Mar-22,04-Nov-21,138,mRNA,49,40 to 49
1049,female,CD,Anti-TNF Only,739,positive,adult,341,primary,13-May-21,12-Nov-20,182,vector,58,50 to 59
1050,female,CD,Anti-TNF Only,49817,positive,adult,225,booster2,28-Oct-21,23-Jul-21,97,vector,59,50 to 59
1051,female,CD,Anti-TNF Only,818,positive,adult,169,booster2,26-May-22,03-Jan-22,143,vector,59,50 to 59
1052,female,CD,Ustekinumab Only,1330,positive,adult,8,pre_dose,31-Aug-21,24-Feb-21,188,mRNA,50,50 to 59
1053,female,CD,Combination Therapy,71490,positive,adult,345,pre_dose,30-Jan-21,24-Nov-20,67,mRNA,54,50 to 59
1054,female,CD,Combination Therapy,372,positive,adult,302,pre_dose,20-Mar-21,22-Nov-20,118,mRNA,54,50 to 59
1055,female,CD,Combination Therapy,54459,positive,adult,187,primary,05-Jun-21,05-Mar-21,92,mRNA,54,50 to 59
1056,female,CD,Combination Therapy,63737,positive,adult,36,booster1,10-Jul-21,04-May-21,67,mRNA,55,50 to 59
1057,female,CD,Combination Therapy,882,positive,adult,,booster1,28-Sep-21,12-May-21,139,mRNA,55,50 to 59
1058,female,CD,Combination Therapy,208,positive,adult,,booster2,09-Nov-21,01-Jul-21,131,mRNA,55,50 to 59
1059,female,CD,Combination Therapy,1433,positive,adult,194,booster2,15-Mar-22,03-Dec-21,102,mRNA,55,50 to 59
1060,female,CD,Combination Therapy,1360,positive,adult,,booster2,17-Apr-22,24-Oct-21,175,mRNA,55,50 to 59
1061,female,UC,Combination Therapy,62983,positive,adult,,booster1,21-Aug-21,08-Jun-21,74,mRNA,43,40 to 49
1062,female,UC,Combination Therapy,24647,positive,adult,,booster2,16-Feb-22,15-Dec-21,63,mRNA,43,40 to 49
1063,female,CD,Ustekinumab Only,1492,positive,adult,,pre_dose,24-Jan-21,17-Sep-20,129,mRNA,37,30 to 39
1064,female,CD,Ustekinumab Only,45897,positive,adult,,pre_dose,24-Jul-21,07-May-21,78,mRNA,38,30 to 39
1065,female,CD,Ustekinumab Only,72803,positive,adult,,primary,27-Jun-21,05-Apr-21,83,mRNA,37,30 to 39
1066,female,CD,Ustekinumab Only,392,positive,adult,,booster1,20-Aug-21,11-Mar-21,162,mRNA,38,30 to 39
1067,female,CD,Ustekinumab Only,68710,positive,adult,23,booster2,12-Nov-21,11-Aug-21,93,mRNA,38,30 to 39
1068,female,CD,Ustekinumab Only,75379,positive,adult,108,booster2,03-Feb-22,28-Nov-21,67,mRNA,38,30 to 39
1069,female,CD,Anti-TNF Only,62877,positive,adult,138,booster1,12-Aug-21,15-May-21,89,mRNA,29,18 to 29
1070,female,CD,Anti-TNF Only,389,positive,adult,355,booster1,23-Sep-21,10-May-21,136,mRNA,29,18 to 29
1071,female,CD,Anti-TNF Only,69672,positive,adult,232,booster2,30-Jan-22,18-Nov-21,73,mRNA,29,18 to 29
1072,female,CD,Combination Therapy,165,negative,adult,137,pre_dose,31-Mar-21,27-Sep-20,185,mRNA,38,30 to 39
1073,female,CD,Combination Therapy,46574,positive,adult,64,primary,27-Jun-21,07-Apr-21,81,mRNA,39,30 to 39
1074,female,CD,Combination Therapy,59,negative,adult,,booster1,24-Jul-21,06-Jan-21,199,mRNA,39,30 to 39
1075,female,CD,Combination Therapy,48668,positive,adult,117,booster2,14-Oct-21,12-Aug-21,63,mRNA,39,30 to 39
1076,female,CD,Combination Therapy,68458,positive,adult,,booster2,04-Feb-22,12-Dec-21,54,mRNA,39,30 to 39
1077,female,CD,Combination Therapy,384,positive,adult,,booster2,01-Apr-22,03-Nov-21,149,mRNA,39,30 to 39
1078,male,UC,Ustekinumab Only,1500,positive,elderly,,primary,08-May-21,24-Oct-20,196,mRNA,68,60 to 69
1079,male,UC,Ustekinumab Only,1254,positive,elderly,61,booster2,22-Feb-22,28-Sep-21,147,mRNA,69,60 to 69
1080,female,CD,Anti-TNF Only,1279,positive,adult,,primary,26-Feb-21,26-Aug-20,184,mRNA,48,40 to 49
1081,female,CD,Anti-TNF Only,55762,positive,adult,,booster1,30-Mar-21,23-Dec-20,97,mRNA,48,40 to 49
1082,female,CD,Anti-TNF Only,698,positive,adult,,booster2,28-Dec-21,25-Jul-21,156,mRNA,48,40 to 49
1083,female,CD,Anti-TNF Only,367,positive,adult,,booster2,09-Apr-22,05-Nov-21,155,mRNA,49,40 to 49
1084,female,CD,Ustekinumab Only,389,positive,adult,,pre_dose,16-Apr-21,06-Dec-20,131,mRNA,57,50 to 59
1085,female,CD,Ustekinumab Only,1226,positive,adult,,booster1,01-Sep-21,20-Mar-21,165,mRNA,57,50 to 59
1086,female,CD,Ustekinumab Only,187,negative,adult,,booster2,29-Jan-22,20-Oct-21,101,mRNA,58,50 to 59
1087,female,CD,Ustekinumab Only,79309,positive,adult,,booster2,11-Jun-22,11-Apr-22,61,mRNA,58,50 to 59
1088,male,CD,Ustekinumab Only,377,positive,adult,,pre_dose,07-Apr-21,20-Nov-20,138,vector,52,50 to 59
1089,male,CD,Ustekinumab Only,68179,positive,adult,30,booster2,12-Oct-21,24-Jul-21,80,vector,53,50 to 59
1090,male,CD,Ustekinumab Only,18,negative,adult,,booster2,08-Dec-21,26-Jun-21,165,vector,53,50 to 59
1091,male,CD,Ustekinumab Only,1460,positive,elderly,,primary,21-May-21,29-Nov-20,173,mRNA,66,60 to 69
1092,male,CD,Ustekinumab Only,1232,positive,elderly,359,booster1,11-Aug-21,19-Feb-21,173,mRNA,67,60 to 69
1093,male,CD,Ustekinumab Only,984,positive,elderly,304,booster2,04-May-22,23-Jan-22,101,mRNA,67,60 to 69
1094,male,UC,Anti-TNF Only,1310,positive,elderly,239,pre_dose,27-Mar-21,24-Oct-20,154,mRNA,72,70+
1095,male,UC,Anti-TNF Only,814,positive,elderly,220,booster2,25-Feb-22,16-Oct-21,132,mRNA,73,70+
1096,male,UC,Anti-TNF Only,1096,positive,elderly,112,booster2,04-May-22,05-Jan-22,119,mRNA,73,70+
1097,male,UC,Anti-TNF Only,945,positive,elderly,50,booster2,19-May-22,04-Jan-22,135,mRNA,73,70+
1098,female,CD,Combination Therapy,893,positive,adult,40,primary,29-May-21,23-Jan-21,126,vector,44,40 to 49
1099,female,CD,Combination Therapy,1123,positive,adult,233,booster1,08-Sep-21,28-Apr-21,133,vector,44,40 to 49
1100,female,CD,Combination Therapy,25810,positive,adult,209,booster2,18-Nov-21,18-Sep-21,61,vector,45,40 to 49
1101,female,CD,Combination Therapy,105,negative,adult,125,booster2,04-Feb-22,21-Sep-21,136,vector,45,40 to 49
1102,female,CD,Combination Therapy,990,positive,adult,13,booster2,05-Jul-22,12-Jan-22,174,vector,45,40 to 49
1103,male,CD,Anti-TNF Only,10336,positive,adult,,primary,26-May-21,18-Mar-21,69,mRNA,59,50 to 59
1104,male,CD,Anti-TNF Only,657,positive,adult,,booster1,10-Aug-21,12-Feb-21,179,mRNA,59,50 to 59
1105,male,CD,Anti-TNF Only,743,positive,adult,,booster2,10-Nov-21,15-May-21,179,mRNA,60,60 to 69
1106,male,CD,Anti-TNF Only,3465,positive,adult,,booster2,01-Mar-22,29-Nov-21,92,mRNA,60,60 to 69
1107,male,UC,Combination Therapy,1330,positive,adult,,booster1,07-Aug-21,16-Mar-21,144,mRNA,48,40 to 49
1108,female,UC,No Immunosuppressives,501,positive,adult,,booster1,28-Apr-21,29-Dec-20,120,mRNA,47,40 to 49
1109,female,CD,Ustekinumab Only,59597,positive,elderly,209,primary,28-Apr-21,18-Feb-21,69,mRNA,72,70+
1110,female,CD,Ustekinumab Only,1097,positive,elderly,,booster1,19-May-21,28-Jan-21,111,mRNA,72,70+
1111,female,CD,Ustekinumab Only,823,positive,elderly,,booster1,04-Aug-21,05-Apr-21,121,mRNA,72,70+
1112,female,CD,Ustekinumab Only,30582,positive,elderly,,booster2,01-Dec-21,25-Sep-21,67,mRNA,72,70+
1113,female,CD,Ustekinumab Only,63421,positive,elderly,,booster2,17-Mar-22,10-Dec-21,97,mRNA,72,70+
1114,female,CD,Ustekinumab Only,937,positive,elderly,,booster2,06-May-22,16-Nov-21,171,mRNA,73,70+
1115,female,CD,Anti-TNF Only,650,positive,adult,,booster1,06-Aug-21,05-Feb-21,182,mRNA,59,50 to 59
1116,female,CD,Anti-TNF Only,223,positive,adult,,booster1,02-Oct-21,06-May-21,149,mRNA,59,50 to 59
1117,female,CD,Anti-TNF Only,1340,positive,adult,,booster2,22-Jan-22,22-Aug-21,153,mRNA,60,60 to 69
1118,female,CD,Anti-TNF Only,360,positive,adult,,booster2,17-May-22,12-Jan-22,125,mRNA,60,60 to 69
1119,female,CD,Combination Therapy,5026,positive,adult,125,pre_dose,02-May-21,30-Jan-21,92,mRNA,35,30 to 39
1120,female,CD,Combination Therapy,383,positive,adult,,primary,25-Jun-21,03-Feb-21,142,mRNA,35,30 to 39
1121,female,CD,Combination Therapy,541,positive,adult,,booster1,05-Sep-21,29-Mar-21,160,mRNA,35,30 to 39
1122,female,CD,Combination Therapy,77793,positive,adult,,booster2,18-Feb-22,23-Nov-21,87,mRNA,36,30 to 39
1123,female,CD,Combination Therapy,25922,positive,adult,,booster2,25-Jun-22,18-Apr-22,68,mRNA,36,30 to 39
1124,male,CD,Ustekinumab Only,61,negative,adult,,primary,19-May-21,07-Dec-20,163,vector,56,50 to 59
1125,male,CD,Ustekinumab Only,379,positive,adult,,booster1,03-Sep-21,27-Mar-21,160,vector,56,50 to 59
1126,male,CD,Ustekinumab Only,3428,positive,adult,,booster1,04-Mar-22,08-Jan-22,55,vector,56,50 to 59
1127,female,CD,Combination Therapy,763,positive,adult,43,pre_dose,20-Feb-21,27-Oct-20,116,mRNA,42,40 to 49
1128,female,CD,Combination Therapy,552,positive,adult,159,primary,16-Jun-21,12-Dec-20,186,mRNA,42,40 to 49
1129,female,CD,Vedolizumab Only,1169,positive,adult,13,booster1,24-Jul-21,12-Mar-21,134,mRNA,42,40 to 49
1130,female,CD,Combination Therapy,63192,positive,adult,302,booster2,06-Nov-21,05-Aug-21,93,mRNA,42,40 to 49
1131,female,CD,Combination Therapy,31221,positive,adult,411,booster2,23-Feb-22,22-Nov-21,93,mRNA,43,40 to 49
1132,female,CD,Combination Therapy,1175,positive,adult,464,booster2,17-Apr-22,14-Nov-21,154,mRNA,43,40 to 49
1133,female,CD,Combination Therapy,1225,positive,adult,566,booster2,28-Jul-22,27-Jan-22,182,mRNA,43,40 to 49
1134,female,CD,Anti-TNF Only,734,positive,adult,,booster1,11-Sep-21,11-May-21,123,mRNA,33,30 to 39
1135,female,CD,Anti-TNF Only,5100,positive,adult,,booster2,04-Feb-22,12-Nov-21,84,mRNA,34,30 to 39
1136,female,CD,Anti-TNF Only,1472,positive,adult,,booster2,13-May-22,01-Feb-22,101,mRNA,34,30 to 39
1137,male,UC,Anti-TNF Only,883,positive,adult,,pre_dose,16-Apr-21,22-Nov-20,145,vector,34,30 to 39
1138,male,UC,Anti-TNF Only,43777,positive,adult,,primary,10-Jun-21,21-Mar-21,81,vector,34,30 to 39
1139,male,UC,Vedolizumab Only,447,positive,adult,,booster1,30-Jul-21,18-Jan-21,193,vector,34,30 to 39
1140,male,UC,Vedolizumab Only,3131,positive,adult,,booster2,13-Nov-21,22-Sep-21,52,vector,34,30 to 39
1141,male,UC,Anti-TNF Only,298,positive,adult,,booster2,12-Apr-22,18-Nov-21,145,vector,35,30 to 39
1142,female,CD,Anti-TNF Only,34268,positive,adult,,primary,26-Feb-21,44193,60,vector,32,30 to 39
1143,female,CD,Anti-TNF Only,501,positive,adult,,primary,10-Sep-21,44322,127,vector,33,30 to 39
1144,female,CD,Combination Therapy,1304,positive,adult,,pre_dose,22-Apr-21,22-Dec-20,121,mRNA,48,40 to 49
1145,female,CD,Vedolizumab Only,12243,positive,adult,352,pre_dose,07-May-21,05-Mar-21,63,vector,42,40 to 49
1146,male,CD,Vedolizumab Only,24972,positive,adult,,pre_dose,23-Mar-21,27-Dec-20,86,mRNA,53,50 to 59
1147,male,CD,Vedolizumab Only,905,positive,adult,,primary,22-May-21,05-Feb-21,106,mRNA,54,50 to 59
1148,female,UC,Anti-TNF Only,15529,positive,adult,,pre_dose,23-Mar-21,17-Dec-20,96,mRNA,45,40 to 49
1149,female,UC,Anti-TNF Only,60,negative,adult,,booster1,22-Jun-21,03-Feb-21,139,mRNA,45,40 to 49
1150,female,UC,Anti-TNF Only,6692,positive,adult,,booster2,08-Oct-21,31-Jul-21,69,mRNA,45,40 to 49
1151,female,UC,Anti-TNF Only,33859,positive,adult,,booster2,24-Mar-22,28-Dec-21,86,mRNA,46,40 to 49
1152,female,UC,Anti-TNF Only,540,positive,adult,,booster2,24-Jun-22,09-Mar-22,107,mRNA,46,40 to 49
1153,male,CD,Ustekinumab Only,26580,positive,adult,,pre_dose,18-Mar-21,17-Dec-20,91,mRNA,37,30 to 39
1154,male,CD,Ustekinumab Only,4745,positive,adult,,booster1,11-Aug-21,11-May-21,92,mRNA,37,30 to 39
1155,male,CD,Ustekinumab Only,1387,positive,adult,,booster2,26-Jan-22,13-Sep-21,135,mRNA,38,30 to 39
1156,male,CD,Ustekinumab Only,600,positive,adult,,booster2,19-Apr-22,10-Oct-21,191,mRNA,38,30 to 39
1157,male,UC,Combination Therapy,979,positive,adult,,pre_dose,20-Mar-21,09-Sep-20,192,mRNA,32,30 to 39
1158,male,UC,Combination Therapy,990,positive,adult,,booster1,02-Sep-21,22-Mar-21,164,mRNA,33,30 to 39
1159,male,UC,Combination Therapy,69971,positive,adult,,booster2,18-Feb-22,29-Nov-21,81,mRNA,33,30 to 39
1160,male,UC,Combination Therapy,1497,positive,adult,,booster2,09-Jun-22,23-Feb-22,106,mRNA,33,30 to 39
1161,male,CD,Anti-TNF Only,31768,positive,adult,,pre_dose,20-Mar-21,25-Jan-21,54,mRNA,37,30 to 39
1162,male,CD,Anti-TNF Only,54653,positive,adult,44,pre_dose,13-Apr-21,02-Feb-21,70,mRNA,51,50 to 59
1163,male,CD,Anti-TNF Only,643,positive,adult,,primary,27-May-21,15-Nov-20,193,mRNA,51,50 to 59
1164,male,CD,Anti-TNF Only,204,positive,adult,96,booster1,31-Aug-21,22-Mar-21,162,mRNA,51,50 to 59
1165,male,CD,Anti-TNF Only,1121,positive,adult,142,booster1,16-Oct-21,06-Apr-21,193,mRNA,51,50 to 59
1166,male,CD,Anti-TNF Only,153,negative,adult,265,booster2,16-Feb-22,26-Aug-21,174,mRNA,52,50 to 59
1167,male,CD,Anti-TNF Only,13935,positive,adult,331,booster2,23-Apr-22,27-Jan-22,86,mRNA,52,50 to 59
1168,male,CD,Anti-TNF Only,1337,positive,adult,404,booster2,05-Jul-22,04-Jan-22,182,mRNA,52,50 to 59
1169,male,UC,Vedolizumab Only,82,negative,elderly,,primary,03-Jun-21,12-Jan-21,142,mRNA,67,60 to 69
1170,male,CD,Combination Therapy,1072,positive,adult,93,pre_dose,21-Apr-21,26-Dec-20,116,mRNA,21,18 to 29
1171,male,CD,Combination Therapy,20150,positive,adult,206,booster1,12-Aug-21,24-May-21,80,mRNA,21,18 to 29
1172,male,UC,Combination Therapy,1405,positive,adult,148,booster1,09-Sep-21,22-Feb-21,199,mRNA,41,40 to 49
1173,male,UC,Combination Therapy,1009,positive,adult,132,booster2,16-Jun-22,18-Jan-22,149,mRNA,41,40 to 49
1174,female,UC,Anti-TNF Only,25955,positive,adult,,pre_dose,24-Mar-21,04-Jan-21,79,mRNA,34,30 to 39
1175,female,UC,Anti-TNF Only,1369,positive,adult,,booster2,02-Nov-21,24-Jul-21,101,mRNA,35,30 to 39
1176,female,UC,Anti-TNF Only,1432,positive,adult,,booster2,23-Feb-22,22-Oct-21,124,mRNA,35,30 to 39
1177,female,CD,Anti-TNF Only,478,positive,adult,232,primary,09-Mar-21,30-Aug-20,191,mRNA,53,50 to 59
1178,male,UC,Anti-TNF Only,845,positive,adult,227,primary,06-Jun-21,01-Dec-20,187,mRNA,33,30 to 39
1179,male,UC,Anti-TNF Only,102,negative,adult,,booster1,18-Aug-21,05-Apr-21,135,mRNA,33,30 to 39
1180,male,UC,Anti-TNF Only,53738,positive,adult,5,booster1,14-Jan-22,01-Nov-21,74,mRNA,33,30 to 39
1181,male,UC,Anti-TNF Only,1340,positive,adult,129,booster2,28-May-22,27-Jan-22,121,mRNA,34,30 to 39
1182,male,CD,Anti-TNF Only,42746,positive,adult,102,primary,29-Sep-21,44410,58,vector,45,40 to 49
1183,male,UC,Anti-TNF Only,599,positive,adult,164,pre_dose,12-Feb-21,06-Aug-20,190,mRNA,29,18 to 29
1184,male,UC,Anti-TNF Only,54319,positive,adult,682,booster1,15-Jul-22,30-Apr-22,76,mRNA,30,30 to 39
1185,female,CD,Anti-TNF Only,47756,positive,adult,223,booster1,27-Aug-21,16-Jun-21,72,mRNA,52,50 to 59
1186,female,CD,Anti-TNF Only,943,positive,adult,125,booster2,03-Dec-21,30-Jul-21,126,mRNA,53,50 to 59
1187,female,CD,Anti-TNF Only,1365,positive,adult,,booster1,10-Jun-21,26-Nov-20,196,mRNA,43,40 to 49
1188,female,CD,Anti-TNF Only,65360,positive,adult,,booster1,25-Sep-21,06-Jul-21,81,mRNA,43,40 to 49
1189,female,CD,Anti-TNF Only,55841,positive,adult,,booster2,02-Jul-22,08-Apr-22,85,mRNA,44,40 to 49
1190,male,CD,Vedolizumab Only,56797,positive,adult,,pre_dose,18-Mar-21,19-Dec-20,89,mRNA,34,30 to 39
1191,male,CD,Vedolizumab Only,902,positive,adult,,booster1,02-Sep-21,14-Feb-21,200,mRNA,34,30 to 39
1192,male,CD,Vedolizumab Only,535,positive,adult,,booster2,16-Feb-22,19-Oct-21,120,mRNA,35,30 to 39
1193,male,CD,Vedolizumab Only,103,negative,adult,,booster1,21-Jul-21,05-Apr-21,107,mRNA,35,30 to 39
1194,male,CD,Vedolizumab Only,624,positive,adult,,booster1,08-Oct-21,30-Mar-21,192,mRNA,35,30 to 39
1195,male,CD,Vedolizumab Only,71852,positive,adult,,booster2,11-Mar-22,18-Dec-21,83,mRNA,36,30 to 39
1196,female,CD,Vedolizumab Only,708,positive,adult,,pre_dose,08-Apr-21,21-Dec-20,108,vector,39,30 to 39
1197,female,CD,Vedolizumab Only,48368,positive,adult,,pre_dose,29-Jul-21,13-May-21,77,vector,39,30 to 39
1198,male,CD,Anti-TNF Only,1415,positive,elderly,,primary,15-Apr-21,28-Dec-20,108,mRNA,81,70+
1199,male,CD,Anti-TNF Only,393,positive,elderly,146,booster1,27-May-21,12-Feb-21,104,mRNA,81,70+
1200,male,CD,Anti-TNF Only,1410,positive,elderly,,booster1,11-Sep-21,02-Apr-21,162,mRNA,82,70+
1201,male,CD,Anti-TNF Only,1479,positive,elderly,,booster2,30-Dec-21,11-Jul-21,172,mRNA,82,70+
1202,male,CD,Anti-TNF Only,26482,positive,elderly,,booster2,04-Mar-22,05-Dec-21,89,mRNA,82,70+
1203,female,CD,Ustekinumab Only,30332,positive,adult,,pre_dose,29-May-21,19-Mar-21,71,vector,28,18 to 29
1204,female,CD,Vedolizumab Only,559,positive,elderly,,booster1,12-Mar-21,11-Nov-20,121,mRNA,65,60 to 69
1205,female,CD,Vedolizumab Only,64616,positive,elderly,,booster1,06-Oct-21,30-Jun-21,98,mRNA,66,60 to 69
1206,female,CD,Vedolizumab Only,602,positive,elderly,,booster2,10-Feb-22,14-Sep-21,149,mRNA,66,60 to 69
1207,male,CD,Anti-TNF Only,236,positive,adult,,pre_dose,02-Sep-21,14-Apr-21,141,mRNA,27,18 to 29
1208,male,CD,Ustekinumab Only,446,positive,adult,,pre_dose,28-Apr-21,29-Oct-20,181,mRNA,46,40 to 49
1209,male,CD,Ustekinumab Only,20814,positive,adult,,booster1,03-Jul-21,14-May-21,50,mRNA,47,40 to 49
1210,male,CD,Ustekinumab Only,209,positive,adult,,booster1,07-Oct-21,08-Jun-21,121,mRNA,47,40 to 49
1211,male,CD,Ustekinumab Only,21868,positive,adult,,booster2,11-Feb-22,15-Dec-21,58,mRNA,47,40 to 49
1212,male,CD,Ustekinumab Only,547,positive,adult,,booster2,01-Jun-22,12-Feb-22,109,mRNA,47,40 to 49
1213,female,CD,Anti-TNF Only,86,negative,adult,191,booster1,18-Aug-21,21-Mar-21,150,mRNA,22,18 to 29
1214,female,CD,Anti-TNF Only,442,positive,adult,13,booster2,12-Feb-22,18-Oct-21,117,mRNA,22,18 to 29
1215,female,CD,Anti-TNF Only,79164,positive,adult,42,booster2,08-Apr-22,08-Feb-22,59,mRNA,22,18 to 29
1216,female,CD,Anti-TNF Only,303,positive,adult,160,booster2,04-Aug-22,27-Feb-22,158,mRNA,23,18 to 29
1217,female,CD,Ustekinumab Only,575,positive,adult,337,primary,06-Jun-21,22-Dec-20,166,mRNA,29,18 to 29
1218,female,CD,Ustekinumab Only,67705,positive,adult,304,booster1,09-Jul-21,08-May-21,62,mRNA,29,18 to 29
1219,male,UC,Ustekinumab Only,541,positive,adult,,pre_dose,10-Apr-21,28-Dec-20,103,mRNA,17,10 to 17
1220,male,UC,Ustekinumab Only,67755,positive,adult,,booster1,04-Aug-21,16-May-21,80,mRNA,18,18 to 29
1221,female,CD,Ustekinumab Only,7146,positive,adult,,booster1,05-Oct-21,23-Jul-21,74,vector,32,30 to 39
1222,female,CD,Ustekinumab Only,2954,positive,adult,,primary,28-May-21,25-Mar-21,64,vector,56,50 to 59
1223,female,CD,Anti-TNF Only,560,positive,adult,,booster1,13-Oct-21,31-Mar-21,196,vector,56,50 to 59
1224,female,CD,Anti-TNF Only,957,positive,adult,,booster2,02-Mar-22,08-Sep-21,175,vector,57,50 to 59
1225,female,CD,Anti-TNF Only,1018,positive,adult,,booster2,20-Jul-22,04-Jan-22,197,vector,57,50 to 59
1226,female,CD,Vedolizumab Only,1261,positive,adult,,pre_dose,31-Mar-21,17-Dec-20,104,mRNA,36,30 to 39
1227,female,CD,Vedolizumab Only,25086,positive,adult,,primary,12-Jun-21,31-Mar-21,73,mRNA,37,30 to 39
1228,female,CD,Vedolizumab Only,66,negative,adult,,booster1,01-Sep-21,14-Apr-21,140,mRNA,37,30 to 39
1229,female,CD,Vedolizumab Only,24781,positive,adult,,booster2,23-Feb-22,02-Dec-21,83,mRNA,37,30 to 39
1230,male,CD,Anti-TNF Only,363,positive,adult,251,pre_dose,18-May-21,07-Nov-20,192,mRNA,42,40 to 49
1231,male,CD,Anti-TNF Only,53238,positive,adult,209,primary,29-Jun-21,30-Apr-21,60,mRNA,42,40 to 49
1232,male,CD,Anti-TNF Only,1060,positive,adult,181,booster1,27-Jul-21,17-Feb-21,160,mRNA,42,40 to 49
1233,female,CD,Vedolizumab Only,44899,positive,adult,39,primary,05-Jun-21,15-Mar-21,82,mRNA,48,40 to 49
1234,female,CD,Vedolizumab Only,30279,positive,adult,120,booster1,25-Aug-21,03-Jul-21,53,mRNA,48,40 to 49
1235,male,CD,Anti-TNF Only,51169,positive,adult,,primary,16-May-21,23-Feb-21,82,mRNA,32,30 to 39
1236,male,CD,Anti-TNF Only,985,positive,pediatric,,booster1,08-Aug-21,08-Apr-21,122,mRNA,1,00 to 09
1237,male,CD,Anti-TNF Only,527,positive,pediatric,,booster2,30-Oct-21,02-Jun-21,150,mRNA,4,00 to 09
1238,male,CD,Anti-TNF Only,787,positive,pediatric,,booster2,05-Feb-22,01-Oct-21,127,mRNA,7,00 to 09
1239,male,CD,Anti-TNF Only,616,positive,pediatric,,booster2,17-Apr-22,23-Nov-21,145,mRNA,10,10 to 17
1240,male,CD,Anti-TNF Only,838,positive,pediatric,,booster2,21-Jul-22,30-Mar-22,113,mRNA,4,00 to 09
1241,female,CD,Vedolizumab Only,1461,positive,pediatric,222,booster1,06-Apr-21,23-Dec-20,104,mRNA,3,00 to 09
1242,female,CD,Vedolizumab Only,6061,positive,pediatric,115,booster2,09-Mar-22,30-Dec-21,69,mRNA,6,00 to 09
1243,male,CD,Combination Therapy,153,negative,pediatric,98,primary,02-Jun-21,21-Feb-21,101,mRNA,12,10 to 17
1244,male,CD,Combination Therapy,470,positive,adult,213,booster1,25-Sep-21,06-Apr-21,172,mRNA,56,50 to 59
1245,male,CD,Combination Therapy,898,positive,pediatric,324,booster2,14-Jan-22,18-Jul-21,180,mRNA,2,00 to 09
1246,male,CD,Combination Therapy,74983,positive,pediatric,435,booster2,05-May-22,26-Jan-22,99,mRNA,2,00 to 09
1247,male,CD,Combination Therapy,1137,positive,pediatric,462,booster2,01-Jun-22,31-Jan-22,121,mRNA,13,10 to 17
1248,female,CD,Ustekinumab Only,1402,positive,pediatric,,booster1,09-Jun-21,29-Jan-21,131,mRNA,13,10 to 17
1249,female,CD,Ustekinumab Only,44997,positive,pediatric,,booster2,05-Jan-22,25-Oct-21,72,mRNA,1,00 to 09
1250,female,CD,Ustekinumab Only,1339,positive,pediatric,,pre_dose,28-Apr-21,12-Nov-20,167,vector,5,00 to 09
1251,female,CD,Ustekinumab Only,33,negative,pediatric,,primary,24-Jun-21,12-Feb-21,132,vector,12,10 to 17
1252,female,CD,Ustekinumab Only,53888,positive,pediatric,,booster1,06-Aug-21,16-May-21,82,vector,5,00 to 09
1253,female,CD,Ustekinumab Only,36336,positive,adult,,booster1,01-Mar-22,04-Dec-21,87,vector,50,50 to 59
1254,female,CD,Ustekinumab Only,25250,positive,adult,,booster2,30-Mar-22,15-Jan-22,74,vector,50,50 to 59
1255,female,CD,Ustekinumab Only,70088,positive,adult,,booster2,08-Jul-22,14-Apr-22,85,vector,51,50 to 59
1256,male,CD,Ustekinumab Only,35119,positive,adult,,pre_dose,01-May-21,20-Feb-21,70,vector,33,30 to 39
1257,female,CD,Ustekinumab Only,157,negative,adult,,primary,25-May-21,29-Jan-21,116,mRNA,34,30 to 39
1258,female,CD,Ustekinumab Only,389,positive,adult,,primary,14-Aug-21,09-Apr-21,127,mRNA,34,30 to 39
1259,female,CD,Ustekinumab Only,68599,positive,adult,,booster2,26-Jan-22,08-Nov-21,79,mRNA,34,30 to 39
1260,female,UC,Anti-TNF Only,,,adult,,primary,25-Sep-21,44402,62,vector,44,40 to 49
1261,male,CD,Combination Therapy,1018,positive,adult,180,booster2,09-Nov-21,02-May-21,191,mRNA,22,18 to 29
1262,female,UC,Combination Therapy,35965,positive,adult,435,pre_dose,16-Mar-21,05-Jan-21,70,mRNA,35,30 to 39
1263,female,UC,Combination Therapy,412,positive,adult,355,primary,04-Jun-21,29-Jan-21,126,mRNA,36,30 to 39
1264,female,UC,Combination Therapy,10937,positive,adult,319,booster1,10-Jul-21,14-Apr-21,87,mRNA,36,30 to 39
1265,female,UC,Combination Therapy,924,positive,adult,194,booster2,12-Nov-21,21-May-21,175,mRNA,36,30 to 39
1266,female,UC,Combination Therapy,934,positive,adult,83,booster2,03-Mar-22,20-Sep-21,164,mRNA,36,30 to 39
1267,female,UC,Combination Therapy,380,positive,adult,27,booster2,28-Apr-22,16-Dec-21,133,mRNA,36,30 to 39
1268,female,CD,Combination Therapy,914,positive,elderly,,booster1,15-May-21,19-Dec-20,147,mRNA,65,60 to 69
1269,female,CD,Combination Therapy,72392,positive,elderly,,booster1,02-Oct-21,30-Jul-21,64,mRNA,66,60 to 69
1270,female,CD,Combination Therapy,598,positive,elderly,,booster2,10-Nov-21,26-Jun-21,137,mRNA,66,60 to 69
1271,female,CD,Combination Therapy,1427,positive,elderly,,booster2,27-Apr-22,24-Oct-21,185,mRNA,66,60 to 69
1272,female,CD,Combination Therapy,310,positive,elderly,,booster2,21-Jul-22,10-Jan-22,192,mRNA,66,60 to 69
1273,female,CD,Vedolizumab Only,562,positive,elderly,340,booster1,01-May-21,22-Nov-20,160,mRNA,79,70+
1274,female,CD,Vedolizumab Only,164,negative,elderly,315,booster1,26-May-21,12-Nov-20,195,mRNA,79,70+
1275,female,CD,Vedolizumab Only,177,negative,elderly,203,booster1,15-Sep-21,21-May-21,117,mRNA,79,70+
1276,female,CD,Vedolizumab Only,38727,positive,elderly,143,booster2,14-Nov-21,06-Sep-21,69,mRNA,80,70+
1277,female,CD,Anti-TNF Only,1004,positive,adult,,booster1,09-Sep-21,27-May-21,105,mRNA,36,30 to 39
1278,female,CD,Anti-TNF Only,1378,positive,adult,,booster2,04-Mar-22,23-Oct-21,132,mRNA,37,30 to 39
1279,female,CD,Anti-TNF Only,448,positive,adult,,booster2,20-Apr-22,06-Oct-21,196,mRNA,37,30 to 39
1280,male,CD,Anti-TNF Only,621,positive,adult,12,pre_dose,02-Feb-21,31-Aug-20,155,mRNA,27,18 to 29
1281,male,CD,Anti-TNF Only,488,positive,adult,68,pre_dose,30-Mar-21,30-Sep-20,181,mRNA,27,18 to 29
1282,male,CD,Anti-TNF Only,523,positive,adult,,primary,15-Jun-21,06-Dec-20,191,vector,35,30 to 39
1283,female,UC,Vedolizumab Only,73969,positive,adult,,pre_dose,23-Mar-21,27-Jan-21,55,mRNA,32,30 to 39
1284,female,UC,Vedolizumab Only,592,positive,adult,,primary,18-May-21,23-Nov-20,176,mRNA,32,30 to 39
1285,female,UC,Vedolizumab Only,1108,positive,adult,,booster1,02-Sep-21,11-May-21,114,mRNA,33,30 to 39
1286,female,CD,Anti-TNF Only,30689,positive,adult,103,pre_dose,27-Mar-21,19-Dec-20,98,mRNA,22,18 to 29
1287,female,UC,No Immunosuppressives,848,positive,adult,87,primary,25-Feb-21,08-Nov-20,109,mRNA,45,40 to 49
1288,female,UC,No Immunosuppressives,143,negative,adult,341,booster1,06-Nov-21,15-Jun-21,144,mRNA,46,40 to 49
1289,female,CD,Ustekinumab Only,813,positive,adult,,pre_dose,21-Apr-21,22-Oct-20,181,mRNA,56,50 to 59
1290,female,CD,Ustekinumab Only,736,positive,adult,,booster1,08-Sep-21,14-Mar-21,178,mRNA,56,50 to 59
1291,female,CD,Ustekinumab Only,61931,positive,adult,,booster2,25-Feb-22,03-Jan-22,53,mRNA,57,50 to 59
1292,female,CD,Anti-TNF Only,928,positive,adult,,pre_dose,01-Apr-21,06-Oct-20,177,mRNA,23,18 to 29
1293,female,UC,Ustekinumab Only,633,positive,adult,,primary,27-Jun-21,09-Jan-21,169,mRNA,35,30 to 39
1294,female,UC,Ustekinumab Only,234,positive,adult,,booster1,26-Jul-21,23-Mar-21,125,mRNA,35,30 to 39
1295,female,UC,Ustekinumab Only,65397,positive,adult,,booster2,22-Dec-21,15-Oct-21,68,mRNA,36,30 to 39
1296,female,UC,Ustekinumab Only,898,positive,adult,,booster2,11-Apr-22,27-Dec-21,105,mRNA,36,30 to 39
1297,male,CD,Ustekinumab Only,7,negative,adult,,pre_dose,09-Apr-21,16-Oct-20,175,vector,55,50 to 59
1298,male,CD,Ustekinumab Only,1080,positive,adult,,primary,01-Jun-21,14-Dec-20,169,vector,55,50 to 59
1299,male,CD,Ustekinumab Only,664,positive,adult,120,booster1,31-Dec-21,15-Sep-21,107,vector,56,50 to 59
1300,male,CD,Ustekinumab Only,1187,positive,adult,,booster2,09-Feb-22,21-Oct-21,111,vector,56,50 to 59
1301,male,CD,Ustekinumab Only,33050,positive,adult,,booster2,10-Jun-22,10-Apr-22,61,vector,56,50 to 59
1302,male,UC,Vedolizumab Only,17443,positive,adult,,pre_dose,09-Mar-21,30-Nov-20,99,mRNA,30,30 to 39
1303,male,CD,Combination Therapy,56182,positive,adult,,pre_dose,18-Apr-21,20-Feb-21,57,mRNA,36,30 to 39
1304,male,CD,Combination Therapy,937,positive,adult,,primary,02-Jul-21,16-Mar-21,108,mRNA,36,30 to 39
1305,male,CD,Combination Therapy,796,positive,adult,390,booster1,06-Aug-21,21-Feb-21,166,mRNA,36,30 to 39
1306,male,CD,Combination Therapy,311,positive,adult,300,booster2,19-Jan-22,18-Aug-21,154,mRNA,37,30 to 39
1307,male,CD,Combination Therapy,41066,positive,adult,185,booster2,20-May-22,12-Mar-22,69,mRNA,37,30 to 39
1308,female,UC,Ustekinumab Only,20,negative,adult,73,booster1,24-Jul-21,07-Apr-21,108,mRNA,24,18 to 29
1309,female,UC,Ustekinumab Only,38021,positive,pediatric,,booster2,22-Jan-22,24-Oct-21,90,mRNA,5,00 to 09
1310,female,UC,Ustekinumab Only,1252,positive,pediatric,,booster2,05-Jun-22,30-Dec-21,157,mRNA,5,00 to 09
1311,male,CD,Anti-TNF Only,136,negative,pediatric,28,pre_dose,29-Mar-21,04-Dec-20,115,mRNA,12,10 to 17
1312,female,CD,Ustekinumab Only,288,positive,pediatric,,pre_dose,27-Mar-21,17-Sep-20,191,mRNA,5,00 to 09
1313,female,CD,Ustekinumab Only,1198,positive,adult,,primary,22-May-21,01-Dec-20,172,mRNA,37,30 to 39
1314,female,CD,Ustekinumab Only,398,positive,adult,,booster1,31-Aug-21,19-Mar-21,165,mRNA,38,30 to 39
1315,female,CD,Ustekinumab Only,530,positive,adult,,booster2,18-Feb-22,21-Oct-21,120,mRNA,38,30 to 39
1316,male,CD,Anti-TNF Only,13553,positive,adult,,pre_dose,31-Mar-21,29-Dec-20,92,vector,47,40 to 49
1317,male,CD,Anti-TNF Only,1328,positive,adult,,primary,12-Jun-21,19-Feb-21,113,vector,47,40 to 49
1318,male,CD,Anti-TNF Only,1405,positive,adult,,booster1,03-Aug-21,04-Mar-21,152,vector,47,40 to 49
1319,male,CD,Anti-TNF Only,1013,positive,adult,,booster1,31-Dec-21,31-Jul-21,153,vector,48,40 to 49
1320,male,CD,Anti-TNF Only,15612,positive,adult,,booster2,01-Feb-22,02-Dec-21,61,vector,48,40 to 49
1321,male,CD,Anti-TNF Only,1340,positive,adult,,booster2,07-May-22,03-Jan-22,124,vector,48,40 to 49
1322,female,CD,Anti-TNF Only,477,positive,adult,,primary,14-Apr-21,29-Dec-20,106,mRNA,60,60 to 69
1323,female,CD,Anti-TNF Only,54096,positive,adult,,booster1,17-Jun-21,14-Apr-21,64,mRNA,60,60 to 69
1324,female,CD,Anti-TNF Only,26988,positive,adult,,booster1,17-Sep-21,12-Jul-21,67,mRNA,60,60 to 69
1325,female,CD,Anti-TNF Only,1449,positive,adult,,booster2,04-Feb-22,21-Aug-21,167,mRNA,61,60 to 69
1326,female,CD,Anti-TNF Only,26473,positive,adult,,booster2,08-Apr-22,15-Feb-22,52,mRNA,61,60 to 69
1327,male,CD,Anti-TNF Only,250,positive,adult,51,pre_dose,25-Feb-21,21-Oct-20,127,mRNA,46,40 to 49
1328,male,CD,Anti-TNF Only,648,positive,adult,147,primary,01-Jun-21,22-Jan-21,130,mRNA,47,40 to 49
1329,male,CD,Anti-TNF Only,177,negative,adult,,booster1,27-Aug-21,26-Feb-21,182,mRNA,47,40 to 49
1330,male,CD,Anti-TNF Only,1035,positive,adult,399,booster2,08-Feb-22,12-Sep-21,149,mRNA,47,40 to 49
1331,male,CD,Anti-TNF Only,53055,positive,adult,491,booster2,11-May-22,20-Mar-22,52,mRNA,48,40 to 49
1332,male,UC,Tofacitinib Only,1239,positive,adult,76,pre_dose,03-Mar-21,23-Sep-20,161,mRNA,37,30 to 39
1333,male,UC,Tofacitinib Only,40535,positive,adult,175,primary,10-Jun-21,01-Apr-21,70,mRNA,37,30 to 39
1334,male,UC,Tofacitinib Only,26043,positive,adult,271,booster1,14-Sep-21,20-Jun-21,86,mRNA,37,30 to 39
1335,female,CD,Ustekinumab Only,754,positive,adult,,primary,05-May-21,19-Jan-21,106,mRNA,60,60 to 69
1336,female,CD,Ustekinumab Only,1092,positive,adult,,booster1,19-Aug-21,03-Feb-21,197,mRNA,60,60 to 69
1337,female,CD,Ustekinumab Only,16193,positive,adult,,booster2,09-Feb-22,26-Nov-21,75,mRNA,61,60 to 69
1338,female,CD,Ustekinumab Only,256,positive,adult,,booster2,17-Jun-22,29-Dec-21,170,mRNA,61,60 to 69
1339,male,CD,Ustekinumab Only,1145,positive,elderly,,pre_dose,08-Apr-21,10-Nov-20,149,mRNA,63,60 to 69
1340,male,CD,Ustekinumab Only,1283,positive,elderly,,booster1,03-Sep-21,08-May-21,118,mRNA,64,60 to 69
1341,male,CD,Ustekinumab Only,1177,positive,elderly,,booster2,22-Feb-22,06-Oct-21,139,mRNA,64,60 to 69
1342,male,CD,Ustekinumab Only,210,positive,elderly,,booster2,04-Jun-22,11-Jan-22,144,mRNA,64,60 to 69
1343,female,CD,Anti-TNF Only,1478,positive,adult,412,primary,26-Feb-21,08-Oct-20,141,mRNA,30,30 to 39
1344,female,CD,Anti-TNF Only,,,adult,376,booster1,03-Apr-21,30-Jan-21,63,mRNA,30,30 to 39
1345,female,CD,Anti-TNF Only,1291,positive,adult,216,booster1,10-Sep-21,30-May-21,103,mRNA,30,30 to 39
1346,female,CD,Anti-TNF Only,20561,positive,adult,78,booster2,26-Jan-22,11-Nov-21,76,mRNA,31,30 to 39
1347,male,CD,Combination Therapy,184,negative,adult,,pre_dose,03-Apr-21,06-Dec-20,118,mRNA,28,18 to 29
1348,male,CD,Combination Therapy,702,positive,adult,223,primary,05-Jun-21,25-Jan-21,131,mRNA,17,10 to 17
1349,male,CD,Combination Therapy,74946,positive,adult,,booster1,23-Jul-21,02-Jun-21,51,mRNA,17,10 to 17
1350,female,CD,Combination Therapy,345,positive,adult,,booster1,25-Aug-21,30-Apr-21,117,mRNA,20,18 to 29
1351,female,CD,Anti-TNF Only,23880,positive,adult,205,primary,17-Jun-21,12-Apr-21,66,mRNA,53,50 to 59
1352,female,CD,Anti-TNF Only,79383,positive,adult,151,booster1,10-Aug-21,22-May-21,80,mRNA,53,50 to 59
1353,female,CD,Anti-TNF Only,1066,positive,adult,35,booster1,12-Feb-22,08-Oct-21,127,mRNA,53,50 to 59
1354,female,CD,Anti-TNF Only,254,positive,adult,62,booster2,11-Mar-22,15-Nov-21,116,mRNA,53,50 to 59
1355,female,CD,Anti-TNF Only,518,positive,adult,152,booster2,09-Jun-22,13-Feb-22,116,mRNA,54,50 to 59
1356,female,UC,Vedolizumab Only,21600,positive,adult,19,pre_dose,28-Feb-21,17-Dec-20,73,mRNA,43,40 to 49
1357,male,CD,Anti-TNF Only,74,negative,adult,121,pre_dose,30-Mar-21,16-Oct-20,165,mRNA,36,30 to 39
1358,male,CD,Anti-TNF Only,45705,positive,adult,213,primary,30-Jun-21,25-Apr-21,66,mRNA,36,30 to 39
1359,male,CD,Anti-TNF Only,997,positive,adult,390,booster1,01-Jan-22,21-Aug-21,133,mRNA,37,30 to 39
1360,female,CD,Anti-TNF Only,66379,positive,adult,,pre_dose,30-Apr-21,08-Feb-21,81,mRNA,50,50 to 59
1361,female,CD,Anti-TNF Only,39,negative,adult,,booster1,15-Jul-21,11-Jan-21,185,mRNA,50,50 to 59
1362,female,CD,Anti-TNF Only,645,positive,adult,,booster1,17-Jul-21,02-Jan-21,196,mRNA,50,50 to 59
1363,female,CD,Anti-TNF Only,1165,positive,adult,,booster2,20-Oct-21,15-Jun-21,127,mRNA,50,50 to 59
1364,female,CD,Anti-TNF Only,50234,positive,adult,,booster2,01-Mar-22,04-Jan-22,56,mRNA,50,50 to 59
1365,female,CD,Ustekinumab Only,409,positive,adult,531,primary,25-Feb-21,14-Aug-20,195,mRNA,49,40 to 49
1366,female,CD,Ustekinumab Only,5270,positive,adult,470,booster1,27-Apr-21,06-Feb-21,80,mRNA,49,40 to 49
1367,female,CD,Ustekinumab Only,48063,positive,adult,274,booster2,09-Nov-21,19-Aug-21,82,mRNA,50,50 to 59
1368,female,CD,Ustekinumab Only,20605,positive,adult,193,booster2,29-Jan-22,25-Oct-21,96,mRNA,50,50 to 59
1369,female,CD,Ustekinumab Only,1366,positive,adult,300,booster2,14-May-22,24-Jan-22,110,mRNA,50,50 to 59
1370,male,CD,Ustekinumab Only,58,negative,adult,132,booster1,09-Sep-21,25-Feb-21,196,mRNA,33,30 to 39
1371,female,UC,Anti-TNF Only,721,positive,adult,329,pre_dose,17-Mar-21,21-Oct-20,147,mRNA,42,40 to 49
1372,female,CD,Anti-TNF Only,403,positive,adult,320,booster1,10-Mar-21,10-Nov-20,120,mRNA,22,18 to 29
1373,female,CD,Anti-TNF Only,996,positive,adult,238,booster1,31-May-21,24-Jan-21,127,mRNA,22,18 to 29
1374,female,CD,Anti-TNF Only,676,positive,adult,87,booster2,29-Oct-21,11-Jul-21,110,mRNA,22,18 to 29
1375,female,CD,Anti-TNF Only,694,positive,adult,11,booster2,04-Feb-22,05-Sep-21,152,mRNA,22,18 to 29
1376,female,CD,Combination Therapy,1080,positive,adult,100,pre_dose,15-May-21,03-Dec-20,163,mRNA,49,40 to 49
1377,female,UC,Immunomodulator Only,1230,positive,adult,,pre_dose,16-Mar-21,04-Sep-20,193,mRNA,53,50 to 59
1378,female,UC,Immunomodulator Only,,,adult,,primary,04-May-21,14-Nov-20,171,mRNA,53,50 to 59
1379,female,UC,Immunomodulator Only,9041,positive,adult,185,booster1,02-Jul-21,26-Apr-21,67,mRNA,53,50 to 59
1380,female,UC,Immunomodulator Only,1081,positive,adult,,booster1,04-Sep-21,18-Mar-21,170,mRNA,54,50 to 59
1381,female,UC,Immunomodulator Only,148,negative,adult,,booster2,18-Nov-21,01-Jun-21,170,mRNA,54,50 to 59
1382,female,UC,Immunomodulator Only,41249,positive,adult,,booster2,09-Feb-22,18-Dec-21,53,mRNA,54,50 to 59
1383,female,UC,Immunomodulator Only,379,positive,adult,,booster2,29-Mar-22,16-Nov-21,133,mRNA,54,50 to 59
1384,female,UC,Immunomodulator Only,65272,positive,adult,,booster2,19-Jul-22,10-May-22,70,mRNA,54,50 to 59
1385,female,CD,Combination Therapy,64403,positive,adult,,primary,10-Mar-21,29-Dec-20,71,vector,38,30 to 39
1386,female,CD,Combination Therapy,506,positive,adult,,booster1,08-Apr-21,02-Dec-20,127,vector,38,30 to 39
1387,female,CD,Combination Therapy,1139,positive,adult,,booster1,01-Oct-21,11-May-21,143,vector,39,30 to 39
1388,female,CD,Combination Therapy,77344,positive,adult,,booster2,13-Jul-22,22-Apr-22,82,vector,39,30 to 39
1389,male,UC,No Immunosuppressives,51031,positive,adult,73,pre_dose,25-Feb-21,16-Dec-20,71,mRNA,27,18 to 29
1390,male,UC,No Immunosuppressives,111,negative,adult,282,booster1,09-May-21,28-Oct-20,193,mRNA,27,18 to 29
1391,male,UC,No Immunosuppressives,690,positive,adult,393,booster1,28-Aug-21,16-Apr-21,134,mRNA,28,18 to 29
1392,male,UC,No Immunosuppressives,146,negative,adult,525,booster1,07-Jan-22,28-Jun-21,193,mRNA,28,18 to 29
1393,male,UC,No Immunosuppressives,384,positive,adult,634,booster2,26-Apr-22,04-Jan-22,112,mRNA,28,18 to 29
1394,female,CD,Ustekinumab Only,872,positive,adult,309,primary,08-Apr-21,22-Oct-20,168,mRNA,40,40 to 49
1395,female,CD,Ustekinumab Only,1162,positive,adult,253,booster1,03-Jun-21,04-Feb-21,119,mRNA,40,40 to 49
1396,female,CD,Ustekinumab Only,1394,positive,adult,155,booster1,09-Sep-21,02-May-21,130,mRNA,41,40 to 49
1397,female,CD,Ustekinumab Only,12736,positive,adult,70,booster2,03-Dec-21,02-Sep-21,92,mRNA,41,40 to 49
1398,male,UC,Anti-TNF Only,1430,positive,adult,,booster1,10-Aug-21,20-Mar-21,143,vector,32,30 to 39
1399,female,CD,Vedolizumab Only,1297,positive,elderly,,primary,05-Mar-21,44065,195,vector,71,70+
1400,female,CD,Vedolizumab Only,496,positive,elderly,,primary,20-Aug-21,44260,168,vector,71,70+
1401,female,CD,Anti-TNF Only,979,positive,adult,,pre_dose,17-Mar-21,26-Nov-20,111,mRNA,47,40 to 49
1402,female,CD,Anti-TNF Only,653,positive,adult,237,booster1,28-May-21,13-Dec-20,166,mRNA,47,40 to 49
1403,female,CD,Anti-TNF Only,784,positive,adult,162,booster1,10-Sep-21,05-May-21,128,mRNA,48,40 to 49
1404,female,CD,Anti-TNF Only,101,negative,adult,50,booster2,15-Dec-21,03-Jun-21,195,mRNA,48,40 to 49
1405,female,CD,Anti-TNF Only,265,positive,adult,56,booster2,15-Mar-22,06-Sep-21,190,mRNA,48,40 to 49
1406,female,UC,No Immunosuppressives,612,positive,adult,,pre_dose,23-Mar-21,04-Dec-20,109,mRNA,45,40 to 49
1407,female,UC,No Immunosuppressives,71243,positive,adult,,booster1,18-Nov-21,20-Sep-21,59,mRNA,46,40 to 49
1408,female,CD,Anti-TNF Only,21019,positive,adult,,booster1,27-Mar-21,03-Feb-21,52,mRNA,34,30 to 39
1409,female,CD,Anti-TNF Only,415,positive,adult,,booster1,28-Sep-21,07-Apr-21,174,mRNA,34,30 to 39
1410,female,CD,Anti-TNF Only,54332,positive,adult,,booster2,18-Nov-21,16-Sep-21,63,mRNA,35,30 to 39
1411,female,CD,Anti-TNF Only,755,positive,adult,,booster2,18-Feb-22,25-Aug-21,177,mRNA,35,30 to 39
1412,female,CD,Anti-TNF Only,19242,positive,adult,,booster2,19-Apr-22,28-Feb-22,50,mRNA,35,30 to 39
1413,female,CD,Ustekinumab Only,1107,positive,elderly,,pre_dose,29-Mar-21,29-Sep-20,181,mRNA,65,60 to 69
1414,female,CD,Ustekinumab Only,572,positive,elderly,,primary,12-May-21,22-Dec-20,141,mRNA,65,60 to 69
1415,female,CD,Ustekinumab Only,1433,positive,elderly,,booster1,15-Jul-21,31-Dec-20,196,mRNA,65,60 to 69
1416,female,CD,Ustekinumab Only,855,positive,elderly,,booster2,12-Oct-21,03-Jun-21,131,mRNA,65,60 to 69
1417,female,CD,Ustekinumab Only,738,positive,elderly,,booster2,27-Jan-22,01-Aug-21,179,mRNA,66,60 to 69
1418,female,CD,Ustekinumab Only,1230,positive,elderly,,booster2,01-Apr-22,29-Oct-21,154,mRNA,66,60 to 69
1419,female,CD,Ustekinumab Only,902,positive,elderly,,booster2,02-Jul-22,18-Mar-22,106,mRNA,66,60 to 69
1420,male,CD,Anti-TNF Only,93,negative,adult,100,pre_dose,28-Mar-21,07-Oct-20,172,mRNA,23,18 to 29
1421,male,UC,Anti-TNF Only,27637,positive,adult,,pre_dose,27-Apr-21,29-Jan-21,88,mRNA,60,60 to 69
1422,male,UC,Anti-TNF Only,699,positive,adult,,booster1,15-Jun-21,18-Dec-20,179,mRNA,60,60 to 69
1423,male,UC,Anti-TNF Only,22919,positive,adult,,booster2,30-Nov-21,04-Oct-21,57,mRNA,61,60 to 69
1424,female,CD,Vedolizumab Only,336,positive,adult,,pre_dose,09-Apr-21,17-Nov-20,143,mRNA,32,30 to 39
1425,female,CD,Vedolizumab Only,21825,positive,adult,,primary,03-Jun-21,04-Apr-21,60,mRNA,32,30 to 39
1426,male,CD,Ustekinumab Only,141,negative,elderly,22,pre_dose,05-Mar-21,26-Sep-20,160,mRNA,72,70+
1427,male,CD,Ustekinumab Only,63820,positive,elderly,83,primary,05-May-21,15-Mar-21,51,mRNA,72,70+
1428,male,CD,Ustekinumab Only,797,positive,elderly,174,booster1,04-Aug-21,20-Apr-21,106,mRNA,72,70+
1429,male,CD,Ustekinumab Only,28608,positive,elderly,237,booster2,20-Nov-21,28-Aug-21,84,mRNA,72,70+
1430,male,CD,Ustekinumab Only,821,positive,elderly,407,booster2,25-Mar-22,08-Nov-21,137,mRNA,73,70+
1431,male,CD,Ustekinumab Only,10494,positive,elderly,465,booster2,22-May-22,03-Mar-22,80,mRNA,73,70+
1432,male,UC,Immunomodulator Only,638,positive,adult,49,pre_dose,16-Apr-21,06-Oct-20,192,mRNA,27,18 to 29
1433,female,CD,Anti-TNF Only,16897,positive,adult,285,pre_dose,31-Mar-21,22-Jan-21,68,mRNA,31,30 to 39
1434,female,CD,Anti-TNF Only,356,positive,adult,208,primary,16-Jun-21,16-Dec-20,182,mRNA,31,30 to 39
1435,female,CD,Anti-TNF Only,1104,positive,adult,180,booster1,14-Jul-21,04-Jan-21,191,mRNA,31,30 to 39
1436,female,CD,Anti-TNF Only,484,positive,adult,24,booster1,03-Feb-22,09-Sep-21,147,mRNA,32,30 to 39
1437,female,CD,Anti-TNF Only,72820,positive,adult,99,booster2,19-Apr-22,18-Jan-22,91,mRNA,32,30 to 39
1438,female,CD,Ustekinumab Only,808,positive,adult,,pre_dose,25-Mar-21,15-Nov-20,130,mRNA,59,50 to 59
1439,female,CD,Ustekinumab Only,1287,positive,adult,162,primary,15-Jun-21,13-Jan-21,153,mRNA,60,60 to 69
1440,female,CD,Ustekinumab Only,255,positive,adult,,booster1,01-Oct-21,13-Jun-21,110,mRNA,60,60 to 69
1441,female,CD,Ustekinumab Only,78891,positive,adult,,booster2,02-Nov-21,20-Aug-21,74,mRNA,60,60 to 69
1442,female,CD,Ustekinumab Only,445,positive,adult,,booster2,01-Mar-22,28-Oct-21,124,mRNA,60,60 to 69
1443,female,CD,Ustekinumab Only,1137,positive,adult,,booster2,05-May-22,04-Nov-21,182,mRNA,61,60 to 69
1444,male,CD,Vedolizumab Only,763,positive,adult,,booster1,20-Mar-21,18-Oct-20,153,mRNA,50,50 to 59
1445,male,CD,Vedolizumab Only,1162,positive,adult,,booster1,24-Sep-21,14-May-21,133,mRNA,51,50 to 59
1446,male,CD,Vedolizumab Only,399,positive,adult,,booster2,15-Feb-22,06-Nov-21,101,mRNA,51,50 to 59
1447,female,CD,Anti-TNF Only,75815,positive,adult,401,primary,20-Apr-21,11-Feb-21,68,mRNA,28,18 to 29
1448,female,CD,Anti-TNF Only,17337,positive,adult,338,booster1,22-Jun-21,30-Mar-21,84,mRNA,29,18 to 29
1449,female,CD,Anti-TNF Only,763,positive,adult,,booster1,01-Sep-21,25-Apr-21,129,mRNA,29,18 to 29
1450,female,CD,Anti-TNF Only,161,negative,adult,112,booster2,03-Feb-22,24-Aug-21,163,mRNA,29,18 to 29
1451,female,CD,Anti-TNF Only,411,positive,adult,9,booster2,04-Jun-22,16-Feb-22,108,mRNA,30,30 to 39
1452,female,CD,Ustekinumab Only,220,positive,adult,,booster1,02-Apr-21,09-Dec-20,114,mRNA,33,30 to 39
1453,female,CD,Ustekinumab Only,622,positive,adult,,booster1,17-Sep-21,23-Apr-21,147,mRNA,33,30 to 39
1454,female,CD,Ustekinumab Only,47139,positive,adult,,booster2,24-Feb-22,14-Dec-21,72,mRNA,34,30 to 39
1455,female,CD,Anti-TNF Only,702,positive,adult,127,primary,28-May-21,10-Dec-20,169,mRNA,33,30 to 39
1456,female,CD,Anti-TNF Only,618,positive,adult,112,booster2,22-Jan-22,01-Aug-21,174,mRNA,33,30 to 39
1457,female,CD,Anti-TNF Only,29712,positive,adult,153,booster2,04-Mar-22,04-Jan-22,59,mRNA,33,30 to 39
1458,male,UC,Anti-TNF Only,3239,positive,adult,177,booster2,21-Oct-21,18-Aug-21,64,mRNA,34,30 to 39
1459,male,CD,Anti-TNF Only,9821,positive,adult,,pre_dose,10-Apr-21,14-Jan-21,86,mRNA,39,30 to 39
1460,male,CD,Anti-TNF Only,44942,positive,adult,,primary,21-May-21,16-Mar-21,66,mRNA,39,30 to 39
1461,male,CD,Anti-TNF Only,530,positive,adult,,booster1,14-Aug-21,28-Feb-21,167,mRNA,39,30 to 39
1462,male,CD,Anti-TNF Only,16234,positive,adult,,booster2,13-Jan-22,16-Oct-21,89,mRNA,39,30 to 39
1463,male,CD,Anti-TNF Only,936,positive,adult,,booster2,07-Apr-22,28-Dec-21,100,mRNA,40,40 to 49
1464,male,CD,Anti-TNF Only,1170,positive,adult,,booster2,04-Jun-22,21-Feb-22,103,mRNA,40,40 to 49
1465,female,CD,Ustekinumab Only,578,positive,elderly,,primary,02-Jun-21,17-Dec-20,167,mRNA,63,60 to 69
1466,female,CD,Ustekinumab Only,1302,positive,elderly,,booster1,30-Sep-21,17-May-21,136,mRNA,63,60 to 69
1467,female,CD,Ustekinumab Only,60164,positive,elderly,,booster2,01-Dec-21,14-Sep-21,78,mRNA,64,60 to 69
1468,female,CD,Combination Therapy,390,positive,adult,,pre_dose,31-Mar-21,23-Sep-20,189,mRNA,58,50 to 59
1469,female,CD,Combination Therapy,1471,positive,adult,,primary,21-May-21,08-Nov-20,194,mRNA,58,50 to 59
1470,female,CD,Combination Therapy,167,negative,adult,,booster1,11-Aug-21,25-Mar-21,139,mRNA,58,50 to 59
1471,female,CD,Combination Therapy,136,negative,adult,,booster2,29-Oct-21,03-May-21,179,mRNA,58,50 to 59
1472,female,CD,Combination Therapy,67403,positive,adult,,booster2,06-Mar-22,31-Dec-21,65,mRNA,59,50 to 59
1473,female,CD,Combination Therapy,820,positive,adult,,booster2,02-Apr-22,31-Oct-21,153,mRNA,59,50 to 59
1474,male,CD,Vedolizumab Only,1084,positive,adult,482,pre_dose,27-Mar-21,01-Oct-20,177,mRNA,34,30 to 39
1475,female,UC,Ustekinumab Only,66864,positive,adult,126,booster1,01-Sep-21,09-Jun-21,84,vector,45,40 to 49
1476,female,UC,Ustekinumab Only,47793,positive,adult,99,booster2,14-Apr-22,13-Feb-22,60,vector,45,40 to 49
1477,female,UC,Ustekinumab Only,671,positive,adult,155,booster2,09-Jun-22,27-Jan-22,133,vector,45,40 to 49
1478,male,CD,Anti-TNF Only,894,positive,elderly,,pre_dose,31-Mar-21,10-Dec-20,111,mRNA,72,70+
1479,male,CD,Anti-TNF Only,1158,positive,elderly,,booster2,08-Feb-22,19-Oct-21,112,mRNA,72,70+
1480,male,UC,Ustekinumab Only,14506,positive,adult,,pre_dose,28-Mar-21,09-Jan-21,78,mRNA,38,30 to 39
1481,male,UC,Ustekinumab Only,1192,positive,adult,,booster1,16-Aug-21,22-Mar-21,147,mRNA,39,30 to 39
1482,male,CD,Ustekinumab Only,24433,positive,adult,297,pre_dose,23-Mar-21,19-Dec-20,94,mRNA,43,40 to 49
1483,male,CD,Ustekinumab Only,963,positive,adult,224,primary,04-Jun-21,20-Nov-20,196,mRNA,43,40 to 49
1484,male,CD,Ustekinumab Only,432,positive,adult,174,booster1,24-Jul-21,14-Apr-21,101,mRNA,43,40 to 49
1485,male,CD,Ustekinumab Only,587,positive,adult,20,booster2,25-Dec-21,29-Jul-21,149,mRNA,43,40 to 49
1486,male,CD,Ustekinumab Only,893,positive,adult,76,booster2,31-Mar-22,18-Dec-21,103,mRNA,44,40 to 49
1487,male,CD,Ustekinumab Only,32692,positive,adult,132,booster2,26-May-22,28-Mar-22,59,mRNA,44,40 to 49
1488,female,CD,Ustekinumab Only,32921,positive,elderly,,pre_dose,09-Apr-21,28-Jan-21,71,mRNA,64,60 to 69
1489,female,CD,Ustekinumab Only,1225,positive,elderly,,primary,23-May-21,04-Feb-21,108,mRNA,64,60 to 69
1490,female,CD,Ustekinumab Only,904,positive,elderly,,booster1,21-Jul-21,27-Mar-21,116,mRNA,64,60 to 69
1491,female,CD,Ustekinumab Only,1057,positive,elderly,,booster1,18-Dec-21,11-Jul-21,160,mRNA,64,60 to 69
1492,female,CD,Ustekinumab Only,487,positive,elderly,,booster2,18-Jan-22,04-Aug-21,167,mRNA,65,60 to 69
1493,female,CD,Ustekinumab Only,288,positive,elderly,,booster2,10-May-22,16-Dec-21,145,mRNA,65,60 to 69
1494,male,UC,Anti-TNF Only,314,positive,adult,,pre_dose,17-Mar-21,15-Oct-20,153,mRNA,22,18 to 29
1495,male,UC,Anti-TNF Only,239,positive,adult,,booster1,21-Jul-21,31-Mar-21,112,mRNA,22,18 to 29
1496,male,UC,Anti-TNF Only,754,positive,adult,,booster2,07-Jan-22,03-Sep-21,126,mRNA,23,18 to 29
1497,male,UC,Anti-TNF Only,1323,positive,adult,,booster2,01-Apr-22,28-Oct-21,155,mRNA,23,18 to 29
1498,female,UC,Ustekinumab Only,29991,positive,adult,377,booster1,04-May-21,03-Mar-21,62,mRNA,38,30 to 39
1499,male,CD,Ustekinumab Only,726,positive,adult,341,primary,29-May-21,07-Dec-20,173,vector,51,50 to 59
1500,male,CD,Ustekinumab Only,52850,positive,adult,225,booster2,16-Feb-22,30-Nov-21,78,vector,52,50 to 59
1501,male,CD,Ustekinumab Only,175,negative,adult,169,booster2,30-Jun-22,21-Dec-21,191,vector,52,50 to 59
1502,male,CD,Anti-TNF Only,411,positive,adult,,booster1,04-Sep-21,04-May-21,123,mRNA,56,50 to 59
1503,male,CD,Combination Therapy,71824,positive,adult,345,pre_dose,09-Apr-21,02-Jan-21,97,mRNA,28,18 to 29
1504,male,CD,Combination Therapy,8398,positive,adult,302,primary,02-Jun-21,19-Mar-21,75,mRNA,29,18 to 29
1505,male,CD,Combination Therapy,573,positive,adult,187,booster1,27-Aug-21,18-May-21,101,mRNA,29,18 to 29
1506,male,CD,Combination Therapy,1093,positive,adult,,booster2,10-Feb-22,20-Oct-21,113,mRNA,29,18 to 29
1507,female,CD,Ustekinumab Only,1386,positive,elderly,,booster1,02-Sep-21,12-May-21,113,vector,64,60 to 69
1508,male,CD,Combination Therapy,88,negative,adult,,pre_dose,13-Mar-21,02-Dec-20,101,mRNA,36,30 to 39
1509,male,UC,Anti-TNF Only,49473,positive,adult,225,booster1,18-Aug-21,17-May-21,93,mRNA,38,30 to 39
1510,male,CD,Combination Therapy,307,positive,adult,,pre_dose,07-Apr-21,21-Sep-20,198,mRNA,57,50 to 59
1511,male,CD,Combination Therapy,33024,positive,adult,,booster1,24-Aug-21,23-May-21,93,mRNA,57,50 to 59
1512,male,CD,Combination Therapy,21828,positive,adult,,booster2,04-Nov-21,02-Aug-21,94,mRNA,57,50 to 59
1513,male,CD,Combination Therapy,772,positive,adult,,booster2,04-Mar-22,07-Nov-21,117,mRNA,58,50 to 59
1514,male,CD,Combination Therapy,82,negative,adult,,booster2,04-Jun-22,31-Dec-21,155,mRNA,58,50 to 59
1515,male,CD,Ustekinumab Only,622,positive,adult,,pre_dose,04-May-21,14-Jan-21,110,mRNA,42,40 to 49
1516,male,CD,Ustekinumab Only,855,positive,adult,,booster1,24-Aug-21,28-Feb-21,177,mRNA,43,40 to 49
1517,male,CD,Ustekinumab Only,1051,positive,adult,,booster2,25-May-22,18-Dec-21,158,mRNA,43,40 to 49
1518,male,CD,Immunomodulator Only,333,positive,elderly,,primary,27-Apr-21,16-Dec-20,132,mRNA,73,70+
1519,male,CD,Immunomodulator Only,,,elderly,169,booster1,19-May-21,28-Feb-21,80,mRNA,73,70+
1520,male,CD,Immunomodulator Only,954,positive,elderly,,booster1,28-Aug-21,28-Feb-21,181,mRNA,73,70+
1521,male,CD,Immunomodulator Only,464,positive,elderly,,booster2,16-Nov-21,24-Jun-21,145,mRNA,74,70+
1522,male,CD,Immunomodulator Only,70833,positive,elderly,,booster2,04-Mar-22,30-Nov-21,94,mRNA,74,70+
1523,male,CD,Immunomodulator Only,561,positive,elderly,,booster2,22-Apr-22,25-Oct-21,179,mRNA,74,70+
1524,male,CD,Anti-TNF Only,46140,positive,elderly,,primary,04-May-21,12-Mar-21,53,mRNA,73,70+
1525,male,CD,Anti-TNF Only,40046,positive,elderly,,booster1,04-Jun-21,03-Apr-21,62,mRNA,73,70+
1526,male,CD,Anti-TNF Only,1280,positive,elderly,,booster1,01-Jan-22,18-Jul-21,167,mRNA,73,70+
1527,male,UC,No Immunosuppressives,1090,positive,elderly,,primary,20-Apr-21,06-Nov-20,165,mRNA,72,70+
1528,male,UC,No Immunosuppressives,57830,positive,elderly,,booster1,09-Jun-21,07-Mar-21,94,mRNA,73,70+
1529,male,UC,No Immunosuppressives,27708,positive,elderly,,booster1,14-Sep-21,22-Jun-21,84,mRNA,73,70+
1530,male,UC,No Immunosuppressives,28141,positive,elderly,,booster2,18-Nov-21,07-Sep-21,72,mRNA,73,70+
1531,male,UC,No Immunosuppressives,14677,positive,elderly,,booster2,08-Feb-22,03-Dec-21,67,mRNA,73,70+
1532,male,UC,No Immunosuppressives,47294,positive,elderly,,booster2,05-Apr-22,29-Jan-22,66,mRNA,73,70+
1533,male,UC,No Immunosuppressives,53190,positive,elderly,,booster2,19-Jul-22,14-May-22,66,mRNA,74,70+
1534,male,UC,No Immunosuppressives,78477,positive,adult,,primary,03-Jul-21,19-Apr-21,75,mRNA,53,50 to 59
1535,male,UC,No Immunosuppressives,823,positive,adult,,booster1,20-Aug-21,04-Apr-21,138,mRNA,53,50 to 59
1536,male,UC,No Immunosuppressives,1211,positive,adult,,booster1,04-Mar-22,15-Sep-21,170,mRNA,53,50 to 59
1537,male,UC,No Immunosuppressives,572,positive,adult,,booster1,29-Jul-22,23-Mar-22,128,mRNA,54,50 to 59
1538,female,CD,Vedolizumab Only,833,positive,elderly,,primary,28-Apr-21,16-Jan-21,102,mRNA,76,70+
1539,female,CD,Vedolizumab Only,1292,positive,elderly,345,booster1,23-Jun-21,16-Feb-21,127,mRNA,76,70+
1540,female,CD,Vedolizumab Only,719,positive,elderly,,booster2,26-May-22,22-Jan-22,124,mRNA,77,70+
1541,female,UC,Anti-TNF Only,386,positive,adult,306,booster1,24-Apr-21,02-Jan-21,112,mRNA,26,18 to 29
1542,female,UC,Anti-TNF Only,879,positive,adult,106,booster2,10-Nov-21,02-Jul-21,131,mRNA,27,18 to 29
1543,male,UC,Ustekinumab Only,12,negative,adult,,booster1,07-Aug-21,19-Feb-21,169,mRNA,54,50 to 59
1544,female,CD,Ustekinumab Only,1090,positive,adult,429,primary,14-Apr-21,31-Oct-20,165,mRNA,23,18 to 29
1545,female,CD,Ustekinumab Only,1441,positive,adult,34,booster2,14-May-22,29-Jan-22,105,mRNA,24,18 to 29
1546,male,CD,Vedolizumab Only,63472,positive,elderly,,primary,24-Apr-21,17-Feb-21,66,mRNA,73,70+
1547,male,CD,Vedolizumab Only,1818,positive,elderly,,booster1,27-May-21,19-Feb-21,97,mRNA,73,70+
1548,male,CD,Vedolizumab Only,1466,positive,elderly,,booster1,18-Sep-21,15-May-21,126,mRNA,73,70+
1549,male,CD,Vedolizumab Only,47633,positive,elderly,302,booster2,13-Nov-21,12-Sep-21,62,mRNA,73,70+
1550,male,CD,Vedolizumab Only,275,positive,elderly,,booster2,04-May-22,31-Dec-21,124,mRNA,74,70+
1551,male,CD,Ustekinumab Only,64628,positive,adult,359,pre_dose,24-Mar-21,30-Jan-21,53,mRNA,47,40 to 49
1552,male,CD,Ustekinumab Only,386,positive,adult,209,primary,21-Aug-21,22-Apr-21,121,mRNA,48,40 to 49
1553,male,CD,Ustekinumab Only,1404,positive,adult,113,booster2,25-Nov-21,04-Aug-21,113,mRNA,48,40 to 49
1554,male,CD,Ustekinumab Only,485,positive,adult,4,booster2,22-Mar-22,11-Dec-21,101,mRNA,48,40 to 49
1555,male,CD,Combination Therapy,233,positive,adult,,pre_dose,22-Apr-21,02-Nov-20,171,mRNA,49,40 to 49
1556,male,CD,Combination Therapy,1487,positive,adult,,primary,21-May-21,11-Jan-21,130,mRNA,49,40 to 49
1557,male,CD,Combination Therapy,625,positive,adult,,booster1,08-Jul-21,06-Feb-21,152,mRNA,49,40 to 49
1558,male,CD,Combination Therapy,990,positive,adult,,booster1,24-Sep-21,15-May-21,132,mRNA,49,40 to 49
1559,male,CD,Combination Therapy,873,positive,adult,187,booster2,30-Oct-21,14-Jun-21,138,mRNA,49,40 to 49
1560,male,CD,Combination Therapy,243,positive,adult,,booster2,25-Feb-22,01-Sep-21,177,mRNA,50,50 to 59
1561,female,UC,Anti-TNF Only,266,positive,elderly,,booster1,06-Jul-21,24-Feb-21,132,mRNA,65,60 to 69
1562,female,UC,Anti-TNF Only,44020,positive,elderly,,booster1,08-Sep-21,10-Jul-21,60,mRNA,65,60 to 69
1563,female,UC,Anti-TNF Only,1228,positive,elderly,,booster2,07-Oct-21,20-Jun-21,109,mRNA,65,60 to 69
1564,female,UC,Anti-TNF Only,637,positive,elderly,,booster2,24-Feb-22,16-Aug-21,192,mRNA,66,60 to 69
1565,female,UC,Anti-TNF Only,1133,positive,elderly,,booster2,19-Apr-22,10-Oct-21,191,mRNA,66,60 to 69
1566,female,CD,Ustekinumab Only,45523,positive,elderly,,primary,15-May-21,16-Mar-21,60,mRNA,74,70+
1567,female,CD,Ustekinumab Only,875,positive,elderly,,booster1,07-Nov-21,14-Jun-21,146,mRNA,75,70+
1568,female,CD,Ustekinumab Only,524,positive,elderly,,booster2,18-Feb-22,07-Sep-21,164,mRNA,75,70+
1569,female,CD,Ustekinumab Only,1119,positive,elderly,,booster2,24-May-22,01-Dec-21,174,mRNA,75,70+
1570,male,CD,Anti-TNF Only,959,positive,adult,268,primary,23-Apr-21,26-Dec-20,118,mRNA,41,40 to 49
1571,male,CD,Anti-TNF Only,1394,positive,adult,164,booster1,05-Aug-21,10-Apr-21,117,mRNA,41,40 to 49
1572,male,CD,Anti-TNF Only,40838,positive,adult,72,booster1,05-Nov-21,22-Aug-21,75,mRNA,41,40 to 49
1573,male,CD,Anti-TNF Only,901,positive,adult,31,booster1,16-Feb-22,14-Aug-21,186,mRNA,42,40 to 49
1574,male,CD,Anti-TNF Only,40555,positive,adult,53,booster1,10-Mar-22,08-Jan-22,61,mRNA,42,40 to 49
1575,female,CD,Vedolizumab Only,1063,positive,adult,,pre_dose,13-Apr-21,29-Sep-20,196,vector,38,30 to 39
1576,female,CD,Vedolizumab Only,14565,positive,adult,,primary,28-May-21,04-Mar-21,85,vector,38,30 to 39
1577,female,CD,Vedolizumab Only,6755,positive,adult,,booster1,21-Aug-21,26-May-21,87,vector,38,30 to 39
1578,female,CD,Vedolizumab Only,969,positive,adult,,booster1,03-Aug-22,09-Mar-22,147,vector,39,30 to 39
1579,female,CD,Ustekinumab Only,24064,positive,adult,,primary,25-Jun-21,02-May-21,54,mRNA,56,50 to 59
1580,female,CD,Ustekinumab Only,53130,positive,adult,,booster1,21-Aug-21,17-May-21,96,mRNA,56,50 to 59
1581,female,CD,Ustekinumab Only,1415,positive,adult,,booster1,15-Dec-21,10-Aug-21,127,mRNA,57,50 to 59
1582,female,CD,Ustekinumab Only,142,negative,adult,,booster2,25-May-22,16-Dec-21,160,mRNA,57,50 to 59
1583,male,CD,No Immunosuppressives,60125,positive,elderly,,primary,27-Apr-21,17-Feb-21,69,mRNA,74,70+
1584,male,CD,No Immunosuppressives,244,positive,elderly,,booster1,21-May-21,03-Nov-20,199,mRNA,74,70+
1585,male,CD,No Immunosuppressives,1148,positive,elderly,,booster1,18-Sep-21,14-Mar-21,188,mRNA,74,70+
1586,male,CD,No Immunosuppressives,1094,positive,elderly,,booster2,14-Jan-22,28-Aug-21,139,mRNA,75,70+
1587,male,CD,No Immunosuppressives,432,positive,elderly,,booster2,12-Apr-22,06-Oct-21,188,mRNA,75,70+
1588,male,CD,No Immunosuppressives,64260,positive,elderly,,booster2,31-May-22,02-Mar-22,90,mRNA,75,70+
1589,female,CD,Anti-TNF Only,14242,positive,adult,,pre_dose,22-Mar-21,08-Jan-21,73,mRNA,59,50 to 59
1590,female,CD,Anti-TNF Only,70774,positive,adult,,booster1,29-Aug-21,05-Jul-21,55,mRNA,60,60 to 69
1591,female,CD,Anti-TNF Only,357,positive,adult,,booster2,10-Nov-21,03-Jul-21,130,mRNA,60,60 to 69
1592,female,CD,Anti-TNF Only,72978,positive,adult,,booster2,26-Jan-22,31-Oct-21,87,mRNA,60,60 to 69
1593,female,CD,Anti-TNF Only,280,positive,adult,,booster2,24-May-22,14-Nov-21,191,mRNA,60,60 to 69
1594,male,CD,Anti-TNF Only,379,positive,adult,277,pre_dose,15-Apr-21,02-Oct-20,195,mRNA,52,50 to 59
1595,male,CD,Anti-TNF Only,806,positive,adult,221,primary,10-Jun-21,08-Jan-21,153,mRNA,53,50 to 59
1596,male,CD,Anti-TNF Only,478,positive,adult,165,booster1,05-Aug-21,14-Mar-21,144,mRNA,53,50 to 59
1597,male,CD,Anti-TNF Only,675,positive,adult,53,booster1,25-Nov-21,23-Jul-21,125,mRNA,53,50 to 59
1598,male,CD,Anti-TNF Only,1019,positive,adult,29,booster2,15-Feb-22,12-Oct-21,126,mRNA,53,50 to 59
1599,male,CD,Anti-TNF Only,714,positive,adult,,booster2,25-May-22,23-Nov-21,183,mRNA,54,50 to 59
1600,male,CD,No Immunosuppressives,3328,positive,adult,,primary,19-Jun-21,16-Apr-21,64,mRNA,35,30 to 39
1601,male,CD,No Immunosuppressives,191,negative,adult,,booster1,21-Jul-21,04-Feb-21,167,mRNA,35,30 to 39
1602,male,CD,No Immunosuppressives,5096,positive,adult,,booster1,25-Dec-21,17-Sep-21,99,mRNA,35,30 to 39
1603,male,CD,No Immunosuppressives,796,positive,adult,,booster2,21-Jan-22,25-Sep-21,118,mRNA,35,30 to 39
1604,male,CD,No Immunosuppressives,6181,positive,adult,,booster2,11-Jun-22,25-Mar-22,78,mRNA,36,30 to 39
1605,male,UC,No Immunosuppressives,1429,positive,elderly,,primary,09-May-21,07-Dec-20,153,mRNA,68,60 to 69
1606,male,UC,No Immunosuppressives,474,positive,elderly,,booster1,06-Jul-21,01-Mar-21,127,mRNA,68,60 to 69
1607,male,UC,No Immunosuppressives,586,positive,elderly,,booster1,16-Oct-21,11-Apr-21,188,mRNA,68,60 to 69
1608,male,UC,No Immunosuppressives,1771,positive,elderly,,booster2,06-Jan-22,01-Oct-21,97,mRNA,69,60 to 69
1609,male,UC,No Immunosuppressives,57076,positive,elderly,,booster2,20-Apr-22,31-Jan-22,79,mRNA,69,60 to 69
1610,male,UC,No Immunosuppressives,544,positive,elderly,,booster2,14-Jun-22,22-Dec-21,174,mRNA,69,60 to 69
1611,female,CD,Ustekinumab Only,1185,positive,adult,,pre_dose,14-Apr-21,11-Oct-20,185,mRNA,49,40 to 49
1612,female,CD,Ustekinumab Only,49817,positive,adult,,primary,09-Jun-21,20-Apr-21,50,mRNA,49,40 to 49
1613,female,CD,Ustekinumab Only,18038,positive,adult,,booster1,06-Aug-21,16-Jun-21,51,mRNA,49,40 to 49
1614,female,CD,Ustekinumab Only,744,positive,adult,,booster2,24-Nov-21,26-Jul-21,121,mRNA,50,50 to 59
1615,female,CD,Ustekinumab Only,64803,positive,adult,,booster2,11-Feb-22,30-Nov-21,73,mRNA,50,50 to 59
1616,female,CD,Ustekinumab Only,398,positive,adult,,booster2,21-Jun-22,11-Dec-21,192,mRNA,50,50 to 59
1617,female,UC,Vedolizumab Only,1226,positive,adult,,booster1,30-Mar-21,16-Oct-20,165,mRNA,35,30 to 39
1618,female,UC,Vedolizumab Only,48371,positive,adult,,booster1,24-Nov-21,22-Sep-21,63,mRNA,35,30 to 39
1619,female,UC,Vedolizumab Only,938,positive,adult,,booster2,01-Mar-22,30-Aug-21,183,mRNA,36,30 to 39
1620,male,CD,Ustekinumab Only,999,positive,adult,383,pre_dose,24-Apr-21,11-Dec-20,134,mRNA,47,40 to 49
1621,male,CD,Ustekinumab Only,39355,positive,adult,327,primary,19-Jun-21,15-Mar-21,96,mRNA,47,40 to 49
1622,male,CD,Ustekinumab Only,79472,positive,adult,271,booster1,14-Aug-21,15-May-21,91,mRNA,47,40 to 49
1623,male,CD,Ustekinumab Only,1259,positive,adult,166,booster2,27-Nov-21,03-Aug-21,116,mRNA,48,40 to 49
1624,male,CD,Ustekinumab Only,607,positive,adult,48,booster2,25-Mar-22,22-Nov-21,123,mRNA,48,40 to 49
1625,male,CD,Ustekinumab Only,1291,positive,adult,299,pre_dose,25-Mar-21,16-Oct-20,160,mRNA,48,40 to 49
1626,male,CD,Ustekinumab Only,1095,positive,adult,242,primary,21-May-21,20-Jan-21,121,mRNA,48,40 to 49
1627,male,CD,Ustekinumab Only,811,positive,adult,139,booster1,01-Sep-21,25-Feb-21,188,mRNA,48,40 to 49
1628,male,CD,Ustekinumab Only,470,positive,adult,59,booster2,20-Nov-21,13-Jun-21,160,mRNA,48,40 to 49
1629,male,CD,Ustekinumab Only,965,positive,adult,,booster2,11-Mar-22,19-Nov-21,112,mRNA,49,40 to 49
1630,male,CD,Ustekinumab Only,12193,positive,adult,130,booster2,28-May-22,20-Mar-22,69,mRNA,49,40 to 49
1631,male,CD,Combination Therapy,58751,positive,adult,,primary,19-May-21,14-Feb-21,94,mRNA,56,50 to 59
1632,male,CD,Combination Therapy,798,positive,adult,,booster1,14-Aug-21,03-Apr-21,133,mRNA,57,50 to 59
1633,male,CD,Combination Therapy,767,positive,pediatric,,booster2,01-Feb-22,19-Aug-21,166,mRNA,8,00 to 09
1634,male,CD,Combination Therapy,27415,positive,pediatric,,booster2,18-May-22,08-Mar-22,71,mRNA,15,10 to 17
1635,male,UC,Vedolizumab Only,855,positive,pediatric,,primary,22-Jul-21,12-Mar-21,132,vector,12,10 to 17
1636,male,UC,Vedolizumab Only,1389,positive,pediatric,,booster1,08-Aug-21,29-Apr-21,101,vector,2,00 to 09
1637,male,UC,Vedolizumab Only,588,positive,adult,,booster1,06-Jan-22,20-Jun-21,200,vector,33,30 to 39
1638,male,UC,Vedolizumab Only,710,positive,adult,,booster2,23-Jun-22,25-Feb-22,118,vector,33,30 to 39
1639,male,UC,Vedolizumab Only,68001,positive,adult,,primary,28-May-21,08-Mar-21,81,mRNA,39,30 to 39
1640,male,UC,Vedolizumab Only,27065,positive,adult,328,booster1,25-Jun-21,27-Apr-21,59,mRNA,39,30 to 39
1641,male,UC,Vedolizumab Only,62377,positive,adult,211,booster2,20-Oct-21,25-Jul-21,87,mRNA,40,40 to 49
1642,male,UC,Vedolizumab Only,811,positive,adult,83,booster2,25-Feb-22,09-Nov-21,108,mRNA,40,40 to 49
1643,male,UC,Vedolizumab Only,371,positive,adult,55,booster2,25-Mar-22,24-Nov-21,121,mRNA,40,40 to 49
1644,male,UC,Vedolizumab Only,622,positive,adult,22,booster2,10-Jun-22,02-Feb-22,128,mRNA,40,40 to 49
1645,male,CD,Ustekinumab Only,829,positive,adult,220,primary,09-Jun-21,21-Nov-20,200,mRNA,36,30 to 39
1646,male,CD,Ustekinumab Only,812,positive,adult,106,booster1,01-Oct-21,14-Jun-21,109,mRNA,36,30 to 39
1647,male,CD,Anti-TNF Only,30548,positive,elderly,232,primary,01-Jun-21,24-Feb-21,97,mRNA,65,60 to 69
1648,male,CD,Anti-TNF Only,1104,positive,elderly,151,booster1,21-Aug-21,28-Apr-21,115,mRNA,65,60 to 69
1649,male,CD,Anti-TNF Only,43392,positive,elderly,,booster2,18-Nov-21,12-Sep-21,67,mRNA,65,60 to 69
1650,male,CD,Anti-TNF Only,1000,positive,elderly,16,booster2,04-Feb-22,12-Aug-21,176,mRNA,65,60 to 69
1651,male,UC,Combination Therapy,827,positive,adult,,pre_dose,30-Mar-21,05-Oct-20,176,mRNA,59,50 to 59
1652,male,UC,Combination Therapy,1224,positive,adult,,booster1,31-Aug-21,26-Apr-21,127,mRNA,60,60 to 69
1653,male,UC,Combination Therapy,20099,positive,adult,,booster2,28-Jun-22,26-Apr-22,63,mRNA,61,60 to 69
1654,male,UC,Vedolizumab Only,59318,positive,adult,,booster1,24-Jul-21,01-May-21,84,vector,60,60 to 69
1655,male,UC,Anti-TNF Only,1119,positive,elderly,,booster1,19-Aug-21,08-Apr-21,133,mRNA,68,60 to 69
1656,male,UC,Anti-TNF Only,148,negative,elderly,,booster2,09-Mar-22,20-Oct-21,140,mRNA,69,60 to 69
1657,male,UC,Vedolizumab Only,1328,positive,adult,279,booster1,31-Jul-21,03-Feb-21,178,mRNA,62,60 to 69
1658,male,UC,Vedolizumab Only,69963,positive,elderly,97,booster2,29-Jan-22,20-Nov-21,70,mRNA,62,60 to 69
1659,male,UC,Vedolizumab Only,21391,positive,elderly,,booster2,21-May-22,22-Feb-22,88,mRNA,63,60 to 69
1660,male,UC,Anti-TNF Only,1317,positive,elderly,,primary,21-May-21,22-Dec-20,150,mRNA,65,60 to 69
1661,male,UC,Anti-TNF Only,1416,positive,elderly,,booster2,01-Feb-22,28-Aug-21,157,mRNA,66,60 to 69
1662,male,UC,Anti-TNF Only,456,positive,elderly,,booster2,26-Apr-22,30-Oct-21,178,mRNA,66,60 to 69
1663,male,UC,Anti-TNF Only,2315,positive,elderly,,booster2,10-Jun-22,03-Mar-22,99,mRNA,66,60 to 69
1664,male,CD,Ustekinumab Only,33623,positive,adult,,primary,20-Apr-21,11-Jan-21,99,vector,61,60 to 69
1665,male,CD,Ustekinumab Only,8589,positive,adult,,booster1,13-Jul-21,17-Apr-21,87,vector,62,60 to 69
1666,male,CD,Ustekinumab Only,42290,positive,elderly,,booster1,24-Dec-21,07-Oct-21,78,vector,62,60 to 69
1667,male,CD,Ustekinumab Only,40610,positive,elderly,,booster2,02-Feb-22,05-Dec-21,59,vector,62,60 to 69
1668,male,CD,Ustekinumab Only,1134,positive,elderly,,booster2,26-May-22,11-Nov-21,196,vector,62,60 to 69
1669,female,UC,Anti-TNF Only,681,positive,adult,,pre_dose,09-Apr-21,30-Nov-20,130,mRNA,31,30 to 39
1670,female,CD,Ustekinumab Only,20872,positive,adult,,primary,10-Jun-21,30-Mar-21,72,vector,53,50 to 59
1671,female,CD,Ustekinumab Only,1,negative,adult,,booster1,07-Aug-21,09-Feb-21,179,vector,54,50 to 59
1672,female,CD,Ustekinumab Only,410,positive,adult,,booster1,21-Nov-21,04-Jul-21,140,vector,54,50 to 59
1673,female,CD,Ustekinumab Only,8922,positive,adult,,booster2,15-Dec-21,14-Sep-21,92,vector,54,50 to 59
1674,female,CD,Ustekinumab Only,788,positive,adult,,booster2,12-Apr-22,22-Dec-21,111,vector,54,50 to 59
1675,female,CD,Ustekinumab Only,26905,positive,adult,,booster2,18-May-22,13-Feb-22,94,vector,54,50 to 59
1676,male,UC,Corticosteroids,63618,positive,elderly,400,booster1,30-Mar-21,30-Dec-20,90,mRNA,62,60 to 69
1677,male,UC,Corticosteroids,500,positive,elderly,281,booster1,27-Jul-21,22-Mar-21,127,mRNA,63,60 to 69
1678,male,UC,Corticosteroids,11,negative,elderly,155,booster2,30-Nov-21,19-May-21,195,mRNA,63,60 to 69
1679,male,UC,Corticosteroids,19599,positive,elderly,,booster2,04-Feb-22,06-Nov-21,90,mRNA,63,60 to 69
1680,male,UC,Corticosteroids,1213,positive,elderly,8,booster2,26-Apr-22,07-Dec-21,140,mRNA,63,60 to 69
1681,female,CD,Anti-TNF Only,54707,positive,elderly,,booster1,15-Jun-21,23-Apr-21,53,mRNA,64,60 to 69
1682,female,CD,Anti-TNF Only,77371,positive,elderly,,booster1,24-Sep-21,02-Aug-21,53,mRNA,64,60 to 69
1683,female,CD,Anti-TNF Only,544,positive,elderly,,booster2,04-Jan-22,09-Aug-21,148,mRNA,64,60 to 69
1684,female,CD,Anti-TNF Only,1201,positive,elderly,,booster2,16-Apr-22,29-Oct-21,169,mRNA,65,60 to 69
1685,female,CD,Anti-TNF Only,194,negative,elderly,,booster2,25-Jun-22,21-Dec-21,186,mRNA,65,60 to 69
1686,female,CD,Combination Therapy,8445,positive,elderly,,primary,25-May-21,03-Apr-21,52,vector,65,60 to 69
1687,female,CD,Combination Therapy,74376,positive,elderly,,booster1,20-Jul-21,23-Apr-21,88,vector,65,60 to 69
1688,female,CD,Combination Therapy,829,positive,elderly,,booster2,09-Dec-21,22-Aug-21,109,vector,65,60 to 69
1689,male,CD,Vedolizumab Only,22477,positive,elderly,,primary,22-May-21,27-Feb-21,84,mRNA,69,60 to 69
1690,male,CD,Vedolizumab Only,76199,positive,elderly,,booster1,23-Jun-21,22-Mar-21,93,mRNA,69,60 to 69
1691,male,CD,Vedolizumab Only,9,negative,elderly,,booster2,09-Nov-21,26-Jul-21,106,mRNA,70,70+
1692,male,CD,Vedolizumab Only,82,negative,elderly,,booster2,23-Feb-22,25-Sep-21,151,mRNA,70,70+
1693,male,CD,Vedolizumab Only,3588,positive,elderly,,booster2,06-May-22,15-Mar-22,52,mRNA,70,70+
1694,female,CD,Anti-TNF Only,39264,positive,adult,,primary,25-May-21,21-Feb-21,93,vector,50,50 to 59
1695,female,CD,Anti-TNF Only,1073,positive,adult,,booster1,06-Jul-21,04-Mar-21,124,vector,50,50 to 59
1696,female,CD,Anti-TNF Only,2662,positive,adult,,booster1,16-Oct-21,31-Jul-21,77,vector,51,50 to 59
1697,female,CD,Anti-TNF Only,24151,positive,adult,,booster2,22-Jan-22,03-Dec-21,50,vector,51,50 to 59
1698,female,UC,Ustekinumab Only,266,positive,adult,,primary,12-Jun-21,29-Dec-20,165,mRNA,62,60 to 69
1699,female,UC,Ustekinumab Only,57668,positive,adult,,booster1,20-Jul-21,12-Apr-21,99,mRNA,62,60 to 69
1700,female,UC,Ustekinumab Only,155,negative,elderly,355,booster2,09-Dec-21,07-Jun-21,185,mRNA,62,60 to 69
1701,female,UC,Ustekinumab Only,757,positive,elderly,232,booster2,30-Mar-22,11-Nov-21,139,mRNA,63,60 to 69
1702,female,UC,Ustekinumab Only,56295,positive,elderly,,booster2,24-May-22,16-Feb-22,97,mRNA,63,60 to 69
1703,female,CD,Corticosteroids,283,positive,elderly,,primary,04-May-21,28-Oct-20,188,mRNA,76,70+
1704,female,CD,Corticosteroids,73494,positive,elderly,,booster1,06-Aug-21,22-May-21,76,mRNA,76,70+
1705,female,CD,Corticosteroids,623,positive,elderly,,booster2,17-Nov-21,16-May-21,185,mRNA,76,70+
1706,female,CD,Corticosteroids,1455,positive,elderly,,booster2,22-Apr-22,12-Nov-21,161,mRNA,77,70+
1707,male,CD,Anti-TNF Only,1194,positive,adult,,booster1,01-Sep-21,17-Apr-21,137,mRNA,54,50 to 59
1708,female,CD,Vedolizumab Only,968,positive,elderly,,primary,24-Jun-21,13-Mar-21,103,mRNA,67,60 to 69
1709,female,CD,Vedolizumab Only,745,positive,elderly,355,booster1,15-Jul-21,18-Feb-21,147,mRNA,67,60 to 69
1710,female,CD,Vedolizumab Only,1420,positive,elderly,,booster1,27-Nov-21,05-Jun-21,175,mRNA,67,60 to 69
1711,female,CD,Vedolizumab Only,198,negative,elderly,,booster2,27-May-22,12-Jan-22,135,mRNA,68,60 to 69
1712,female,CD,Combination Therapy,38515,positive,elderly,,primary,27-May-21,11-Mar-21,77,mRNA,70,70+
1713,female,CD,Combination Therapy,29,negative,elderly,,booster1,28-Aug-21,10-Apr-21,140,mRNA,70,70+
1714,female,CD,Combination Therapy,822,positive,elderly,,booster2,19-Nov-21,19-Jul-21,123,mRNA,71,70+
1715,female,CD,Combination Therapy,1095,positive,elderly,,booster2,10-Mar-22,09-Sep-21,182,mRNA,71,70+
1716,male,UC,Vedolizumab Only,16355,positive,adult,,primary,28-May-21,05-Apr-21,53,mRNA,62,60 to 69
1717,male,UC,Vedolizumab Only,17110,positive,adult,,booster1,06-Aug-21,30-Apr-21,98,mRNA,62,60 to 69
1718,male,UC,Vedolizumab Only,1455,positive,elderly,,booster1,24-Nov-21,01-Aug-21,115,mRNA,62,60 to 69
1719,male,UC,Vedolizumab Only,1319,positive,elderly,232,booster2,26-Feb-22,14-Oct-21,135,mRNA,62,60 to 69
1720,male,UC,Vedolizumab Only,603,positive,elderly,,booster2,29-Apr-22,23-Oct-21,188,mRNA,63,60 to 69
1721,male,CD,Vedolizumab Only,33313,positive,adult,,primary,15-May-21,14-Feb-21,90,mRNA,56,50 to 59
1722,male,CD,Vedolizumab Only,53677,positive,adult,,booster1,10-Jul-21,13-Apr-21,88,mRNA,56,50 to 59
1723,male,CD,Vedolizumab Only,755,positive,adult,,booster2,30-Oct-21,19-Apr-21,194,mRNA,56,50 to 59
1724,male,CD,Vedolizumab Only,1479,positive,adult,,booster2,16-Apr-22,21-Oct-21,177,mRNA,56,50 to 59
1725,female,CD,Anti-TNF Only,1097,positive,adult,,primary,26-Jun-21,17-Feb-21,129,mRNA,23,18 to 29
1726,female,CD,Anti-TNF Only,879,positive,adult,,booster1,24-Jul-21,06-Mar-21,140,mRNA,23,18 to 29
1727,female,CD,Anti-TNF Only,390,positive,adult,,booster2,05-Mar-22,17-Sep-21,169,mRNA,24,18 to 29
1728,female,CD,Anti-TNF Only,134,negative,adult,,booster2,07-Apr-22,23-Sep-21,196,mRNA,24,18 to 29
1729,female,CD,No Immunosuppressives,823,positive,elderly,,primary,06-May-21,26-Nov-20,161,mRNA,64,60 to 69
1730,female,CD,No Immunosuppressives,224,positive,elderly,,booster1,22-Jul-21,09-Jan-21,194,mRNA,64,60 to 69
1731,female,CD,No Immunosuppressives,20133,positive,elderly,,booster1,01-Jan-22,04-Nov-21,58,mRNA,64,60 to 69
1732,female,CD,No Immunosuppressives,60624,positive,elderly,,booster2,05-Feb-22,01-Dec-21,66,mRNA,64,60 to 69
1733,female,CD,No Immunosuppressives,659,positive,elderly,,booster2,24-May-22,29-Jan-22,115,mRNA,65,60 to 69
1734,male,UC,Immunomodulator Only,1451,positive,adult,,primary,05-Jun-21,18-Jan-21,138,vector,57,50 to 59
1735,male,UC,Immunomodulator Only,865,positive,adult,,booster1,19-Aug-21,10-Apr-21,131,vector,57,50 to 59
1736,male,UC,Immunomodulator Only,368,positive,adult,,booster2,11-Feb-22,10-Aug-21,185,vector,58,50 to 59
1737,male,UC,Immunomodulator Only,979,positive,adult,,booster2,23-Apr-22,14-Nov-21,160,vector,58,50 to 59
1738,male,CD,Corticosteroids,233,positive,adult,,pre_dose,07-Apr-21,01-Nov-20,157,mRNA,55,50 to 59
1739,male,CD,Corticosteroids,842,positive,adult,,primary,20-May-21,09-Nov-20,192,mRNA,55,50 to 59
1740,male,CD,Corticosteroids,1185,positive,adult,,booster1,08-Jul-21,31-Dec-20,189,mRNA,55,50 to 59
1741,male,CD,Corticosteroids,6505,positive,adult,,booster2,15-Oct-21,23-Aug-21,53,mRNA,56,50 to 59
1742,male,CD,Corticosteroids,76837,positive,adult,,booster2,16-Mar-22,22-Jan-22,53,mRNA,56,50 to 59
1743,male,CD,Corticosteroids,51933,positive,adult,,booster2,18-Jun-22,17-Mar-22,93,mRNA,56,50 to 59
1744,male,CD,Combination Therapy,18973,positive,adult,44,pre_dose,21-May-21,29-Mar-21,53,mRNA,36,30 to 39
1745,male,CD,Combination Therapy,1936,positive,adult,,primary,04-Jul-21,30-Mar-21,96,mRNA,36,30 to 39
1746,female,UC,Tofacitinib Only,594,positive,adult,,primary,10-Jun-21,24-Feb-21,106,mRNA,25,18 to 29
1747,female,UC,Tofacitinib Only,1120,positive,adult,,booster1,05-Aug-21,17-Mar-21,141,mRNA,25,18 to 29
1748,female,UC,Tofacitinib Only,53140,positive,adult,,booster1,05-Jan-22,11-Nov-21,55,mRNA,26,18 to 29
1749,female,UC,Tofacitinib Only,69963,positive,adult,,booster2,15-Feb-22,07-Dec-21,70,mRNA,26,18 to 29
1750,male,UC,Anti-TNF Only,1125,positive,elderly,,booster1,10-Jun-21,26-Nov-20,196,mRNA,68,60 to 69
1751,male,UC,Anti-TNF Only,89,negative,elderly,,booster1,30-Sep-21,19-Apr-21,164,mRNA,69,60 to 69
1752,male,UC,Anti-TNF Only,712,positive,elderly,,booster2,19-Mar-22,08-Oct-21,162,mRNA,69,60 to 69
1753,female,CD,Vedolizumab Only,1122,positive,adult,396,primary,30-Jun-21,14-Jan-21,167,mRNA,38,30 to 39
1754,female,CD,Vedolizumab Only,815,positive,adult,229,booster2,14-Dec-21,26-Jul-21,141,mRNA,39,30 to 39
1755,female,CD,Vedolizumab Only,52250,positive,adult,117,booster2,05-Apr-22,31-Jan-22,64,mRNA,39,30 to 39
1756,female,UC,Anti-TNF Only,,,elderly,,primary,11-May-21,02-Mar-21,70,mRNA,65,60 to 69
1757,female,UC,Anti-TNF Only,1453,positive,elderly,,booster1,13-Jul-21,19-Mar-21,116,mRNA,65,60 to 69
1758,female,UC,Anti-TNF Only,1433,positive,elderly,,booster2,13-Jan-22,16-Sep-21,119,mRNA,66,60 to 69
1759,female,UC,Anti-TNF Only,69221,positive,elderly,,booster2,12-May-22,18-Feb-22,83,mRNA,66,60 to 69
1760,male,CD,Ustekinumab Only,1307,positive,elderly,,primary,05-Aug-21,16-Mar-21,142,vector,62,60 to 69
1761,female,UC,Immunomodulator Only,48803,positive,adult,,primary,15-Jun-21,24-Mar-21,83,mRNA,24,18 to 29
1762,female,UC,Immunomodulator Only,208,positive,adult,,booster1,03-Aug-21,14-Apr-21,111,mRNA,24,18 to 29
1763,female,UC,Immunomodulator Only,825,positive,adult,,booster1,27-Nov-21,05-Aug-21,114,mRNA,25,18 to 29
1764,female,CD,Combination Therapy,53377,positive,adult,,primary,18-May-21,14-Feb-21,93,mRNA,59,50 to 59
1765,female,CD,Combination Therapy,180,negative,adult,,booster1,10-Aug-21,19-Mar-21,144,mRNA,59,50 to 59
1766,female,CD,Combination Therapy,972,positive,adult,,booster2,21-Jan-22,10-Jul-21,195,mRNA,59,50 to 59
1767,female,CD,Ustekinumab Only,708,positive,adult,300,booster1,21-May-21,28-Nov-20,174,mRNA,24,18 to 29
1768,female,CD,Ustekinumab Only,348,positive,adult,182,booster1,16-Sep-21,29-Mar-21,171,mRNA,25,18 to 29
1769,male,CD,Combination Therapy,8101,positive,adult,,primary,11-Jun-21,16-Apr-21,56,mRNA,55,50 to 59
1770,male,CD,Combination Therapy,63830,positive,adult,79,booster1,21-Jul-21,25-May-21,57,mRNA,55,50 to 59
1771,male,CD,Combination Therapy,1061,positive,adult,133,booster2,18-Feb-22,30-Aug-21,172,mRNA,55,50 to 59
1772,male,CD,Combination Therapy,1150,positive,adult,259,booster2,24-Jun-22,19-Feb-22,125,mRNA,56,50 to 59
1773,male,CD,Combination Therapy,1200,positive,adult,,booster1,11-Jul-21,18-Jan-21,174,mRNA,33,30 to 39
1774,male,CD,Combination Therapy,585,positive,adult,,booster1,03-Oct-21,29-May-21,127,mRNA,33,30 to 39
1775,female,CD,Combination Therapy,783,positive,adult,,primary,25-Jun-21,28-Dec-20,179,vector,23,18 to 29
1776,female,CD,Combination Therapy,994,positive,adult,,booster1,20-Aug-21,29-Mar-21,144,vector,23,18 to 29
1777,female,CD,Anti-TNF Only,521,positive,elderly,341,booster1,11-May-21,12-Nov-20,180,mRNA,81,70+
1778,male,CD,Vedolizumab Only,20151,positive,elderly,,booster1,06-May-21,02-Mar-21,65,mRNA,78,70+
1779,male,CD,Vedolizumab Only,26672,positive,elderly,,booster1,22-Oct-21,14-Aug-21,69,mRNA,78,70+
1780,female,UC,No Immunosuppressives,11465,positive,adult,,primary,26-May-21,06-Apr-21,50,mRNA,50,50 to 59
1781,female,UC,No Immunosuppressives,70506,positive,adult,,booster1,31-Jul-21,12-May-21,80,mRNA,50,50 to 59
1782,female,CD,Anti-TNF Only,918,positive,adult,,booster1,14-Jul-21,12-Jan-21,183,mRNA,53,50 to 59
1783,female,CD,Anti-TNF Only,1280,positive,adult,,booster2,19-Oct-21,30-Jun-21,111,mRNA,54,50 to 59
1784,female,CD,Anti-TNF Only,820,positive,adult,,booster2,04-Feb-22,10-Sep-21,147,mRNA,54,50 to 59
1785,female,CD,Anti-TNF Only,1175,positive,adult,,booster2,11-May-22,06-Nov-21,186,mRNA,54,50 to 59
1786,male,CD,Ustekinumab Only,627,positive,adult,,primary,05-Jun-21,22-Feb-21,103,vector,60,60 to 69
1787,male,CD,Ustekinumab Only,318,positive,adult,,booster1,11-Aug-21,23-Jan-21,200,vector,60,60 to 69
1788,male,CD,Ustekinumab Only,1492,positive,adult,,booster1,01-Dec-21,30-May-21,185,vector,61,60 to 69
1789,male,CD,Ustekinumab Only,532,positive,adult,,booster2,02-Apr-22,02-Nov-21,151,vector,61,60 to 69
1790,male,CD,Ustekinumab Only,296,positive,adult,,booster2,01-Jun-22,10-Jan-22,142,vector,61,60 to 69
1791,male,CD,No Immunosuppressives,57507,positive,adult,,booster1,05-May-22,07-Feb-22,87,mRNA,38,30 to 39
1792,male,CD,Corticosteroids,1188,positive,adult,,primary,25-May-21,28-Nov-20,178,vector,31,30 to 39
1793,male,CD,Corticosteroids,75659,positive,adult,,booster1,15-Jun-21,20-Apr-21,56,vector,31,30 to 39
1794,male,CD,Corticosteroids,31642,positive,adult,,booster2,14-Oct-21,23-Aug-21,52,vector,32,30 to 39
1795,male,CD,Corticosteroids,1077,positive,adult,,booster2,20-Jan-22,13-Jul-21,191,vector,32,30 to 39
1796,male,CD,Corticosteroids,54,negative,adult,,booster2,08-Jun-22,26-Jan-22,133,vector,32,30 to 39
1797,female,CD,Ustekinumab Only,28441,positive,adult,292,primary,03-Jun-21,17-Mar-21,78,mRNA,56,50 to 59
1798,female,CD,Ustekinumab Only,,,adult,229,booster1,05-Aug-21,30-May-21,67,mRNA,56,50 to 59
1799,female,CD,Ustekinumab Only,255,positive,adult,,booster1,04-Nov-21,17-Jun-21,140,mRNA,56,50 to 59
1800,female,CD,Ustekinumab Only,537,positive,adult,,booster2,24-Feb-22,05-Sep-21,172,mRNA,57,50 to 59
1801,female,CD,Anti-TNF Only,331,positive,adult,,primary,09-Jun-21,02-Jan-21,158,mRNA,34,30 to 39
1802,female,CD,Anti-TNF Only,543,positive,adult,,booster1,29-Jul-21,23-Jan-21,187,mRNA,34,30 to 39
1803,female,CD,Anti-TNF Only,15,negative,adult,,primary,01-Jun-21,27-Jan-21,125,mRNA,39,30 to 39
1804,female,CD,Anti-TNF Only,71712,positive,adult,,booster1,25-Aug-21,20-Jun-21,66,mRNA,40,40 to 49
1805,female,CD,Anti-TNF Only,440,positive,adult,,booster2,08-Feb-22,01-Aug-21,191,mRNA,40,40 to 49
1806,female,CD,Anti-TNF Only,66060,positive,adult,,booster2,25-Jun-22,02-May-22,54,mRNA,40,40 to 49
1807,male,CD,Ustekinumab Only,20576,positive,adult,,booster1,06-Jul-21,02-May-21,65,mRNA,20,18 to 29
1808,male,CD,Ustekinumab Only,898,positive,adult,,booster2,23-Feb-22,06-Sep-21,170,mRNA,20,18 to 29
1809,female,UC,Vedolizumab Only,246,positive,adult,,booster1,02-Jun-21,14-Dec-20,170,mRNA,58,50 to 59
1810,female,UC,Vedolizumab Only,1367,positive,adult,,booster1,30-Sep-21,22-Apr-21,161,mRNA,58,50 to 59
1811,female,UC,Vedolizumab Only,8,negative,adult,,booster2,30-Jun-22,06-Mar-22,116,mRNA,59,50 to 59
1812,male,UC,Vedolizumab Only,200,positive,adult,,booster1,04-Jun-21,08-Feb-21,116,mRNA,33,30 to 39
1813,male,UC,Vedolizumab Only,74,negative,adult,,booster1,19-Oct-21,01-Jun-21,140,mRNA,34,30 to 39
1814,female,CD,Combination Therapy,1488,positive,adult,,primary,27-May-21,02-Jan-21,145,mRNA,28,18 to 29
1815,female,CD,Combination Therapy,137,negative,adult,85,booster1,20-Aug-21,11-Feb-21,190,mRNA,28,18 to 29
1816,male,CD,Ustekinumab Only,23,negative,adult,,primary,26-Jun-21,07-Feb-21,139,mRNA,44,40 to 49
1817,male,CD,Ustekinumab Only,4257,positive,adult,,booster1,29-Sep-21,12-Jul-21,79,mRNA,44,40 to 49
1818,male,CD,Ustekinumab Only,412,positive,adult,,booster2,06-Apr-22,26-Sep-21,192,mRNA,45,40 to 49
1819,female,CD,Anti-TNF Only,729,positive,adult,,booster1,02-Jun-21,03-Feb-21,119,mRNA,32,30 to 39
1820,female,CD,Anti-TNF Only,2099,positive,adult,,booster1,06-Oct-21,16-Jul-21,82,mRNA,33,30 to 39
1821,female,CD,Anti-TNF Only,1325,positive,adult,,booster1,07-Aug-21,02-Apr-21,127,mRNA,51,50 to 59
1822,female,CD,Anti-TNF Only,725,positive,adult,,booster1,13-Nov-21,28-Jun-21,138,mRNA,51,50 to 59
1823,female,CD,Anti-TNF Only,206,positive,adult,,booster2,11-Mar-22,31-Oct-21,131,mRNA,52,50 to 59
1824,female,CD,Anti-TNF Only,612,positive,adult,,booster2,14-Jul-22,19-Feb-22,145,mRNA,52,50 to 59
1825,female,CD,Anti-TNF Only,608,positive,adult,,booster1,12-Jun-21,03-Mar-21,101,vector,54,50 to 59
1826,female,CD,Anti-TNF Only,754,positive,adult,,booster2,23-Oct-21,05-May-21,171,vector,55,50 to 59
1827,female,CD,Anti-TNF Only,72534,positive,adult,269,primary,22-May-21,22-Feb-21,89,mRNA,22,18 to 29
1828,female,CD,Anti-TNF Only,14951,positive,adult,223,booster1,07-Jul-21,18-May-21,50,mRNA,22,18 to 29
1829,male,CD,Anti-TNF Only,18370,positive,adult,,primary,03-Jun-21,44280,70,vector,34,30 to 39
1830,male,CD,Anti-TNF Only,520,positive,adult,,primary,28-Sep-21,44303,164,vector,35,30 to 39
1831,male,CD,Ustekinumab Only,39,negative,adult,,primary,04-Jun-21,31-Jan-21,124,mRNA,58,50 to 59
1832,male,CD,Ustekinumab Only,1340,positive,adult,,booster1,13-Aug-21,23-Feb-21,171,mRNA,58,50 to 59
1833,male,CD,Ustekinumab Only,1055,positive,adult,,booster2,21-Jan-22,10-Oct-21,103,mRNA,59,50 to 59
1834,male,CD,Ustekinumab Only,572,positive,adult,,booster2,28-Apr-22,23-Nov-21,156,mRNA,59,50 to 59
1835,female,CD,Anti-TNF Only,25093,positive,adult,31,pre_dose,04-May-21,14-Mar-21,51,mRNA,30,30 to 39
1836,female,CD,Anti-TNF Only,1011,positive,adult,60,primary,02-Jun-21,03-Dec-20,181,mRNA,30,30 to 39
1837,female,CD,Anti-TNF Only,50029,positive,adult,157,booster1,07-Sep-21,25-Jun-21,74,mRNA,30,30 to 39
1838,female,CD,Anti-TNF Only,1152,positive,adult,236,booster1,25-Nov-21,11-Jun-21,167,mRNA,30,30 to 39
1839,female,CD,Anti-TNF Only,31970,positive,adult,,booster2,25-Feb-22,26-Dec-21,61,mRNA,31,30 to 39
1840,male,CD,Anti-TNF Only,711,positive,adult,,primary,25-Jun-21,28-Dec-20,179,mRNA,57,50 to 59
1841,male,CD,Anti-TNF Only,1307,positive,adult,,booster1,04-Aug-21,05-Feb-21,180,mRNA,57,50 to 59
1842,male,CD,Anti-TNF Only,25156,positive,adult,,booster2,11-Dec-21,08-Oct-21,64,mRNA,57,50 to 59
1843,male,CD,Anti-TNF Only,438,positive,adult,,booster2,02-Mar-22,29-Aug-21,185,mRNA,57,50 to 59
1844,female,CD,Combination Therapy,33307,positive,adult,55,pre_dose,14-Apr-21,15-Feb-21,58,mRNA,27,18 to 29
1845,male,CD,Combination Therapy,1368,positive,elderly,,primary,06-May-21,18-Nov-20,169,vector,64,60 to 69
1846,male,CD,Combination Therapy,886,positive,elderly,,primary,10-Jun-21,08-Feb-21,122,vector,64,60 to 69
1847,male,CD,Combination Therapy,37617,positive,elderly,,booster1,07-Aug-21,12-Jun-21,56,vector,64,60 to 69
1848,male,CD,Combination Therapy,73088,positive,elderly,,booster2,08-Oct-21,30-Jul-21,70,vector,64,60 to 69
1849,male,CD,Combination Therapy,1354,positive,elderly,,booster2,22-Jan-22,11-Jul-21,195,vector,65,60 to 69
1850,male,CD,Combination Therapy,65956,positive,elderly,,booster2,11-Mar-22,11-Dec-21,90,vector,65,60 to 69
1851,male,CD,Combination Therapy,5513,positive,elderly,,booster2,01-Jul-22,18-Apr-22,74,vector,65,60 to 69
1852,female,CD,Ustekinumab Only,203,positive,adult,219,primary,22-Jun-21,14-Jan-21,159,mRNA,32,30 to 39
1853,female,CD,Ustekinumab Only,41583,positive,pediatric,184,booster1,27-Jul-21,17-May-21,71,mRNA,1,00 to 09
1854,female,CD,Ustekinumab Only,728,positive,pediatric,75,booster1,12-Apr-22,13-Nov-21,150,mRNA,2,00 to 09
1855,female,CD,Anti-TNF Only,64,negative,elderly,237,booster1,11-Sep-21,29-Apr-21,135,mRNA,65,60 to 69
1856,female,CD,Anti-TNF Only,291,positive,elderly,40,booster2,15-Jun-22,08-Feb-22,127,mRNA,66,60 to 69
1857,male,UC,Vedolizumab Only,367,positive,elderly,,booster1,05-Jun-21,04-Feb-21,121,mRNA,68,60 to 69
1858,male,UC,Vedolizumab Only,68367,positive,elderly,,booster1,24-Sep-21,05-Aug-21,50,mRNA,68,60 to 69
1859,male,UC,Vedolizumab Only,1245,positive,elderly,,booster2,19-Nov-21,09-May-21,194,mRNA,68,60 to 69
1860,male,UC,Vedolizumab Only,1360,positive,elderly,,booster2,12-Feb-22,26-Aug-21,170,mRNA,68,60 to 69
1861,male,UC,Vedolizumab Only,693,positive,elderly,,booster2,13-May-22,19-Nov-21,175,mRNA,69,60 to 69
1862,male,CD,Combination Therapy,232,positive,pediatric,101,primary,10-Jul-21,22-Mar-21,110,mRNA,3,00 to 09
1863,male,CD,Combination Therapy,1145,positive,pediatric,155,booster1,02-Sep-21,16-May-21,109,mRNA,12,10 to 17
1864,male,CD,Combination Therapy,60227,positive,pediatric,211,booster1,28-Oct-21,06-Aug-21,83,mRNA,15,10 to 17
1865,male,CD,Combination Therapy,13196,positive,pediatric,272,booster1,28-Dec-21,01-Oct-21,88,mRNA,12,10 to 17
1866,female,CD,Anti-TNF Only,1148,positive,pediatric,110,primary,01-Jun-21,14-Jan-21,138,mRNA,1,00 to 09
1867,female,CD,Anti-TNF Only,962,positive,pediatric,161,booster1,22-Jul-21,16-Feb-21,156,mRNA,2,00 to 09
1868,female,CD,Anti-TNF Only,197,negative,pediatric,273,booster2,11-Nov-21,18-May-21,177,mRNA,3,00 to 09
1869,female,CD,Anti-TNF Only,76655,positive,pediatric,,booster2,03-Mar-22,04-Jan-22,58,mRNA,4,00 to 09
1870,female,CD,Anti-TNF Only,751,positive,pediatric,,primary,02-Jun-21,15-Jan-21,138,mRNA,5,00 to 09
1871,female,CD,Anti-TNF Only,1092,positive,pediatric,,booster1,11-Aug-21,26-Feb-21,166,mRNA,6,00 to 09
1872,female,CD,Anti-TNF Only,1483,positive,pediatric,,booster1,21-Oct-21,31-May-21,143,mRNA,7,00 to 09
1873,female,UC,Vedolizumab Only,1351,positive,pediatric,316,booster1,20-Apr-21,27-Oct-20,175,mRNA,8,00 to 09
1874,female,UC,Vedolizumab Only,952,positive,pediatric,29,booster2,31-Mar-22,27-Oct-21,155,mRNA,9,00 to 09
1875,male,UC,Corticosteroids,17415,positive,elderly,257,primary,24-May-21,03-Apr-21,51,mRNA,63,60 to 69
1876,male,UC,Corticosteroids,940,positive,elderly,155,booster1,03-Sep-21,25-May-21,101,mRNA,63,60 to 69
1877,male,UC,Corticosteroids,9774,positive,elderly,76,booster2,21-Nov-21,30-Sep-21,52,mRNA,63,60 to 69
1878,male,UC,Corticosteroids,458,positive,elderly,36,booster2,13-Mar-22,26-Sep-21,168,mRNA,64,60 to 69
1879,female,UC,Vedolizumab Only,631,positive,elderly,,booster1,04-Sep-21,08-Mar-21,180,mRNA,79,70+
1880,female,UC,Vedolizumab Only,18484,positive,elderly,,booster2,19-Feb-22,19-Nov-21,92,mRNA,80,70+